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1. INTRODUCTION 
1.1.PLANT CELL WALLS 
Plant cell walls are usually divided into two categories: primary walls that surround growing 
cells or cells capable of growth and secondary walls that are thickened structures containing 
lignin and surrounding specialized cells, such as vessel elements or fiber cells. However, in 
reality all differentiated cells contain walls with distinct compositions, resulting in a spectrum 
of specialized cell walls with primary and secondary walls as two extremes.
1
 In the primary 
plant cell wall the most common carbohydrates are cellulose, hemicellulose and pectin. The 
cellulose microfibrils are linked via hemicellulosic tethers to form the cellulose-hemicellulose 
network which is embedded in the pectin matrix (Fig. 1). 
 
Fig.1. The plant cell wall diagram
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Pectins are a family of complex polysaccharides. The extracted pectin can be devided into 
homogalacturonan (HG), rhamnogalacturonan-I (RG-I), rhamnogalacturonan-II (RG-II) and 
xylogalacturonan (XGA).
3 
The different pectic polysaccharides are not separate molecules but 
covalently linked domains.
4
 Unbranched homopolymer chains of α(1→4) linked D-GalA are 
described as HG. The GalA residues of HG can be methyl-esterified at C-6 and carry acetyl 
groups on O-2 and O-3. XGA is a branched galacturonan with β-D-Xylp-(1→3) side chains.5,6 
The GalA residues of XGA can be methyl-esterified as in HG. Homogalacturonans can 
contain clusters of four different (heterooligomeric) side chains with very peculiar sugar 
residues (such as Api, AceA, Dha, and Kdo). These side chains, together with the 
approximately nine galacturonyl residues to which they are connected, are referred to as RG-
II.
7,8 
The RG-I is composed of the disaccharide unit galacturonic acid–rhamnose [(1→4)-α-D-
GalpA-(1→2)-α-L-Rhap-]n, 20–80% of the Rhap residues being substituted with neutral 
oligosaccharides, mainly arabinofuranose and galactose (α-L-Araf and β-D-Galp).9,10,11 
Furthermore, fucose, glucopyranuronic acid and 4-O-methylglucopyranuronic(α-l-Fucp, β-d-
GlcpA, and 4-O-methyl-β-d-GlcpA) can be found as terminal residues of the side chains (Fig. 
2). The galacturonyl residues can carry acetyl groups on O-2 and O-3. The branched RG-I 
domain is the so called “hairy region”. 
 
Fig. 2. Schematic structure of pectin. Pectin consists of four different types of 
polysaccharides, and their structures are shown.
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1.2. THE ROLE OF PECTIN 
 
The main role of pectin is to participate in giving physical strength to the plant and providing 
a barrier against the outside environment together with other polymers.
4
 Especially HG and 
RG-II are well known to be involved in strengthening the cell wall. The mechanical properties 
of HG and RG-II have been reviewed and described by Ryden at al. .
12 
Furthermore, HG plays 
additional roles besides pure mechanical support. Oligogalacturonides, i.e. α(1→4) linked 
oligomers of GalA, are well established to be part of a signaling cascade that senses wall 
degradation upon pathogen attack.
8,13
 In the plant cell wall these macromolecules assemble is 
in large networks, where different kinds of crosslinks between pectic molecules exist. Two 
unesterified HG chains can engage in a complex, in which the carboxyl groups of two GalA 
residues form a negatively charged pocket.
15
 This pocket can accommodate a Ca
2+
 cation.
16,17
 
The interaction through insertion of Ca
2+
 ions between the unesterified carboxyl groups of the 
galacturonosyl residues of two HG chains is shown (Fig.3 A). This regulation may prevent 
the formation of Ca
2+
-mediated interactions between HG regions and hence, the removal of 
arabinan may induce a stiffening of the cell wall. Furthermore, it was reported that two 
molecules of RG-II can complex with boron, forming a borate-diol ester (Fig.3 B).
17 
Only the 
apiofuranosyl residues of the 2-O-ethyl-D-Xyl-containing side chains in each of the subunits 
of the dimer participate in the cross-linking.
18 
Because RG-II is an integral part of HG, borate-
diol esters can cross-link two HG chains.
19 
Ishii at al. have reported, that certain cations, such 
as Ca
2+
, Pb
2+
, Sr
2+
, and La
3+
, promote dimer formation in vitro in a concentration- and pH-
dependent manner.
18
 The widespread occurrence of RG-II in the plant kingdom and its 
structural conservation indicate a distinct role in wall integrity for this constituent of pectin.
20
  
 
Fig.3.  A) Ca
2+
-mediated interactions between HG regions. B) HG molecules 
cross-linked by borate-diol esters. 
 
Compared with the numerous studies of HG and RG-II function, far less is known about the 
function of RG-I. Treatment of leaf epidermis with arabinanase resulted in blocking of the 
opening and closing of the stomata.
21
 Further evidence for the role of RG-I side chains in the 
physical properties of the wall come from the investigation of transgenic plants.
22  The elastic 
properties of the tubers were also altered, with a stiffening of the cell wall, as observed in 
stomatal cells.
22,23
 Absence of arabinan in the side chains of the pectic polysaccharides are 
strongly associated with cell walls of Nicotiana plumbaginifolia non-organogenic callus with 
loosely attached constituent cells.
24
 Willats et al. reviewed those different forms of RG-I,  
bearing either galactan or arabinan, occur in a developmental fashion at definite locations in 
the plant. The authors are suggest that those fragments have a specific function.
25
 The 
removal of RG-I arabinan side-chains by the expression of an apoplast-directed endo-1,5-α-
arabinanase resulted severe phenotypic changes in transgenic potato plants: the plants did not 
produce side shoots, flowers or stolons, and were unable to produce tubers.
26
 This information 
confirms the importance of RG-I fragments, but the specific arrangement and the 
biochemistry of the process are still undefined. 
1.3. PECTIN IN THE HUMAN DIET 
The development of isolation, purification and characterization methods during the last 25 
years made it possible to investigate a biochemical basis of traditional use pectic 
polysaccharides isolated from plant as immunostimulatory, antitumor, antimutagen or anti-
inflammatory agents.
27
 Pectin is used as natural food ingredient because of their gelling and 
thickening properties.
28
 Food applications of pectin have been revised exhaustively by 
Voragen et al..
29 
The ability of pectins to bind cations is due to the anionic character of non-
methyl esterified GalA residues. Pectins have also been employed as thickener, water binder 
and stabilizer in beverages and dairy products. The addition of pectic polysaccharides to the 
human diet has been shown to reduce the uptake of toxic metals, lhanthanides and actinides. 
Yablokov et al., writing in Chernobyl: Consequences of the Catastrophe for People and the 
Environment , that "adding pectin preparations to the food of inhabitants of the Chernobyl-
contaminated regions promotes an effective excretion of incorporated  radionuclides´´. The 
authors report on the positive results of using pectin food additive preparations in a number of 
clinical studies conducted on children in severely polluted areas, with up to 50% improvement 
over control groups.
30
  
Pectin, as a soluble fiber, helps to lower LDL (low-density lipoprotein) levels, thereby helping 
balance cholesterol. Cholesterol belongs to the class of lipids. It is produced by the liver and 
found in diet, and helps body function. Due to modern diet several people have more 
cholesterol in the body than needed. The LDL transports cholesterol to all organs. This excess 
cholesterol can accumulate in organs and arteries and form plaque that can reduce the blood 
flow. The introduction of pectin in the human diet may well effect on the blood flow. 
It has been shown that the pectic polysaccharides play critical therapeutic roles against 
cancer.
31
 Modified pectin has been evaluated for the efficacy in cancer treatment. Their effect 
is suggested to be the ability to bind to cancer cell surface galectins (galactose-binding 
lectins) and cause mitochondrial disruption.
32,33,34
 
 
The presence of a rigid pectin gel inside the particulates imparts a stronger and more stable 
vehicle in acidic and alkaline solutions, which could prolong drug release. This particulate 
system may have potential use as a carrier for drugs which are poorly absorbed after oral 
employ.
35,36
 
All those positive effects belongs to pectin fragments, but which kind of fragments are 
responsible for the exact biological activity has not been clearly defined yet. Isolation of HG, 
RG-I, RG-II or XGA separate fragments from natural materials is difficult. The discovery of 
new molecular tools for biosynthesis could lead to advances for the use of pectin in the future.  
The new methods for synthesize of pectin fragments are requested to investigate the 
structural-biological activity relationship and to elucidate the biological role of pectin in cell 
wall. 
 
1.4 OBJECTIVES 
It has been shown that pectin fragments play significant roles in biology of plants and that 
they have positive effects on human health. The repeating unit of pectin fragments are often 
linked by α(1→4) or α(1→2) glycosidic bonds between D-galacturonic acid itself and L-
rhamnose residues respectively. The synthesis of such homogalacturonan is based on two 
main strategies. Ogawa and Nakahara
 prepared α(1→4) linked galactose derivates.37,38 The 
primary hydroxyl groups were deprotected and converted by selective oxidation into carboxyl 
groups. The alternative way for the synthesis of homogalacturonan fragments is the 
preparation of glycosyl acceptors and donors directly synthesized from D-galacturonic acid, 
followed by the glycosylation.
39,40
 This seems to be advantageous in comparison to the 
approach involving D-galactose-derived intermediates, because the crucial oxidation step can 
be avoided.
41
  
In our working group the synthesis of modules starting from D-galacturonic acid have been 
investigated for synthesizing homogalacturonan and rhamnogalacturonan-I fragments by 
modular design principle.
42
 This type of blockwise build-up of homogalacturonan and 
rhamnogalacturonan fragments is based on an orthogonal protecting group strategy.
42
  
To realize α(1→4) or α(1→2) linkages between D-galacturonic acid itself and L-rhamnose 
residues, D-galacturonic donors are needed, which carry at the 2-position a nonparticipating 
protection group.
43,44
 On the other hand, to realize the blockwise synthesis oligomers of 
rhamnogalacturonates D-galacturonic  and L-rhamnose acceptors are needed which will be 
able to bind at 4-OH and 2-OH with aforementioned donors, respectively. Based on the 
current knowledge the following tasks should be performed in this work: 
 
 Preparation of a new glycosyl donor and acceptor derived from D-galacturonic acid 
 Preparation of  a new rhamnosyl acceptor and donor derived from L-rhamnose 
 Synthesis of RG-I fragments by modular design principle using new modules 
 Synthesis of RG-I fragments bearing a D-galactose residue as a branching unit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. RESULTS AND DISCUSSION 
2.1. IMPROVED SYNTHESIS OF ALLYL GALACTOPYRANOSIDURONATE BUILDING BLOCK 9 
SUITABLE FOR MODULAR DESIGN PRINCIPLE 
Following our modular design principle strategy a D-galacturonic acid derivative was needed 
suitable as glycosyl donor and as glycosyl acceptor. Required glycosyl acceptor and donor 
could be synthesized from monosaccharide compound 9 in one and two steps, respectively. In 
our working group the preparation of the key compound 9 and some other similar 
galacturonic acid derivatives were previously shown starting directly from commercially 
available D-galacturonic acid (Scheme 1).
41,45
 
 
Scheme 1. Synthesis of allyl galactopyranosiduronate building block suitable for modular 
design principle. (a) Ac2O, cat. 70% HClO4, 5 h, 0 
o
C→RT (1, 85%); (b) ethereal CH2N2, 
CHCl3, 1 h, RT (2, 95%); (c) 40% HBr in AcOH, 3 h, 0 
o
C→RT (3, 90%); (d) Hg(CN)2, 
HgBr2, AllOH, MS 3Å, 12 h, RT (4, 91%); (e) KH2PO4-Na2HPO4, EtOH-H2O, Acylase I 
(from hog kidney), 5 h, 25 
o
C (5, 95%); (f) BnO(HN=)CCl3, CH2Cl2-heptane, cat. FCSO3H, 2 
h, 20 
o
C (6, 62%); (g) 0.28 M methanolic HCl, 12 h, RT (7, 90%); (h) 1. n-Bu2SnO, toluene, 
reflux on Dean-Stark apparatus, 2 h, 2. n-Bu4NBr, BnBr, 60
o
C→85oC, 4 h (8, 58%); (i) Ac2O, 
pyridine, -20 
o
C to 20 
o
C, 5 h, Ar atmosphere (9, 90%). 
This synthesis
41,45
 started with tetra-O-acetyl-D-galactopyranuronic acid 1, which was earlier 
reported by Tajima and used by Steglich et al..
46,47
 Later, preparation of compound 1 in 85% 
yields was reported by the acetylation glacturonic acid with acetic anhydride in presence of 
perchloric acid.
48
 Esterification of compound 1 was achieved with diazomethane to provide 
compound 2 in 95% yield.
48
 The Helferich glycosylation with bromide 3, obtained by 
treatment of compound 2 with HBr in acetic acid (90%), led to the allyl glycoside 4 (91%).
41
 
Enzyme-catalyzed, regioselective deacetylation under optimized conditions gave compound 
5.
41
 The acid catalyzed benzylation
5,13
 achieved compound 6 in 62% yield.
41,49
 The 
deacetylation with methanolic 0.28 M HCl provided compound 7. Since the esters of 
galacturonic acid tend to undergo base-catalyzed β-elimination, most protection and 
deprotection operations were performed under acidic conditions.
50
 One exception was the 
regioselective benzylation of compound 7 via 3,4-O-butylstannyl intermediate, which gave 
the desired glycosyl acceptor 8 in 58% yield, together with benzyl ester in 25% yield as 
corresponding side product.
51,52
 This compound can also be used as acceptor in glycosylation 
reactions. Finally, acetylation with acetic anhydride in pyridine provided derivative 9 in 90% 
yield. In Carbohydrate Chemistry Proven Synthetic Methods we reported an improved 
synthesis of compound 9.
53
 Accordingly to the article,
53
 deacetylation of compound 4 with 
0.28 M methanolic HCl (90% yield)
42
 followed by treatment of product 10 with triethyl 
orthoacetat and regioselective opening of the orthoester structures formed 4-O-acetyl 
derivative 12 in 85% yield (Scheme 2).
52,54 
 
Scheme 2. Improved synthesis of allyl galactopyranosiduronate building block 9 suitable for 
modular design principle. (a) 0.28 M methanolic HCl, 24 h, RT (10, 90%); (b) H3C(OEt)3, cat. 
camphersulfonic acid, CH2Cl2, 1.5 h, RT, Ar atmosphere (11); (c) aq 95% AcOH, 10 min, RT 
(12, 85%); (d) BnO(HN=)CCl3, dioxane, TfOH, 15-30 min, 0 
o
C (9, 89%). 
Benzylation of compound 12 according to Madsen and Lauritsen gave the compound 9 in 
89% yield.
55
 Thus, compared to the former pathway, the overall yield of module 9 
significantly increased (from 18% to nearly 40%), the total number of synthetic steps was 
reduced from 9 to 7, and the formation of the benzyl ester as a side product of the conversions 
was avoided. In addition, every synthetic step led to a crystalline product, which makes the 
laboratory work more convenient.  
 
2.2. SYNTHESIS OF D-GALACTOPYRANOSIDURONATE ACCEPTOR 17 WITH SPACER 
Michael Heidelberger’s research proceeded along a clearly defined line from his and Osvald 
Avery’s finding in 1923 that type-specific antigens of pneumococcus bacteria were 
polysaccharides.
56
 Bacterial capsular polysaccharides are cell surface antigens composed of 
identical repeat units which form extended saccharide chains. Conjunction of polysaccharide 
antigens to thymus dependent antigens such as proteins enhances their immunogenicity. The 
protein stimulates carrier-specific T-helper cells which play a role in the induction of anti-
carbohydrate antibody synthesis.
56,57
 The development of vaccines, based on polysaccharides, 
has been going on for many years, and many studies are still in progress. Oligosaccharide and 
polysaccharide conjugates are reported to be immunogenic in infants and elicit a thymus 
dependent response.
58,59,60,61,62,63 Porro establish methods to couple esterified N. meningitidis 
oligosaccharides to carrier proteins.
64
 Tsay and Collins have been developed that  the 
conjugate vaccines containing polysaccharides of Pseudomonas aeruginosa coupled by the 
periodate procedure to detoxified protein from the same organism.
65 
Cryz and Furer used 
adipic acid dihydrazide as a spacer arm to produce conjugate vaccines against P. aeruginosa.
66 
We were interested in preparation of several pectin fragments with spacer, which can be 
connected with peptides in future. These conglomerates can then be used to produce 
monoclonal antibodies against carbohydrate structures.  
The Helferich glycosylation of bromide 3 with 2-(4-nitrophenoxy)ethanol in acetonitrile gave 
galactopyranosiduronate-spacer 13.  
 
 Scheme 3. Synthesis of a galactopyranosiduronate acceptor with spacer 17. (a) 2-(4-
nitrophenoxy)ethanol, Hg(CN)2, HgBr2, acetonitrile, MS 3Å, 12 h, RT (13, 86%); (b) 0.28 M 
methanolic HCl, 24 h, RT (14, 74%); (c) H3C(OEt)3, cat. camphersulfonic acid, CH2Cl2, 1.5 h, 
RT, Ar atmosphere, aq 95% AcOH, 10 min, RT (15, 92%); (d) BnO(HN=)CCl3, dioxane, 
TfOH, 15-30 min, 0 
o
C (16, 72%);(e) 0.28 M methanolic HCl, 24 h, RT (17, 88%). 
Accordingly to synthesis of compound 10, deacetylation of compound 13 with 0.28 M 
methanolic HCl (74% yield),
42
 followed by the treatment of product 14 with triethyl 
orthoacetat and regioselective opening of the orthoester structures, gave compound  15 with 
the acetyl group  in 4-O position (92% yield) (Scheme 3).
52,54 
Benzylation of compound 15 
with benzyl 2,2,2-trichloroacetimidate and cat. trifluoromethansulfonic acid gave compound 
16 in 72% yield. After deacetylation with 0.28 M methanolic HCl, acceptor 17 was obtained 
in 88% yield.  
 
 
Scheme 4. Galactopyranosiduronate with spacer suitable for coupling with protein 19. (a) 
Pd/C, H2, MeOH/EtOAc, 1h, RT (18, 90%); (b) thiophosgen, BaCO3, EtOH/H2O, 1 h, RT (19, 
77%); (c) LiOH, MeOH/H2O, 15 min, RT (20, 92%) 
 In evidence that such galactopyranosiduronate-spacer can be connect with proteins, the nitro-
group was converted into an amino-group by using hydrogenation in presence of PdCl2 to give 
compound 18 in 90% yield (Scheme 4). Isothiocyanates are a class of heteroallenic 
compounds which are a suitable functional group to get covalent connections with proteins.  
The amino-group of compound 18 was reacted with thiophosgen in an ethanol/water solution 
in the presence of BaCO3 as base to afford isothiocyanate 19 in 77% yield. The ester cleavage 
with lithium hydroxide in methanol/water solution was achieved
27
 to obtain galacturonic acid 
derivative 20 connected with the isothiocyanate-spacer  in 92% yield. Thus it seems to be sure 
that in future we can achieve the same reactions with larger pectin fragments caring 2-(4-
nitrophenoxy)ethyl group as a spacer. 
 
2.3. IMPROVED SYNTHESIS OF L-RHAMNOPYRANOSYL DONOR 27 
In addition to galacturonic acid donor and acceptor, a rhamnopyranosyl donor was needed for 
the synthesis of the repeating units of rhamnogalacturonan fragments. The preparation of 
several L-rhamnose derivatives were done before by co-workers in our laboratory.
68,69
 B. 
Nolting reported the synthesis of a series of rhamnopyranosyl donor.
68
 M. Farouk presented a 
simple approach to benzylated rhamnopyranosides with an O-acetyl group in 2-position.
69
 
This strategy was the perspective way for our purpose. The pathway started with acetylation 
of L-rhamnopyranose performed in acetanhydride with a small amount of perchloric acid. The 
exchange of the acetyl group in 1-position of compound 21 to form bromide 22 was achieved 
with 40% HBr solution in acetic acid according to literature.
70
 3,4-Di-O-acetyl-1,2-O-(1-exo-
ethoxyethyliden)-β-L-rhamnopyranose (23) was prepared by the reaction of bromide 22 with 
dry EtOH in the presence of sym-collidine  and tetra-n-butylammonium bromide (Scheme 
5).
71,69
 This procedure is extremely sensitive to water. For this reason, the reaction was carried 
out in the presence of molecular sieves and under an atmosphere of argon. Thus, the yield of  
compound 23 increased from 81% to 95%.  Compound 23 was deacetylated under Zemplén 
conditions. But the following neutralization with acid solution reduced the yield of the 
product, because the cyclic orthoester structure is extremely sensitive to acid. Instead of 
Zemplén conditions, deacetylation was done by refluxing 23 with KOH in dry toluene to 
obtain compound 24. Without further purification, the benzylation of compound 24 was 
achieved with benzylchloride in an one-pot reaction.
72
 
 Scheme 5. Improved synthesis of rhamnopyranosyl donor 27. (a) Ac2O, cat. 70% HClO4, 1.5 
h, 0 
oC→RT (21, 98%); (b) 40% HBr in AcOH, 40 min, 0 oC→RT (22, 96%); (c) EtOH, sym-
collidine   tetrabutylammonium bromide, MS 4Å, CH2Cl2, 9 h, RT, Ar atmosphere (23, 95%); 
(d) KOH, toluene, 20 min, under reflux (24); (e) BnCl, 2.5 h, under reflux (25, 88%); (f) 70% 
AcOH in H2O, 7 min, RT, Ac2O, pyridine, 1 h, 0 
o
C→RT (26, 83%); (g) oxalyl bromide, 
CH2Cl2, 4 h, -40 °C→RT (27, 96%). 
Compound 25 was obtained as a crystalline product after classical work up. In this case, the 
yield was increased from 82% to 88%.  In the 
1
H-NMR spectrum of compound 25, the 
exchange of the acetyl groups at O-3 and O-4 positions by benzyl groups caused a significant 
upfield shift (ca. 1.5 ppm) of the H-3 and H-4 ring protons. The X-ray diffraction studies of 
compound 25 established the configuration at C-1, C-2 and provided information on the 
1
C4 
chair conformation of the pyranose ring.
69
 The ring opening with 70% aq. acetic acid was 
followed by classical acetylation with acetic anhydride in pyridine to give compound 26 in 
83% yield. Purification by column chromatography provided the isomers 26α and 26β (69% 
and 14%, respectively). 
1
H-NMR study showed that the coupling constant between H-1 and 
H-2 of compound 26α is twice as big compared with compound 26β. The NOESY spectrum 
secures the configuration at 1-position of compounds 26α and 26β. Compound 26 can be used 
as a donor in coupling reaction with galacturonate acceptors in the presence of trimethylsilyl 
triflouromethanesulfonate.
73,74,75
 According to the procedure of Wessel and Bundle,
 
compound 26(α/β) was converted into bromide 27 in 96% yield.76 Compound 27 was unstable 
on storage and was used directly without further purification. Practical experience showed 
that it is better to use compound 27 instead of compound 26 as a donor to become higher yield 
in glycosylation reaction. 
 
2.4. SYNTHESIS OF RHAMNOPYRANOSYL ACCEPTOR 29 WITH SPACER 
We were interested in the preparationof a rhamnosyl acceptor, which have some similarity to 
galacturonate acceptor 17. The Helferich glycosylation of bromide 27 with 2-(4-
nitrophenoxy)ethanol in acetonitrile gave rhamnopyranosid-spacer 28 in 96% yield. Finally 
deacetylation of compound 28 with 0.28 M methanolic HCl gave acceptor 29 in 95% 
yield(Scheme 6).
42 
 
Scheme 6. Synthesis of rhamnopyranosyl acceptor 29 with spacer. (a) 2-(4-
nitrophenoxy)ethanol, Hg(CN)2, HgBr2, acetonitrile, MS 4Å, 12 h, RT (28, 96%); (b) 0.28 M 
methanolic HCl, 24 h, RT (29, 95%). 
Compound 21 as an acceptor can either used to get rhamnogalacturonan oligomers or with the 
spacer arm it has potential for coupling with proteins.  
2.5. SYNTHESIS OF A RHAMNOGALACTURONAN BUILDING BLOCK 30 SUITABLE FOR MODULAR 
DESIGN PRINCIPLE 
Our strategy for the synthesis of RG-I oligomers is based on the preparation of building 
blocks suitable for modular design principle.  To achieve this aim, monosaccharide module 9 
was deacetylated with 0.28 M methanolic HCl to provide acceptor 8 in 90% yield bearing 
only a free hydroxyl group in 4-position.  For the preparation of disaccharide module 30, 
bromide 27 was employed as glycosyl donor and coupled with the galacturonate acceptor 8 
(Scheme 7).  
 Scheme 7. Synthesis of a rhamnogalacturonan building block 30 suitable for modular design 
principle. (a) 0.28 M methanolic HCl, 24 h, RT (8, 90%); (b) Hg(CN)2, HgBr2, acetonitrile, 
MS 4Å, 24 h, RT (30, 67%). 
The Helferich glycosylation in the presence of mercuric cyanide and mercuric bromide 
provided compound 30 in 67% yield.
77,78
 In the 
1
H NMR spectrum the signified anomeric 
signals appeared for H-1´ proton at  = 5.22 ppm shows a coupling constant of 3J1´,2´ 1.9 Hz. 
Due to the manno-configuration of the donor, the stereochemical outcome of the 
glycosylation reaction cannot be only proven on the basis of chemical shift and the coupling 
constant 
3
J1´,2´.  The absence of a correlation between protons H-1´↔ H-5´ and H-1´↔ H-3´  
in a NOESY spectrum of compound 30 confirmed still the α(1→4) coupling. Now, this 
building block can be used as a donor or an acceptor due to the 2-O-acetyl group in the 
rhamnosyl residue and the O-allyl group in the galacturonic residue, respectively.  
 
 2.6 SYNTHESIS OF A RHAMNOGALACTURONAN ACCEPTOR 32 WITH A SPACER CONNECTED TO 
GALACTURONATE 
To furnish blockwise buildup of RG-I fragments with a spacer connected to the galacturonate 
moiety, acceptor 32 was synthesized (Scheme 8). The Helferich glycosylation between Donor 
27 and acceptor 17 in the presence of mercuric cyanide and mercuric bromide provided 
compound 31 in 68% yield.
77,78
 Deacetylation with 0.28 M methanolic HCl gave 
rhamnogalacturonan-spacer 32 in 87% yield. This compound can be used as an acceptor in 
consecutive blockwise buildup of rhamnogalacturonana fragments with spacer.  
 
 Scheme 8. Synthesis of a rhamnogalacturonan acceptor 32 with spacer connected to 
galacturonate. (a) Hg(CN)2, HgBr2, acetonitrile, MS 4Å, 24 h, RT (31, 68% α 15% β-is); (b) 
0.28 M methanolic HCl, 24 h, RT (32, 87%). 
 
2.7. SYNTHESIS OF A NEW GALACRURONIC DONOR 34 
After successful preparation of glycosyl acceptors for blokwise buildup of RG-I fragments a 
new galacturonate glycosyl donor 34 was synthesized (Scheme 9). 
 
Scheme 9. Synthesis of  galacturonate glycosyl donors 34 and 35. (a) PdCl2, AcOH, NaOAc, 
H2O, 3 h, 45 
o
C (33, 75%); (b) Cs2CO3, 2,2,2-trifluoro-N-phenyl-acetimidoyl chloride, 
acetone, 3 h, RT (34, 88%); (c) trichloroacetonitrile, cat. DBU, CH2Cl2, 2 h, -20 
o
C→RT (35, 
75%). 
 Compound 9 was converted to hemiacetal 33 with the aid of the system  
PdCl2/NaOAc/HOAc/H2O 
 
in 75% yield.
79
 In the 
1
H NMR spectrum, the assignment of the 
signals to  and   anomers, which appears in chloroform as an , mixture in a ratio of 4:1, 
is based on the vicinal couplings of protons H-1 and H-2. The doublet at  = 5.37 shows a 
coupling constant of 
3
J1,2 3.6 Hz (H-1) and the doublet at  = 4.69 has a coupling constant of 
3
J1,2 7.5 Hz (H-1),. In the 
1
C-NMR spectrum, deallylation was evidenced by the expected 
downfield shift of C-1  = 92.1 ppm and  = 97.4 ppm for α and β, respectively. To get an 
glycosyl donor from hemiacetal 33, which can allows stereoselective α(1→2) coupling, a new 
leaving group was introduced which has not been used for D-galacturonate donor before. 
Treatment of 33 with N-phenyltrifluoroacetimidoyl chloride
39
 in the presence of Cs2CO3 in 
acetone
40
 led to the formation of N-phenyltrifluoroacetimidate 34 which was isolated as an 
, mixture in a ratio of  1:5 in overall 88% yield.80,81,82 The anomeric proton signals 
appeared broadened at room temperature due to a dynamic process in the N-
phenyltrifluoroacetimidate moiety. Therefore, 
1
H NMR spectra were recorded at lower 
temperature to allow the assignment of the corresponding isomer signal. At –40 oC both 
anomeric signals appear as doublets at  = 6.83 ppm (3J1,2  3.3 Hz, H-1) and at  = 5.78 ppm 
(
3
J1,2  8.3 Hz, H-1), respectively. Accordingly to literature,
75,69
 D-galacturonate glycosyl 
donor 35 was synthesized as α/β mixture in a ratio of 3:1 in overall 75% yield. Earlier 
experiments using the α- or β-stereoisomers of the corresponding trichloroacetimidates have 
shown that the α- or β-configuration at the anomeric centre of such glycosyl donors had no 
influence on the stereoselectivity of the subsequent glycosylation reaction.
75
 Therefore the α/β 
mixture of compound 34 and 35 were used in glycosylation reactions. 
 
2.8. SYNTHESIS OF A RHAMNOGALACTURONAN ACCEPTOR 37 WITH A SPACER CONNECTED TO 
RHAMNOSE  
To compare the suitability of the leaving groups of donors 34 and 35 the disaccharide 36 was 
synthesized by using both glycosyl donors (Scheme 10). For the glycosylation reaction with 
glycosyl acceptor 29 an α/β (1:5) mixture of 34 was used. The reaction was started at -20 oC 
using TMSOTf as promoter. Disaccharide 36 was obtained in 85% yield as a α/β (20:1) 
mixture. In the 
1
H NMR spectrum of 36 proton H-1´ appears as a doublet at  = 5.08 ppm 
with a coupling constant 
3
J1´,2´ 3.6 Hz, proving an -linkage. This is also supported by the 
NOESY spectrum where no correlation was found between H-1´ and H-5´. The same 
disaccharide 36 was synthesized using glycosyl donor 35. The reaction was started at -70 
o
C 
using TMSOTf as promoter and gave compound 36 in 63% yield as a α/β (9:1) mixture. 
 Scheme 10. Synthesis of a rhamnogalacturonan acceptor 37 with a spacer connected to 
rhamnose. (a) via 34, cat. TMSOTf, MS 4Å, CH2Cl2, 3 h, -20 
o
C-RT (36, 85%), via 35, cat. 
TMSOTf, MS 4Å, CH2Cl2, 13 h, -70 
o
C-RT (36, 67%); (b) 0.28 M methanolic HCl, 24 h, RT 
(37, 90%). 
 
On the basis of these results it seems to be clear that the glycosyl donor 34 is better to use for 
glycosylation reactions compared with donor 35. The treatment of compound 36 with 0.28 M 
methanolic HCl gave acceptor 37 in 90% yield. 
 
2.9. SYNTHESIS OF RG-I TETRASACCHARIDE 45 BY MODULAR DESIGN PRINCIPLE  
To compare the suitability of the N-phenyltrifluroacetimidate and trichloracetimidate glycosyl 
donors higher RG-I derivatives were synthesized by using both donors. The working group 
Prof. Paulsen from Norway asked us to synthesize rhamnogalacturonan fragments for 
investigation of the bioactivity of these structures, which were observed as a motif of plants 
isolated from medicinal plants.
83 In the framework of this joint work a tetrasaccharide and 
hexasaccharide of rhamnogalacturonan fragments were synthesized for the investigation of 
the structure-bioactivity relationship. In order to achieve this aim, we used the strategy of 
blockwise build-up by modular design principle. After one or two steps modification of 
disaccharide module 30 can be used as an acceptor or as a donor, respectively.  Deacetylation 
of compound 30 with 0.28 M methanolic HCl gave acceptor 38 (Scheme 11). Compound 30 
was converted to hemiacetal 39 with the aid of the system PdCl2/NaOAc/HOAc/H2O in 76% 
yield.
79
 Treatment of 39 with N-phenyltrifluoroacetimidoyl chloride in the presence of 
Cs2CO3 in acetone led to the formation of N-phenyltrifluoroacetimidate 40 which was isolated 
as an , mixture in a ratio of  1:3 in 91% yield. The anomeric proton signals appeared 
broadened at room temperature due to a dynamic process in the N-phenyl trifluoroacetimidate 
moiety. Therefore, 
1
H NMR spectra were recorded at lower temperature to allow the 
assignment of the corresponding isomeric signals. At –40 oC, both anomeric signals appear as 
doublets, at  = 6.78 ppm (3J1,2  3.3 Hz, H-1) and at  = 5.70 ppm (
3
J1,2  8.3 Hz, H-1), 
respectively.  
 
Scheme 11. Synthesis of RG-I tetrasaccharide 45 by modular design principle. (a) 0.28 M 
methanolic HCl, 24 h, RT (38, 90%); (b) PdCl2, AcOH, NaOAc, H2O, 2.5 h, 45 
o
C (39, 76%); 
(c) Cs2CO3, 2,2,2-trifluoro-N-phenyl-acetimidoyl chloride, acetone, 3 h, RT (40, 91%); (d) 
trichloroacetonitrile, cat. DBU,  CH2Cl2, 2 h, -20 
o
C→RT (41, 67%); (e) via 40, cat. TMSOTf, 
MS 4Å, CH2Cl2, 3 h, -20 
o
C→RT (42, 90%), via 41, cat. TMSOTf, MS 4Å, CH2Cl2, 13 h, -70 
o
C→RT (42, 67%); (f) 0.28 M methanolic HCl, 24 h, RT (43, 86%); (g) Pd/C, H2, MeOH, 24 
h, RT (44, 97%); (h) LiOH, MeOH, H2O, 15 min, RT (45, 92%). 
Accordingly to literature,
35
 the D-galacturonate glycosyl donor 41 was synthesized. To 
compare the suitability of the leaving groups in the glycosyl donors, the disaccharide 42 was 
synthesized via 40 and via 41. The α/β- mixture of donor 41 and acceptor 38 in the presence 
of TMSOTf as promoter gave tetrasaccharide 42 in 90% yield. In the 
1
H NMR spectrum of 
compound 42, the proton H-1´´ appears as doublet at  = 4.98 ppm 3J1´´,2´´ 3.6 Hz proving an 
-linkage. However, the deacetylation of compound 42 with 0.28 M methanolic HCl gave 
acceptor 43. In the 
1
H NMR spectrum of compound 43 proton H-1´´ appears as a doublet at  
= 5.02 ppm with a coupling constant 
3
J1´´,2´´ 3.6 Hz, proving an -linkage too. In the 
13
C NMR 
spectrum the signal at  = 96.5 ppm for C-1´´ confirms an -linkage, too. This is also 
supported by the NOESY spectrum where no correlation was found between H-1´´ and H-5´´. 
The glycosylation between donor 41 and acceptor 38 in presence of TMSOTf as promoter 
gave tetrasaccharide 42 in 67% yield. 
These results confirm the effectivity of of N-phenyl trifluoroacetimidate as a new leaving 
group for glycosylation reaction again. 
The benzyl protecting groups of compound 43 were removed by hydrogenolysis over Pd/C to 
obtain the propyl glycoside 44 in 97% yield. The compound 44 has been sent to colleague 
from Norway for their biological tests. The ester cleavage with lithium hydroxide in 
methanol/water solution gave fully deprotected tetrasaccharide 45 in 92% yield.
68 
 
2.10. SYNTHESIS OF RG-I HEXASACCHARIDE 49 BY MODULAR DESIGN PRINCIPLE 
Our strategy adopted for the synthesis of rhamnogalacturonan-I fragments was extended for 
the synthesis of higher rhamnogalacturonan-I oligomers. In the next phase of our 
collaboration with our Norwegian colleagues, the hexasaccharide 46 was synthesized with 
acceptor 43 and donors 40 or 41 (Scheme 12). The donor 40 and acceptor 43 in the presence 
of TMSOTf as promoter gave hexasaccharide 46 in 79% yield. In the 
1
H NMR spectrum of 
tetrasaccharide 46 proton H-1´´´´ appears as an overlapped multiplet at  = 4.98 ppm with a 
proton from CH2Ph. Because of that the coupling constant 
3
J1´´,2´´ could not be determined and 
can not prove an -linkage. But, in the 13C NMR spectrum the signal at  = 96.6 ppm for C-
1´´´´ confirms an -linkage. This is also supported by the NOESY spectrum where no 
correlation was found between H-1´´´´ and H-5´´´´. The glycosylation using donor 41 and 
acceptor 43 gave hexasaccharide 46 in 60% yield. Deacetylation of compound 46 with 0.28 M 
methanolic HCl provided compound 47 in 93% yield.  
 
 
Scheme 12. Synthesis of RG-I hexasaccharide 49 by modular design principle. (a) via 40, cat. 
TMSOTf, MS 4Å, CH2Cl2, 3 h, -20 
o
C-RT (46, 79%), via 41, cat. TMSOTf, MS 4Å, CH2Cl2, 
13 h, -70 
o
C-RT (46, 60%); (b) 0.28 M methanolic HCl, 24 h, RT (47, 93%); (g) Pd/C, H2, 
MeOH, 28 h, RT (48, 95%); (h) LiOH, MeOH, H2O, 15 min, RT (49, 93%). 
The cleavage of the benzyl protecting groups of compound 47 by hydrogenolysis over Pd/C 
provided propyl glycoside 48 in 95% yield. The ester cleavage with lithium hydroxide in 
methanol/water solution gave hexasaccharide 49 in 93% yield.
68
 The hexasacchride 49 was 
used by the colleagues from Norway for their biological tests. 
 
2.11. SYNTHESIS OF RG-I TETRASACCHARIDE 50 BY MODULAR DESIGN PRINCIPLE CONNECTED 
TO A SPACER 
Following our modular design principle the rhamnogalacturonana-I tetrasaccharide 50 was 
synthesized (Scheme 13). Because of the better yields in former glycosylation reactions, only 
compound 40 was used as donor for this synthesis. The donor 40 and acceptor 32 in presence 
of TMSOTf as a promoter provided compound 50 in 77% yield. In the 
1
H NMR spectrum of 
50 proton H-1´´ appears as a doublet at  = 4.97 ppm with a coupling constant 3J1´´,2´´ 3.6 Hz 
confirms an -linkage. In the 13C NMR spectrum the signal at  = 96.7 ppm for C-1´´ 
confirms an -linkage, too. This is also supported by the NOESY spectrum where no 
correlation was found between H-1´´ and H-5´´. 
 
Scheme 13. Synthesis of RG-I tetrasaccharide 50 by modular design principle connected to a 
spacer. (a) cat. TMSOTf, MS 4Å, CH2Cl2, 3 h, -20 
o
C-RT(50, 77%). 
After selective deacetylation, compound 50 may be used as an acceptor similar to compound 
43 to obtain higher RG-I fragments, connected with a spacer. Additionaly, compound 50 may 
be used for immunological studies after cleavage of all protecting groups and conversion of 
the nitro group into an isothiocyanate group and coupling of this oligosaccharide with protein. 
 
2.12. SYNTHESIS OF GALACTOPYRANOSYL-RHAMNOPYRANOSIDE BUILDING BLOCK 56 
 BEARING A D-GALACTOSE RESIDUE AS A BRANCHING UNIT 
Highly branched pectins, which are comprised of a rhamnogalacturonan (RG-I) backbone 
carrying galactan and arabinan side-chains, are generally referred to as hairy regions. The 
backbone of the RG-I polymer is composed of repeating units of the disaccharide [→ 2)-L-
Rha-α(1→4)-L-GalA-α(1→]. In these oligomers, the first D-galactopyranose residue is β-
glycosidically linked to the O-4 position of a rhamnose moiety. Our strategy adopted for the 
synthesis of building blocks for D-galactose-branched RG-I fragments involved the 
preparation of a β-D-galactose-(1→4)-L-rhamnose intermediate 56 which allowed either as a 
donor the stereoselective formation of the required α(1→4)-glycosidic bond to a D-galact-
uronate, or as an acceptor the α(1→2)-linkage with a D-galacturonate. For the synthesis of a 
suitable galactosylrhamnose disaccharide L-rhamnose was glycosylated with allyl alcohol to 
obtain allyl α-L-rhamnopyranoside 51 in 81% yield(Scheme 14).84  
 
Scheme 14. Synthesis of galactopyranosyl-rhamnopyranoside building block 56 bearing a D-
galactose residue as a branching unit. (a) AcCl, AllOH, 3 h, under reflux (51, 81%); (b) 
Dibutylitin oxide, toluene, reflux, 3.5 h; then CsF, BnBr, DMF, 12 h (52, 70%); AcCl in 
toluene, pyridine, 14 h, -40 
o
C→-10 oC, Ar atmosphere (53, 60%); (d) BzCl, MS 4Å, pyridine, 
18 h, -7 
o
C→RT, Ar atmosphere (54, 99%); (e) 40% HBr in AcOH, 40 min, 0 oC→RT (55, 
97%); (f) Hg(CN)2, HgBr2, acetonitrile, MS 4Å, 24 h, RT, Ar atmosphere (56, 82%). 
Compound 51 was regioselectively mono-benzylated to achieve compound 52 in 70% yield 
by stannylation methodology.
85,86
 The regioselective esterification of benzyl derivative 52 was 
achieved by dropwise addition of diluted acetyl chloride at low temperature to provide the 
rhamnosyl acceptor 53 in 60% yield.
87
 In 
1
H NMR spectrum a significant downfield shift of 
about Δ = 1.34 ppm of proton H-2 in compound 53 compared to compound 52 confirmed 
the acetylation at the 2-position. Nemati and all. has reported the synthesis of another 
rhamnosyl acceptor with methyl group instead of allyl, which can be coupled with a donor at 
4-position. After glycosylation at 4-position, in this case, reported module in future step can 
be used only as an acceptor at 2-position.
88
 In compare of this work the synthesis of acceptor 
53 is more efficient (3 steps instead of 6). Now, compound 53 can be used as an acceptor for 
the cupling with a galactose donor at 4-position. 
To provide a galactopyranose donor commercial D-galactose was benzoylated with benzoyl 
chloride in pyridine at -7 
o
C. The reaction gave compound 54 in quantitative yield.
89,90
 The 
benzoylated galactosyl donor 55 was derived from penta-O-benzoyl-α-D-galactopyranose 54 
using the procedure by Kochetkov and co-workers.
 91,92,93,94
 Details for the experimental 
procedure as well as analytical data for the perbenzoylated D-galactose and the corresponding 
bromide 55 are provided in the experimental section, since the available literature contains 
abridged information only.
82 
Acceptor 53 was glycosylated with bromide 55 in the presence of Helferich promotors
53,37
 to 
give disaccharide 56 in 82% yield.
95,78
 The (1→4) linkage was confirmed by 1 D and 2 D 
NMR experiments. In the 
1
H NMR spectrum of compound 56, proton H-1´ appears as a 
doublet at  = 5.33 ppm with a coupling constant 3J1´,2´ 7.9 Hz, while the HMBC spectrum 
shows a correlation between proton H-1´ and carbon atom C-4. This galactopyranosyl-
rhamnopyranoside building block allowed either as donor to provide the stereoselective 
formation of the required α(1→4)-glycosidic bond or as an acceptor to achieve the α(1→2)-
linkage to a D-galacturonate. 
 
 
2.13. EFFICIENT SYNTHESIS OF BUILDING BLOCKS 62 AND 63 FOR BRANCHED RG-I FRAGMENTS 
In this part of my work an efficient synthesis of branched RG-I fragments is presented, which 
can be used as a building block for the synthesis of higher branched rhamnnogalacturonan 
oligosaccharides. After deallylation of disaccharide 56 using palladium(II)chloride, resulting 
hemiacetal 57 was converted to donor 58 in 79% yield.
75,79
 On the other hand, to obtain 
additional donor, the hemiacetal 57 was acetylated, and then converted into bromide 60 in 
85% yield applying the procedure of Wessel and Bundle.
76
 In parallel, selective cleavage of 
the 2-O-acetyl group of disaccharide 56 provided the glycosyl acceptor 61 in 63% yield 
taking advantage of the differences in the reactivity between the acetyl and benzoyl esters 
(Scheme 15).
96,97 
 
Scheme 15. Efficient synthesis of building blocks 62 and 63 for branched RG-I fragments. (a) 
PdCl2, AcOH, NaOAc, H2O, 2 h, 45 
o
C (57, 78%); (b) Cs2CO3, 2,2,2-trifluoro-N-phenyl-
acetimidoyl chloride, acetone, 2 h, RT (58, 79%); (c) Ac2O, pyridine, 20 
o
C, 24 h (59, 77%); 
(d) oxalyl bromide, CH2Cl2, 5 h, -40 °C→RT, Ar atmosphere (60, 85%); ; (e) Hg(CN)2, 
HgBr2, acetonitrile, MS 4Å, 24 h, RT (62, 65%); (f) 0.28 M methanolic HCl, 24 h, RT (61, 
63%); (g) cat. TMSOTf, MS 4Å, CH2Cl2, 3 h, -40 °C→RT, Ar atmosphere (63, 66%). 
 
The galacturonate acceptor 8 was coupled with rhamnosyl bromide 60 to provide 
trisaccharide 2 in 65% yield. Due to the manno-configurated glycosyl donor, the 
stereochemical outcome of the glycosylation reaction cannot be proven on the basis of 
chemical shift and the coupling constant 
3
J1,2 alone, but again both, the absence of a 
correlation between protons H-1´ and H-5´ in a NOESY spectrum of compound 62 and the 
C,H coupling constant (
1
JC-1´,H-1´ = 174 Hz), suggest an -linkage. 
The potential of methyl 4-O-acetyl-2,3-di-O-benzyl-α/β-D-galactopyranosyluronate N-phenyl 
trifluoroacetimidate 40 as glycosyl donor has been proven once more. The galacturonate 
donor 40 and acceptor 61 in the presence of TMSOTf were glycosylated and gave compound 
63 in 66% yield.  In the 
1
H NMR spectrum of compound 63 proton H-1´ appears at  = 4.97 
ppm as a doublet with a coupling constant 
3
J1´,2´ 3.8 Hz, proving an -linkage. This is also 
supported by the NOESY spectrum where no correlation was found between H-1´ and H-5´ 
and the C,H coupling constant 
1
JC-1´,H-1´ = 170 Hz, which is in the range of -manno 
configurated O-glycosides.
98
   
The obtained trisaccharides 62 and 63 are suitable modules for branched pectin fragment 
synthesis by modular design principle. 
 
2.14. SYNTHESIS OF BRANCHED RG-I ACCEPTOR 65 WITH SPACER 
Following our strategy, several tetrasaccharide building blocks were synthesized by modular 
design principle. In order to compare with glycosylation reaction with bromide 60 rhamnosyl 
N-phenyl trifluoroacetimidate 58 was used as donor, too. The glycosylation reaction in 
presence of TMSOTf between acceptor 58 and rhamnogalacturonate with spacer 32 provided 
tetrasaccharide 64 in 77% yield (Schemie 16). Due to the manno-configurated glycosyl 
donor, as for compound 62, the stereochemical outcome of the glycosylation reaction cannot 
be proven only on the basis of chemical shift of proton H-1´´, wich appears as a doublet at  = 
5.36 ppm with a coupling constant 
3
J1´´,2´´ 1.7 Hz. 
 Scheme 16. Synthesis of RG-I acceptor 65 with spacer. (a) TMSOTf (cat.), MS 4Å, CH2Cl2, 3 
h, -25 
o
C-RT (64, 77%); (b) 0.28 M methanolic HCl, 20 h, RT (65, 82%). 
The absence of a correlation between protons H-1´´ and H-5´´ or H-1´´ and H-3´´ in a 
NOESY spectrum of compound 64 proved -linkage, too. The selective cleavage of the 2-O-
acetyl group of tetrasaccharide 62 furnished the branched RG-I glycosyl acceptor with spacer 
65 in 82% yield taking advantage of the differences in the reactivity between the esters of 
acetic and benzoic acid.
96,97
 This acceptor 65 was then used for the synthesis of higher 
rhamnogalacturonan-I fragments. 
 
2.15. SYNTHESIS OF BRANCHED RG-I DONOR 68 
The synthesis of additional branched RG-I tetrasaccharide 66 was achieved by glycosylation 
between acceptor 61 and donor 40 in the presence of TMSOTf in 80% yield (Scheme 17). In 
the 
1
H NMR spectrum of compound 66 proton H-1´ appears as a doublet at  = 4.91 ppm with 
a coupling constant 
3
J1´,2´ 3.7 Hz, confirm an -linkage. This is also supported by the NOESY 
spectrum where no correlation was found between H-1´ and H-5´. After deallylation of 
tetrasaccharide 66 using palladium(II)chloride, resulting hemiacetal 67 was converted into 
donor 68 in 86% yield.
99
 This donor was also used for the synthesis of higher 
rhamnogalacturonan-I fragments. 
 
 Scheme 17. Synthesis of branched RG-I donor 68. (a) TMSOTf (cat.), MS 4Å, CH2Cl2, 3 h, -
25 
o
C→RT (66, 80%); (b) PdCl2, MeOH, CH2Cl2, 16 h, RT (67, 88%); (c) Cs2CO3, 2,2,2-
trifluoro-N-phenyl-acetimidoyl chloride, acetone, 3 h, RT (68, 86%). 
 
2.16. SYNTHESIS OF BRANCHED RG-I HEXASACCHARIDE 71 WITH SPACER 
The final step in this work was the synthesis of the branched rhamnogalacturonan-I 
hexasaccharide 69 connected with the spacer to a rhamnosyl derivative. To achieve this target 
two different disaccharides and tetrasaccharides were used followed to blockwise buildup 
strategy.  Acceptor 65 and donor 40 were used to provide hexasaccharide 69 in 30% yield 
(scheme 18). In the 
1
H NMR spectrum of compound 69 proton H-1´´´ appears as a doublet at 
 = 4.97 ppm with a coupling constant 3J1´´´,2´´´ 3.7 Hz proving an -linkage. This is also 
supported by the NOESY spectrum where no correlation was found between H-1´´´ and H-
5´´´. 
On the other hand, glycosylation of donor 68 with acceptor 37 gave compound 69 in 51% 
yield. Due to the manno-configurated glycosyl donor, the stereochemical outcome of a 
glycosylation reaction cannot be proven only on the basis of chemical shift of proton H-1´´, 
which appears as a doublet at  = 5.60 ppm with a coupling constant 3J1´´,2´´ 1.3 Hz, similar to 
compound 62. The absence of a correlation between protons H-1´´ and H-5´´ or H-1´´ and H-
3´´  in a NOESY spectrum of compound 69 proved the -linkage too. 
  
Scheme 18. Synthesis of branched RG-I hexasaccharide 71 with spacer. (a) TMSOTf 
(cat.), MS 4Å, CH2Cl2, 3 h, -25 
o
C→RT (69, 30%); (b) TMSOTf (cat.), MS 4Å, 
CH2Cl2, 3 h, -25 
o
C→RT(69, 51%); (c) Pd/C, H2, MeOH, EtOAc, 28 h, RT(70); (d) 
LiOH, MeOH, H2O, 15 min, RT (71, 85%). 
The deprotection of compound 69 was succeeded stepwise. The hydrogenation of compound 
69 in methanol-ethylacetat solution in presence of Pd/C provided compound 70. The ester 
cleavage of the acetyl, benzoyl and methyl groups, was achieved, similar to compound 49, 
with lithium hydroxide in methanol/water solution
 
to obtain branched rhamnogalacturonan-I 
hexasaccharide with spacer 71 in 85% yield.
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3. SUMMARY  
Pectins are complex polysaccharides, which are an important part of plants cell walls. 
Furthermore, they play a significant role in human diet and have positive effects on health. 
Due to the complexity of the structure of pectins fragments of defined structure are difficult to 
obtain in sufficient quantity. Therefore, new methods for the synthesis of pectin fragments are 
requested. 
The task of the present work was the efficient synthesis of building blocks for the preparation 
of pectin fragments by modular design principle. In order to achieve this aim, the following 
syntheses were carried out. In general all D-galacturonic derivatives were synthesized 
stepwise starting from D-galacturonic acid directly. 
 First, the synthesis of module 9 was significantly improved. Compared to the known 
pathway, the overall yield of module 9 increased from 18% to nearly 40%, and the 
total number of synthetic steps was reduced from 9 to 7 (Scheme 19). 
 Using bromide 3 a galacturonan acceptor with spacer 17 was synthesized. In future 
used this structural element for the connection of pectin fragments with proteins to get 
monoclonal antibodies for immunological investigations. 
 On the base of module 9 the known glycosyl acceptor 8 and glycosyl donor 35 can be 
achieved. Additionally, a new glycosyl donor bearing N-phenyltrifluoroacetimidate 
group 34 was prepared. 
 
Scheme 19. Synthesis of galacturon donors and acceptors starting from D-galacturonicacid. 
  In order to get suitable L-rhamnose building blocks for the synthesis of RG-I 
fragments glycosyl acceptor 53 was prepared via known intermediate 52. 
Regioselective acetylation of compound 52 at -40 
o
C gave acceptor 53 in 60% yield. 
This step simplified significantly the pathway to get 53 (from 6 to 3 synthetic steps) 
which was then coupled with perbenzoylated D-galactosyl bromide (55) to furnish 
disaccharide 56 (Scheme 20). 
 The synthesis of donor 27 was significantly improved. Compared to the known 
pathway, the overall yield of bromide 27 was increased from 49% to nearly 62%. 
 Using rhamnosyl bromide 27 we got a spacer modified monosaccharide (29), aswell. 
 
 
Scheme 20. Synthesis of rhamnosyl donor and acceptors starting from L-rhamnose. 
 
 
 
 
 Furthermore bromide 27 was used to provide the RG-I-module 30 in 67% yield by 
incorporation of galacturonate acceptor 8 (Scheme 21). 
 
 
Scheme 21. Synthesis of rhamnogalacturonan module 30. 
 According to our modular design principle, RG-I-module 30 can be transformed in 
one step into glycosyl acceptor 38 in 90% yield and in two steps in glycosyl donors 40 
and 41 in 69% and 51% yield, respectively (Scheme 22).  
 
Scheme 22. Synthesis of RG-I acceptor 38 and donors 40 and 41.  
 To get a RG-I building block where the rhamnosyl moiety carries the spacer function, 
acceptor 29 was glycosylated with both trichloracetimidate 35 and N- phenyltrifluoro-
acetimidate  34 donors (Scheme 23).  Via donor 35 at -70 
o
C the RG-I 36 with spacer 
was obtained in 67% yield. Via new donor 34 at -20 
o
C the  same RG-I 36 was 
obtained in 85% yield. 
 
Scheme 23. Synthesis of rhamnogalacturonan 36 with spacer. 
 
 To get a RG-I tetrasaccharide 42 acceptor 38 was glycosylated with both 
trichloracetimidate 41 and N- phenyltrifluoroacetimidate  40 donors (Scheme 24).  Via 
donor 41 at -70 
o
C the RG-I 42 was obtained in 67% yield. Via new donor 40 at -20 
o
C 
the same RG-I 42 was obtained in 90% yield. Tetrasaccharide 42 was deprotected to 
obain tetrasaccharide 44. 
 
 
Scheme 24. Synthesis of rhamnogalacturonan 44. 
  To get a RG-I tetrasaccharide with spacer acceptor 37 was glycosylated with donor 41 
and provided compound 50 in 77% yield (Scheme 25). Compound 50 may be used for 
immunological studies after cleavage of all protecting groups and conversion of the 
nitro group into an isothiocyanate group.  
 
Scheme 25. Synthesis of rhamnogalacturonan 50 with spacer. 
 
 
 
 
 
 
 
 
 
 To get a RG-I hexasaccharide acceptor 47 was glycosylated with both 
trichloracetimidate 41 and N- phenyltrifluoroacetimidate  40 (Scheme 26).  Via donor 
41 at -70 
o
C the RG-I 46 was obtained in 60% yield. Via new donor 40 at -20 
o
C the 
same RG-I 46 was obtained in 79% yield. Hexasaccharide 46 was deprotected to 
furnish RG-I 49. The tetrasaccharide 44 and hexasaccharide 49 has been sent to 
colleagues from Norway for the biological tests. 
 
Scheme 26. Synthesis of rhamnogalacturonan 49. 
 
A special task of my PhD work was the synthesis of branched RG-I modules (Scheme 27). 
 Starting from allyl 2-O-acetyl-3-O-benzyl-α-L-rhamnopyranoside (53),  module 56 
was synthesized under Helferich conditions. Module 56 was converted to bromide 60 
which was then coupled with acceptor 37 to provide branched tetrasaccharide 64 with 
spacer. Alternatively, module 56 was transformed into derivatives 61 suitable as an 
acceptor for the glycosylation with glycosyl donor 40 to yield tetrasaccharide 66. Both 
tetrasaccharides 64 and 66 are suitable modules for branched pectin fragments 
accessible by modular design principle. 
 
 
 Scheme 27. Synthesis of branched rhamnogalacturonan fragments 64 and 66. 
 
 
 
 
 
 
 
 To get a higher branched RG-I fragments with spacer the hexasaccharide 69 was synthesized 
by using modular design principle. The synthesis of RG-I 69 was achieved by glycosylation of 
the previously synthesized donor 40 and acceptors 65. In parallel, RG-I 69 was synthesized 
via donor 68 and acceptor 37. After deprotaction branched hexasaccharide 71 with spacer was 
obtained (Scheme 28). 
 
Scheme 28. Synthesis of branched RG-I  fragment with spacer. 
 
 
 
 
 
 
 
4. EXPERIMENTAL SECTION 
4.1 GENERAL METHODS 
Melting points were determined with a Boetius micro-heating plate BHMK 05 (Rapido, 
Dresden) and were not uncorrected. Optical rotation was measured for solutions in a 2-cm cell 
with an automatic polarimeter GYROMAT (Dr. Kernchen Co.). 
1
H NMR spectra 
(500.13 MHz, 300.13 MHz and 250.13 MHz) and 
13
C NMR spectra (125.8 MHz, 75.5 MHz 
and 62.9 MHz) were recorded using Bruker instruments AVANCE 500, ARX 300 and 
AVANCE 250, with CDCl3 and DMSO-d6 as solvents. NMR spectra were calibrated using 
solvent signals (CDCl3: δ 
1
H 7.25 and δ 13C 77.0, DMSO-d6: δ 
1
H 2.49 and δ 13C 39.50). The 
1
H and
 13
C NMR signals were assigned by DEPT and two-dimensional 
1
H,
1
H COSY, 
1
H,
1
H 
NOESY, and 
1
H,
13
C correlation spectra (HMBC and HSQC). Elemental analysis was 
performed on a CHNS-Flash-EA-1112 instrument (Thermoquest). All washing solutions were 
cooled to ~5 °C. The NaHCO3 solution was saturated. Reactions were monitored by thin-layer 
chromatography (TLC, Silica Gel 60, F254, 0.25 mm, Merck KGaA). The spots were made 
visible by spraying with ethanolic 10% H2SO4 solution and charring them for 10–30 sec with 
a heat gun. Detection of benzyl derivatives was effected by UV fluorescence. Preparative 
flash chromatography was performed by elution from columns of slurry-packed Silica gel 60 
(Merck, 40–63 m). All solvents and reagents were purified and dried according to standard 
procedures.
100
 After classical work–up of the reaction mixtures, organic layers were dried 
over MgSO4 and then concentrated under reduced pressure (rotary evaporator).  
 
 
 
 
 
 
 
 
 
4.2. PREPARATIVE METHODS 
1,2,3,4-tetra-O-acetyl-α-D-galactopyranuronic acid (1) 
 
D-galacturonic acid monohydrate (40.32 g, 190.2 mmol) was added in small portions to a 
stirred solution of 70% perchloric acid (1.5 mL) in acetic anhydride (250 mL) at 5 
o
C. The 
reaction mixture was stirred for 30 min at that temperature, the cooling-bath was removed and 
stirring was continued for 3 h at ambient temperature (monitored by TLC). The mixture was 
cooled to 0 
o
C, and methanol (60 mL) was added dropwise. After stirring for 30 min, the 
solution was poured into ice-water (600 mL) and the aqueous layer was extracted with 
chloroform (3 × 100 mL). The combined organic solutions were washed with ice-water (3 × 
25 mL), dried and concentrated. Heptane (20 mL) was added to a solution of the crude 
material in EtOAc (100 mL) and the precipitate was collected. A similar precipitation 
procedure was repeated with the mother liquor (3-4 times). Crystallization from diethyl tether 
gave compound 7 as colourless crystals. 
Yield: 58.5 g (85%)  
M.p.: 162
 
- 164
 o
C (from dietyl ether)  
Rƒ : 0.25 (2 : 1 EtOAc - MeOH) 
[α] 21D : +125 (c 1.0, CHCl3)  
NMR data an elemental analysis are published, yet.
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Methyl 1,2,3,4-tetra-O-acetyl-α-D-galactopyranuronate (2) 
 
Compound 1 (7.25 g, 20.0 mmol) was dissolved in a minimum of chloroform and treated with 
ethereal diazomethane until yellow color persisted. The excess diazomethane was destroyed 
with acetic acid. The solution was diluted with heptane (200 mL), washed with sat aq NHCO3 
(2 × 60 mL), ice-water (2 × 60 mL), dried and concentrated. Crystallization from Heptane - 
EtOAc gave compound 7 as colourless crystals. 
Yield: 7.15 g (95%) 
M.p.: 138 - 140
 o
C (from Heptane - EtOAc) 
Rƒ: 0.35 (2 : 1 Toluene - EtOAc) 
[α] 23D : +159.9 (c 1.0, CHCl3)   
NMR data an elemental analysis are published, yet.
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Methyl 2,3,4-tri-O-acetyl-α-D-galactopyranosyluronate bromide (3) 
  
Foregoing 40% HBr solution in acetic acid (90 mL) was added to a solution of compound 2 
(9.4 g, 25.0 mmol) in dry chloroform (80 mL) at 0 
o
C. After 15 min cooling-bath was 
removed, and the reaction mixture was stirred at ambient temperature. After 3 h (monitored 
by TLC) the solution was poured into ice-water (300 mL). The organic layer was separated 
and the aqueous layer was extracted with chloroform (3 × 75 mL). The combined organic 
layers were washed with ice-water (150 mL), sat aq NHCO3 (2 × 150 mL), ice-water (2 × 150 
mL), dried and concentrated. Obtained compound 3, which was sufficiently pure (NMR) to be 
used in the next step without further purification. Crystallization gave an analytical sample as 
colourless crystals. 
Yield: 8.7 g (90%) 
M.p.: 128 - 130 
o
C (from dry diethyl ether) 
Rƒ: 0.49 (2 : 1 toluene - EtOAc) 
[α] 20D : +240 (c 1.0, CHCl3)   
 
Methyl (allyl 2,3,4-tri-O-acetyl-β-D-galactopyranosid)uronate (4) 
 
Bromide 3 (12 g, 30.2 mmol), Hg(CN)2 (5.88 g, 23.3 mmol), HgBr2 (1 g, 2.8 mmol) and 
molecular sieves (3Å, 5 g) in dry allyl alcohol (100 mL) were stirred overnight at ambient 
temperature under an atmosphere of argon. The mixture was concentrated, diluted with 
chloroform (200 mL) and filtered.  The filtrate was washed with aq 10% KBr (3 × 50 mL) and 
ice-water (2 × 25 mL), dried and concentrated. The crude product was purified by column 
chromatography (2 : 1 PE - EtOAc ) to give compound 4 as colourless crystals. 
Yeld: 10.33 g (91%) 
M.p.: 98 - 99 
 o
C (from heptane - EtOAc) 
Rƒ: 0.44 (1 : 1 PE - EtOAc) 
[α] 20D : 0 (c 1.0, CHCl3)   
NMR data an elemental analysis are published, yet.
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Methyl (allyl β-D-galactopyranosid)uronate (10) 
 
Compound 4 (3.74 g, 10 mmol) was added with stirring to methanolic 0.28 M hydrochloric 
acid [prepared by adding of acetyl chloride (7.3 mL) to ice-cold dry methanol (360 mL)] and 
the mixture was stirred for 24 h at ambient temperature under an atmosphere of argon 
(monitored by TLC). PbCO3 x Pb(OH)2 (30 g) was added and the reaction mixture was stirred 
for additional 2 h at ambient temperature. The salts were filtered off, washed with methanol (3 
× 30 mL) and the combined organic solutions were concentrated. The purification of the 
residue by flash chromatography (3 : 1 CHCl3 - MeOH) gave compound 10 as colourless 
crystals. 
Yield: 2.22 g (90%) 
M.p.: 151 - 153
 o
C (from MeOH - EtOAc) 
Rƒ: 0.3 (8 : 1 EtOAc - MeOH) 
[α] 22D : –62.9 (c 1.0, acetone)   
NMR data an elemental analysis are published, yet.
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Methyl (allyl 4-O-acetyl-β-D-galactopyranosid)uronate (12) 
  
Triethyl orthoacetate (5 × 5.5 mL, 150 mmol) and anhydrous camphorsulfonic acid (2 × 400 
mg, 3.4 mmol) were added in portions into a stirred solution of compound 10 (10.2 g, 41.1 
mmol) in dry CH2Cl2 (300 mL) at amient temperature under an atmosphere of argon. After 
1.5 h (monitored by TLC) the reaction was terminated by addition of triethylamine (20 mL, 
144.5 mmol), and the mixture was diluted with CHCl3 (500 mL). The organic phase was 
washed with ice-water (2 × 50 mL), dried and concentrated.  The residue was immediately 
dissolved in aqueous 95% acetic acid (100 mL) and the solution was kept for 10 min in 
ambient temperature. After concentration, the residue was co-evaporated with toluene (4 × 50 
mL) to remove traces of acetic acid. The purification of the crude product by flash 
chromatography (2 : 1 Toluene - EtOAc) gave compound 12 as colourless crystals. 
Yield: 10.1 g (85%) 
M.p.: 105 - 107
 o
C (from hot EtOAc) 
Rƒ: 0.3 (EtOA) 
[α] 23D : +2.2 (c1.0, methanol)   
1
H NMR (300 MHz, DMSO):   5.93 (m, 1H, CH2CH=CH2), 5.58 (dd,1H,
 3
J4,5 1.3 Hz, H-4), 
5.32, 5.22 (2 × m, 2H, CH2CH=CH2), 4.46 (m, 1H,CH2CH=CH2), 4.35 (d, 1H, 
3
J1,2 7.7 Hz, 
H-l), 4.24 (m, 1H, H-5), 4.14 (m, 1H, CH2CH=CH2), 3.83 (m, 1H, H-2), 3.74 (s, 3H, OCH3), 
3.71 (dd, 1H, 
3
J2,3 9.4 Hz, H-3), 3.26 (bs, 1H, OH), 3.18 (bs, 1H, OH), 2.09 (s, 3H, CH3CO); 
13
C NMR (75.5 MHz, CDC13):  169.4 (CH3COO), 167.8 (COO), 134.6 (OCH2CH=CH2), 
116.7 (CH2CH=CH2), 102.1 (C-l), 71.8 (C-3), 71.3 (C-2), 70.6 (C-4), 70.3 (C-5), 69.2 
(CH2CH=CH2), 51.9 (OCH3), 20.6 (CH3COO).  
Anal. Calcd for C12H18O8 (290.27): C, 49.65; H, 6.25. Found: C, 49.54; H, 6.18. 
 
Methyl (allyl 4-O-acetyl-2,3-di-O-benzyl-β-D-galactopyranosid)uronate (9) 
 
Freshly distilled benzyl 2,2,2-trichloroacetimidate (12 mL, 64.3 mmol) was added to a 
solution of compound 12 (5 g, 17.2 mmol) in freshly distilled dioxane (130 mL) at 0 
o
C under 
an atmosphere of argon. The mixture was made strongly acidic by addition of 
trifluoromethanesulfonic acid (0.9 mL). After stirring for 15-30 min, the reaction mixture was 
passed through a layer of alkaline alumina and concentrated. The residue was suspended in 
Heptane - EtOAc (6 : 1 v/v, 300 mL), the carbohydrate-free precipitates were filtered off and 
washed with Heptane - EtOAc (6 : 1 v/v, 150 mL). The filtrate and washings were combined 
end concentrated. The purification of crude product by flash chromatography (2 : 1 PE - 
EtOAc) gave compound 9 as colourless crystals. 
Yield: 7.15 g (89%) 
M.p.: 136
 o
C (from heptane-EtOAc) 
Rƒ: 0.54 (1 : 1 PE - EtOA) 
[α] 23D : +35.8 (c 1.0, chloroform)  
NMR data an elemental analysis are published, yet.
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Methyl (allyl 2,3-di-O-benzyl-β-D-galactopyranosid)uronate (8) 
 
Compound 9 (428 mg, 1.0 mmol) was added with stirring to methanolic 0.28 M hydrochloric 
acid [prepared by adding of acetyl chloride (2 mL) to ice-cold dry methanol (100 mL)] and 
the mixture was stirred for 24 h at ambient temperature under an atmosphere of argon 
(monitored by TLC). The solution was filtered through a layer of alkaline alumina by elution 
with CHCl3. The combined eluates (ca. 400 mL) were dried, concentrated and the crude 
product was chromatographed (3 : 1 Pet - EtOAc) to provide acceptor 8 as colourless crystals. 
Yield: 430 mg (90%)  
M.p.: 111 
o
C ( EtOAc - heptane) 
Rƒ: 0.45 (2 : 1 heptane - EtOAc) 
[α] 22D : –4.7 (c 1.0, CHCl3) 
1
H NMR (300 MHz, CDCl3):  7.40–7.23 (m, 10H, 2 × Ph), 5.95 (m, 1H, CH2CH=CH2), 
5.33, 5.19 (2 × m, 2H, CH2CH=CH2), 4.92, 4.73 (2 × d, 2H, CH2Ph), 4.73 (s, 2H, CH2Ph), 
4.48 (m, 1H,CH2CH=CH2), 4.41 (d, 1H, 
3
J1,2 7.6 Hz, H-l), 4.31 (m, 1H, H-4), 4.13 (m, 1H, 
CH2CH=CH2), 4.04 (m, 1H, H-5), 3.82 (s, 3H, OCH3), 3.71 (dd, 1H,  
3
J 2,3  9.5 Hz, H-2), 3.55 
(dd, 1H, 
3
J3,4 3.5 Hz, H-3), 2.53 (m, 1H, 4-OH); 
13
C NMR (75.5 MHz, CDC13):  168.4 
(COO), 133.9 (OCH2CH=CH2), 138.4, 137.6, 128.5, 128.3, 128.2, 128.00, 127.9, 127.7 (2 × 
Ph,),  117.4 (CH2CH=CH2), 102.3 (C-l), 79.8 (C-3), 78.3 (C-2), 73.7 (C-5), 75.2 
(CH2CH=CH2), 72.6, 70.3 (2 x CH2Ph,), 68.0 (C-4), 52.5 (OCH3).  
Anal. Calcd for C24H28O7 (428.48): C, 67.28; H, 6.59. Found: C, 67.17; H, 6.62. 
 
 
 
 
Methyl (2-(4-nitrophenoxy)ethyl 2,3,4-tri-O-acetyl-β-D-galactopyranosid)uronate (13) 
 
Bromide 3 (1 g, 2.5 mmol), 2-(4-nitrophenoxy)ethanol (620 mg, 3.4 mmol), Hg(CN)2 (255 
mg, 1.0 mmol), HgBr2 (110 mg, 0.3 mmol) and molecular sieves (3Å, 1 g) in dry acetonitrile 
(20 mL) were stirred overnight at ambient temperature under an atmosphere of 
argon(monitored by TLC). The mixture was concentrated and the residue was dissolved in 
chloroform (30 mL) and filtered.  The filtrate was washed with aq 10% KBr (3 × 10 mL) and 
ice-water (2 × 10 mL), dried and concentrated. The crude product was purified by column 
chromatography (1 : 1 PE - EtOAc ) to give compound 13 as foam. 
Yeld: 1.07 g (86%) 
Rƒ: 0.2 (1 : 1 PE - EtOAc) 
1
H NMR (300 MHz, DMSO):  8.18 (d, 2H, J 8.9 Hz, 2 × m-OPhNO2), 6.95 (d, 2H, J 8.9 
Hz, 2 × o-OPhNO2), 5.70 (dd, 1H,
 3
J3,4 3.4 Hz,
 3
J4,5 1.3 Hz, H-4), 5.26 (dd, 1H, 
3
J1,2 7.9 Hz,
 
3
J2,3 10.4 Hz, H-2), 5.07 (dd, 1H, 
3
J3,4 3.4 Hz, 
3
J2,3 10.4 Hz, H-3) 4.28-4.23 (m, 2H, CH2CH2O, 
CH2CH2O), 4.00 (m, 2H, CH2CH2O, CH2CH2O), 3.74 (s, 3H, OCH3),  2.11 (s, 3H, CH3), 1.98 
(s, 3H, CH3), 1.92 (s, 3H, CH3); 
13
C NMR (125.8 MHz, CDCl3):  170.0 (COOCH3), 169.7, 
169.2, 166.3 (3 × COO), 163.6 (p-OPhNO2), 141.7 (o-OPhNO2), 125.9 (m-OPhNO2), 114.9 
(o-OPhNO2), 101.3 (C-1), 72.4 (C-3), 70.3 (C-4), 68.2 (C-5), 68.0 (C-2), 67.5 (CH2CH2O), 
61.6 (CH2CH2O), 52.8 (OCH3), 20.5 (3 × CH3). 
Anal. Calcd for C21H25NO13 (499.42): C, 50.50; H, 5.05; N, 2.80 Found: C, 50.48; H, 5.08; N, 
2.85. 
Methyl (2-(4-nitrophenoxy)ethyl β-D-galactopyranosid)uronate (14) 
 
Compound 13 (1.0 g, 2 mmol) was added to a stirred solution of methanolic 0.28 M 
hydrochloric acid [prepared by adding of acetyl chloride (2.5 mL) to ice-cold dry methanol 
(120 mL)] and the mixture was stirred for 24 h at ambient temperature under an atmosphere 
of argon (monitored by TLC). PbCO3 x Pb(OH)2 (10 g) was added and the reaction mixture 
was stirred for additional 2 h at ambient temperature. The salts were filtered off, washed with 
methanol (3 × 30 mL) and the combined organic solutions were concentrated. The 
purification of the residue by flash chromatography (7 : 1 EtOAc - MeOH) gave compound 14 
as yellow foam. 
Yield: 555 mg (74%) 
Rƒ: 0.35 (6 : 1 EtOAc - MeOH) 
1
H NMR (300 MHz, DMSO):  8.25 (d, 2H, J 9.4 Hz, 2 × m-OPhNO2), 7.24 (d, 2H, J 9.3 
Hz, 2 × p-OPhNO2), 5.07 (d,1H, J 4.5 Hz, OH), 4.93 (d, 1H,
 
J 5.1 Hz,  OH), 4.90 (d,1H, J  5.1 
Hz, OH), 4.37 (t, 2H, CH2CH2O), 4.32 (d, 1H, 
3
J1,2 8.0 Hz, H-1), 4.30 (s, 1H, H-5), 4.13 (m, 
1H, CH2CH2O), 3.96 (m, 1H, H-4), 3.90 (m, 1H, CH2CH2O), 3.67 (m, 1H,  
3
J3,4 3.6 Hz, H-3), 
3.68 (s, 3H, OCH3), 3.42 (m, 1H, H-3), 3.34 (s, 1H, H-2); 
13
C NMR (75.5 MHz, DMSO):  
168.8 (COO), 163.8 (C-12), 140.3 (C-9), 125.9 (C-11, C-11´), 115.1 (C-10, C-10´), 103.4 (C-
1), 73.4 (C-4), 72.6 (C-2),  69.9 (C-5), 69.7 (C-3), 68.4 (C-8), 67.2 (C-7), 51.6 (CH3O). 
Anal. Calcd for C15H19NO10 (373.31): C, 48.26; H, 5.23; N, 3.75. Found: C, 48.32; H, 5.18; 
N, 3.85. 
 
Methyl (2-(4-nitrophenoxy)ethyl 4-O-acetyl-β-D-galactopyranosid)uronate (15) 
 
Triethyl orthoacetate (2 × 0.35 mL, 3.8 mmol) and anhydrous camphorsulfonic acid (15 mg, 
0.064 mmol) were added in portions to a stirred solution of compound 14 (200 mg, 0.536 
mmol) in dry CH2Cl2 (10 mL) at ambient temperature under an atmosphere of argon. After 
1.5 h (monitored by TLC) the reaction was terminated by addition of triethylamine (2 mL, 
0.022 mmol). The reaction mixture was then concentrated and the residue co-evaporated with 
toluene (3 × 2 mL).  The residue was immediately dissolved in aqueous 95% acetic acid (5 
mL) and the solution was kept for 10 min in ambient temperature. After concentration, the 
residue was co-evaporated with toluene (4 × 5 mL) to remove traces of acetic acid. The 
purification of the crude product by flash chromatography (EtOAc) gave compound 15 as 
yellow foam. 
Yield: 205 mg (92%) 
Rƒ: 0.2 (EtOA) 
1
H NMR (300 MHz, DMSO):  8.25 (d, 2H, J 9.3 Hz, 2 × m-OPhNO2), 7.23 (d, 2H, J 9.3 
Hz, 2 × p-OPhNO2), 5.34 (dd, 1H, 
3
J4,5 1.1 Hz, 
3
J3,4 3.6 Hz,  H-4), 5.29 (d,1H, J 5.2 Hz, OH), 
5.26 (d, 1H,
 
J 6.4 Hz,  OH), 4.56 (d,1H, 
3
J4,5 1.1 Hz, H-5),  4.42 (d, 1H, 
3
J1,2 7.7 Hz, H-1), 
4.37 (t, 2H, CH2CH2O),  4.15 (m, 1H, CH2CH2O), 3.94 (m, 1H, CH2CH2O), 3.67 (m, 1H,  
3
J3,4 3.6 Hz, H-3), 3.63 (s, 3H, OCH3), 3.36 (s, 2H ), 3.30 (m, 1H, H-2) 2.01 (s, 3H, 
CH3COO); 
13
C NMR (75.5 MHz, DMSO):  169.4 (CH3CO), 167.7 (COO), 163.8 (C-12), 
141.9 (C-9), 125.9 (C-11, C-11´), 115.1 (C-10, C-10´), 103.2 (C-1), 71.9 (C-4), 71.3 (C-2),  
70.6 (C-5), 70.2 (C-3),68.3 (C-8), 67.4 (C-7), 51.9 (CH3O), 20.6 (CH3CO). 
Anal. Calcd for C17H21NO11 (415.16): C, 49.16; H, 5.10; N, 3.37. Found: C, 49.19; H, 5.08; 
N, 3.42. 
 
Methyl (2-(4-nitrophenoxy)ethyl 4-O-acetyl-2,3-di-O-benzyl-β-D-
galactopyranosid)uronate (16) 
 
Freshly distilled benzyl 2,2,2-trichloroacetimidate (0.2 mL, 1.1 mmol) was added to a solution 
of compound 15 (180 mg, 0.43 mmol) in freshly distilled dioxane (1.5 mL) at 0 
o
C under an 
atmosphere of argon. The mixture was made strongly acidic by addition of 
trifluoromethanesulfonic acid (0.02 mL). After stirring for 15-30 min, the reaction mixture 
was passed through a layer of alkaline alumina and concentrated. The purification of crude 
product by flash chromatography (2 : 1 PE - EtOAc) gave compound 16 as yellow foam. 
Yield: 185 mg (72%) 
Rƒ: 0.27 (1 : 1 PE - EtOA) 
1
H NMR (300 MHz, CDCl3):  8.16 (d, 2H, J 8.9 Hz, 2 × m-OPhNO2), 7.34–7.25 (m, 10H, 
2×C6H5), 6.92 (d, 2H, J 8.9 Hz, 2 × p-OPhNO2), 5.80 (q, 1H, 
3
J4,5 1.3 Hz, 
3
J3,4 2.8 Hz,  H-4), 
4.84 (d, 1H, 
2
J 11.0 Hz, CH2Ph), 4.77 (d, 1H, 
2
J 11.5 Hz, CH2Ph), 4.71 (d, 1H, 
2
J 11.0 Hz, 
CH2Ph), 4.56 (d, 1H, 
2
J 11.5 Hz, CH2Ph), 4.53 (d, 1H, 
3
J1,2 7.9 Hz, H-1 ), 4.37 (m, 1H, 
3
J1,2 
7.9 Hz, 
3
J2,3 3.2 Hz,  H-2), 4.32 (m, 1H, 
3
J2,3 3.2 Hz, 
3
J3,4 2.8 Hz, H-3), 4.25 (m, 2H,
 
CH2CH2O), 4.24 (m, 1H, CH2CH2O), 4.20 (d, 1H, , 
3
J4,5 1.3 Hz, H-5), 3.99 (m, 1H,
 
CH2CH2O),  3.77 (s, 3H, OCH3), 2.12 (s, 3H, CH3COO); 
13
C NMR (62.9 MHz, CDCl3):  
169.9 (CH3CO), 167.2 (COO), 163.6 (C-12), 141.6 (C-9), 138.3, 137.4 (i-Ph), 128.3, 128.2, 
128.0, 127.8 127.6, 127.4 (o-Ph, m-Ph, p-Ph), 125.8 (C-11, C-11´), 114.5 (C-10, C-10´), 
103.7 (C-1), 78.4 (C-3), 78.0 (C-2), 75.2 (CH2), 72.5 (C-5), 72.2 (CH2), 68.2 (C-8), 67.8 (C-
7), 67.4 (C-4), 52.6 (CH3O), 20.7 (CH3CO). 
Anal. Calcd for C24H26NO10 (488.46): C, 59.01; H, 5.37; N, 2.87. Found: C, 59.09; H, 5.28; 
N, 2.92. 
Methyl (2-(4-nitrophenoxy)ethyl 2,3-di-O-benzyl-β-D-galactopyranosid)uronate (17) 
  
Compound 16 (750 mg, 1.26 mmol) was added to a stirring solution of methanolic 0.28 M 
hydrochloric acid [prepared by adding of acetyl chloride (1 mL) to ice-cold dry methanol (50 
mL)] and the mixture was stirred for 24 h at ambient temperature under an atmosphere of 
argon (monitored by TLC). The solution was filtered through a layer of alkaline alumina by 
elution with CHCl3. The combined eluates (ca. 200 mL) were dried, concentrated and the 
crude product was chromatographed (1 : 1 PE- EtOAc) to provide acceptor 17 as yellow 
foam. 
Yield: 592 mg (88%)  
Rƒ: 0.15 (1 : 1 PE - EtOAc) 
Anal. Calcd for C22H24NO19 (446.43): C, 59.19; H, 5.42; N, 3.14. Found: C, 59.15; H, 5.35; 
N, 3.22. 
 HRMS, ESI-TOF/MS positive (m/z): calcd for C29H31NO10 [M+Na]
+
: 576.1840, found: 
576.1846. 
Methyl (2-(4-aminophenoxy)ethyl β-D-galactopyranosid)uronate (18) 
 
10% Palladium on charcoal (30 mg) was added to a solution of compound 14 (150 mg, 0.4 
mmol) in mixture of methanol and EtOAc (4 : 1, v/v,10 mL). The reaction mixture was stirred 
at ambient temperature under an atmosphere of hydrogen. After 1 h (monitored by TLC) the 
reaction mixture was filtered over celite by elution with methanol, and combined organic 
solutions were concentrated. The residue was purified by column chromatography (6 : 1 
EtOAc - MeOH) to provide compound 18 as orange powder. 
Yield: 125 mg (90%) 
Rƒ: 0.26 (5 : 1 EtOAc - MeOH) 
1
H NMR (300 MHz, DMSO):  6.67 (d, 2H, J 8.9 Hz, 2 × o-OPhNH2), 6.51 (d, 2H, J 8.9 Hz, 
2 × m-OPhNH2), 5.01 (d, 1H, J 4.5 Hz, OH-2), 5.89 (d, 1H, J 5.1 Hz, OH-3), 4.85 (d, 1H, J 
5.1 Hz, OH-4), 4.59 (bs, 2H, NH2), 4.24 (s, 1H, H-5), 4.23 (d, 1H, 
3
J1,2 4.5 Hz, H-1), 4.05-
3.95 (m, 3H, CH2CH2O, CH2CH2O), 3.91 (m, 1H, H-4), 3.75 (m, 1H, CH2CH2O), 3.65 (s, 3H, 
OCH3),  3.44-3.28 (m, 2H, H-2, H-3); 
13
C NMR (125.8 MHz, DMSO):  168.9 (COOCH3), 
149.7 (C-9), 142.5 (C-12), 115.4 (C-10, C-10´), 114.9 (C-11, C-11´), 103.3 (C-1), 73.9 (C-5), 
72.6 (C-3), 69.9 (C-4), 69.8 (C-2), 67.6 (CH2CH2O), 67.5 (CH2CH2O), 51.6 (CH3O). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C15H21NO8 [M+H]
+
: 344.1340, found: 
344.1342. calcd for C15H21NO8 [M+Na]
+
: 366.1160, found: 366.1163. 
 
Methyl (2-(4-isothiocyanphenoxy)ethyl β-D-galactopyranosid)uronate (19) 
 
Thiophosgen (1 ml, 5.8 mmol) was added to a solution of compound 18 (650 mg, 1.9 mmol) 
and BaCO3 (100~200 mg, pH~8) in mixture of ethanol and water (4 : 1, v/v, 100 ml), and the 
reaction mixture was stirred at ambient temperature. After 1 h (monitored by TLC) the 
reaction mixture was filtered over celite by elution with methanol. After concentration the 
residue was purified by column chromatography (6 : 1 EtOAc - MeOH) to provide compound 
19 as read powder. 
Yield: 560 mg (77%) 
Rƒ: 0.45 (5 : 1 EtOAc - MeOH) 
1
H NMR (300 MHz, DMSO):  7.41 (d, 2H, J 9.0 Hz,  m-OPhNCS), 7.06 (d, 2H, J 8.9 Hz, 
o-OPhNCS), 5.54 (d, 1H, J 4.7 Hz, OH-2), 4.92 (d, 1H, J 5.1 Hz, OH-3), 4.89 (d, 1H, J 5.1 
Hz, OH-4), 4.30 (d, 1H, 
3
J1,2 4.3 Hz, H-1), 4.28 (s, 1H, H-5), 4.22 (m, 2H, H-4, CH2CH2O), 
4.09 (m, 1H, CH2CH2O),  3.98-3.93 (m, 1H, CH2CH2O), 3.91-3.80 (m, 1H, H- CH2CH2O), 
3.68 (s, 3H, OCH3),  3.44-3.29 (m, 1H, H-2), 3.39-3.33 (m, 1H, H-3); 
13
C NMR (125.8 MHz, 
DMSO):  168.9 (COOCH3), 157.8 (p-OPhNCS), 132.0 (i-OPhNCS), 127.3 (C-11, C-11´), 
122.2 (C-13), 115.6 (C-10, C-10´), 103.3 (C-1), 73.9 (C-5), 72.5 (C-3), 69.8 (C-4), 69.7 (C-2), 
67.7 (CH2CH2O), 67.2 (CH2CH2O), 51.5 (OCH3). 
Anal. Calcd for C16H19NO8S (385.39): C, 49.86; H, 4.97; N, 3.63, S, 8.32.  Found: C, 49.80; 
H, 4.95; N, 3.68; S, 8.35. 
 
2-(4-Isothiocyanphenoxy)ethyl β-D-galactopyranosiduronic acid (20) 
 
Lithiumhydroxid (12 mg, 0.5 mmol) was added to a suspension of compound 19 (184 mg, 
0.48 mmol) in a mixture of methanol and water (2 : 1, v/v, 40 ml). After stirring for 15 min at 
ambient temperature (monitored by TLC), the solution was passed through a column of 
Dowex-50 (H
+
). Methanol was removed from solution by evaporation under reduced pressure 
and the residue was purified by column chromatography (1 : 1 CHCl3 - MeOH) to provide 
compound 20 as read powder. 
Yield: 63 mg (92%)  
Rƒ: 0.3 (1 : 1 CHCl3 - MeOH) 
1
H NMR (300 MHz, DMSO-d6):  7.40 (d, 2H, J 9.0 Hz, 2 × m-OPhNCS), 7.05 (d, 2H, J 8.9 
Hz, 2 × o-OPhNCS), 5.54 (d, 1H, J 4.7 Hz, OH-2), 4.91 (d, 1H, J 5.1 Hz, OH-3), 4.89 (d, 1H, 
J 5.1 Hz, OH-4), 4.29 (d, 1H, 
3
J1,2 4.3 Hz, H-1), 4.27 (s, 1H, H-5), 4.22 (m, 2H, H-4, 
CH2CH2O), 4.09 (m, 1H, CH2CH2O),  3.98-3.93 (m, 1H, CH2CH2O), 3.91-3.80 (m, 1H, 
CH2CH2O), 3.44-3.29 (m, 1H, H-2), 3.39-3.33 (m, 1H, H-3); 
13
C NMR (125.8 MHz, DMSO-
d6):    172.0 (COOH), 157.8 (p-OPhNCS), 132.0 (i-OPhNCS), 127.3 (m-OPhNCS), 122.2 
(NCS), 115.6 (o-OPhNCS), 103.3 (C-1), 73.9 (C-5), 72.5 (C-3), 69.8 (C-4), 69.7 (C-2), 67.7 
(CH2CH2O), 67.2 (CH2CH2O). 
Anal. Calcd for C15H17NO8S (371.36): C, 48.51; H, 4.61; N, 3.77, S, 8.63.  Found: C, 48.49; 
H, 4.58; N, 3.78; S, 8.8.65. 
 
1,2,3,4-Tetra-O-acetyl-α-L-rhamnose (21)68 
 
Perchloric acid (0.4 mL, 60%) was added to a fresh distilled acetic anhydride (36 mL) at 0 
o
C. 
After stirring for 30 min L-rhamnose monohydrate (5.0 g, 27.5 mmol) was added in portions 
(0.5 g, 2.75 mmol) to solution at that temperature, the cooling bath was removed and stirring 
was continued at ambient temperature. After 1.5 h (monitored by TLC) the reaction mixture 
was cooled to 0 
o
C and poured into ice-water (200 mL). The aqueous layer was extracted with 
chloroform (3 × 30 mL). The combined organic solutions were washed with ice-water (3 × 20 
mL), sat aq NHCO3 (3 × 30 mL), ice-water (2 × 30 mL), dried and concentrated. Drying 
under high vacuum gave compound 21 as a colourless syrup. 
Yield: 8.96 g (98%) 
Rƒ: 0.3 ( 3 : 1 PE - EtOAc) 
 
 
 
2,3,4-Tri-O-acetyl-α-L-rhamnopyranosyl bromide (22)68 
  
General procedure: 
Water (33 mL) was added dropweise to a mixture of acetyl bromide (136 mL) and glacial 
acetic acid (100 mL) at –8 oC. At the end acetic anhydride (4 mL) was added to the solution. 
The resulting viscous mixture, which contains 40% (w/w) of hydrogen bromide and 1% (w/w) 
of acetic anhydride, can be safely kept in a refrigirator.  
Foregoing solution (40 mL) was added to a solution of compound 21 (9.02 g, 28.0 mmol) in 
dry chloroform (50 mL) at 0 
o
C. The cooling-bath was then removed and the reaction mixture 
was stirred at ambient temperature. After 40 min (monitored by TLC) the reaction mixture 
was diluted with chloroform (20 mL), poured into ice-water (100 mL) and after 5 min organic 
layer was separated. The aqueous layer was extracted with chloroform (3 × 15 mL). The 
combined organic solutions were washed with ice-water (2 × 20 mL), sat aq NHCO3 (3 × 30 
mL), ice-water (2 × 10 mL), dried and concentrated. The residue was dried under high 
vacuum to give compound 22 as a yellow syrup. Bromide 22 was used for the next step 
directly without further purification. 
Yield: 9.45 g (96%) 
Rƒ: 0.45 (3 : 1 PE - EtOAc) 
 
3,4-Di-O-acetyl-1,2-O-(1-exo-ethoxyethyliden)-β-L-rhamnopyranose (23)68 
 
Bromide 22 (5.0 g, 14.1 mmol) and molecular sieves (4Å, 0.5 g) were stirred in dry 
dichlormethane (50 mL) for 20 min at ambient temperature in darkness. Dry ethanol (1.8 mL, 
20.6 mmol), sym-collidine (2.5 mL, 19.1 mmol) and tetrabutylammonium bromide (2 g, 6.2 
mmol) were added to the mixture.  After stirring for 9 h (monitored by TLC) at ambient 
temperature under an atmosphere of argon, the precipitated sym-collidine hydrobromide was 
filtered off and the filtrate was passed through a layer of silica gel. The solution was diluted 
with chloroform (50 mL) and heptane (150 mL), washed with ice-water (3 × 30 mL), dried 
end concentrated. The purification of the residue by column chromatography (2 : 1 PE - 
EtOAc with 1% Et3N) gave compound 23 as a colourless syrup. Analytical sample was 
crystallized from diethyl ether to provide stereo structure.   
Yield: 4.26 g (95%) 
M.p.: 87 - 88 
o
C (from diethyl ether) 
Rƒ: 0.3 (2 : 1 PE - EtOAc) 
[α] 23D : +33.2 (c 1.0, CHCl3) 
1
H NMR (500.13 MHz, CDCl3): δ 5.39 (d, 1H, 
3
J1,2 2.4 Hz, H-1), 5.06 (m, 2H, 
3
J Hz, H-4, 
CH2CH3), 4.57 (dd, 1H, 
3
J2,3 3.6 Hz, 
3
J1,2 2.4 Hz, H-2), 3.54 (m, 2H, 
3
J3,4 9.1 Hz, 
3
J2,3 4.1 Hz, 
H-3, CH2CH3), 3.49 (m, 1H, 
3
J4,5 9.1 Hz, 
3
J5,6 6.0 Hz, H-5), 2.10 (s, 3H, CH3CO), 2.05 (s, 3H, 
CH3CO),  1.72 (s, 3H, CH3), 1.22 (d, 3H,
 3
J5,6 6.0 Hz, H-6), 1.16 (t, 3H, 
3
J 7.0 Hz, CH2CH3); 
13
C NMR (125.8 MHz, CDCl3): δ 170.5 (CH3CO), 169.7 (CH3CO), 124.8 (COC2H5), 97.2 
(C1), 76.6 (C-2), 70.8 (C-3), 73.0 (C-4),  69.1 (C-5), 58.0 (CH2CH3),  24.9 (CH3), 20.8 
(CH3CO), 20.7 (CH3CO), 17.5 (C-6) 15.3 (CH2CH3).  
 
2,3-Di-O-benzyl-1,2-O-(1-exo-ethoxyethyliden)-β-L-rhamnopyranose (25)68 
 
Powdered potassium hydroxide (10.0 g, 178.6 mmol) was added to a solution of compound 
23 (4.3 g, 13.5 mmol) in dry toluene (30 mL) and the mixture was heated under reflux. After 
20 min benzyl chloride (15 mL, 130.3 mmol) was added dropwise. The reaction mixture was 
heated under reflux for 2.5 h (monitored by TLC), cooled to room temperature and diluted 
with toluene (30 mL). The salts were filtered off and washed with toluene (3 × 5 mL). The 
combined organic solutions were washed with ice-water (5 × 10 mL), dried and concentrated. 
The crude product was purified by column chromatography (4 : 1 PE - EtOAc with 1%  Et3N) 
to give colourless crystalline compound 25.  
Yield: 4.94 g (88%) 
M.p.: 76 - 78 
o
C (from Hept - EtOAc, similar to litr.) 
Rƒ: 0.6 (2 : 1 PE - EtOAc) 
[α] 23D : +3.3 (c 1.0, CHCl3) 
1
H NMR (500.13 MHz, CDCl3): δ 7.42–7.30 (m, 10H, 2 × Ph), 5.27 (d, 1H, 
3
J1,2 2.3 Hz, H-
1), 4.97 (d, 
2
J 10.8 Hz, CH2Ph), 4.78 (s, 2H, 2 × CH2Ph),  4.68 (d, 
2
J 10.8 Hz, CH2Ph), 4.38 
(dd, 1H, 
3
J2,3 4.1 Hz, 
3
J1,2 2.3 Hz, H-2), 3.69 (dd, 1H, 
3
J3,4 9.1 Hz, 
3
J2,3 4.1 Hz, H-3), 3.56 (m, 
2H, 
3
J 7.0 Hz, CH2CH3), 3.49 (t, 1H, 
3
J3,4 9.1 Hz, H-4), 3.33 (m, 1H, 
3
J4,5 9.1 Hz, 
3
J5,6 6.0 Hz, 
H-5),  1.73 (s, 3H, CH3), 1.35 (d, 3H,
 3
J5,6 6.0 Hz, H-6), 1.22 (t, 3H, 
3
J 7.0 Hz, CH2CH3); 
13
C 
NMR (125.8 MHz, CDCl3): δ 138.3 (i-Ph), 137.9 (i-Ph), 128.5, 128.4, 128.1, 128.0, 127.9, 
127.8 (m-Ph, p-Ph, o-Ph), 123.6 (COC2H5), 97.3 (C-1), 79.5 (C-4), 79.0 (C-3), 77.0 (C-2), 
75.5 (CH2Ph), 72.3 (CH2Ph), 70.0 (C-5), 58.0 (CH2CH3),  24.7 (CH3), 17.9 (C-6) 15.2 
(CH2CH3).  
 
1,2-Di-O-acetyl-3,4-di-O-benzyl-α/β-L-rhamnopyranose (26) 
 
                        α                                              β 
Compound 25 (8.8 g, 21.2 mmol) was hydrolyzed by treatment with 70% aqueous acetic acid 
(60 mL) for 7 min at ambient temperature. The solution was concentrated and acetic acid was 
removed by co-evaporation with toluene (5 × 20 mL). Without further purification, the crude 
syrupy residue was dissolved in dry pyridine (220 mL). Acetic anhydride was added to the 
solution at 0 
o
C, cooling-bath was then removed and the reaction mixture was stirred at 
ambient temperature. After 1 h (monitored by TLC) the mixture was poured into ice-water 
and the aqueous layer was extracted with chloroform (3 × 100 mL). The combined organic 
solutions were washed with aq 1% HCl (3 × 50 mL), ice-water (3 × 30 mL), sat aq NHCO3 (3 
× 50 mL), ice-water (3 × 30 mL), dried and concentrated. The syrupy residue was purified by 
flash chromatography (3 : 1 PE - EtOAc) to give compound 26α as a colourless solid and 26β 
as a colourless syrup. 
1,2-di-O-Acetyl-3,4-di-O-Benzyl-β-L-Rhamnopyranose  colourless syrup. 
Yield: 5α 6.28 g (69%) and 5β 1.27 g (14%) 
Rƒ : 0.5 (5α); 0.47 (5β) (2 : 1 PE - EtOAc)  
(5α) 1H NMR (500.13 MHz, CDCl3): δ 7.38–7.30 (m, 10H, 2×Ph), 6.02 (d, 1H, 
3
J1,2 2.0 Hz, 
H-1), 5.37 (dd, 1H, 
3
J2,3 3.4 Hz, 
3
J1,2 2.0 Hz, H-2), 4.94 (d, 
2
J 10.7 Hz, CH2Ph), 4.74 (d, 
2
J 
11.1 Hz, CH2Ph), 4.64 (d, 
2
J 10.7 Hz, CH2Ph), 4.56 (d, 
2
J 11.1 Hz, CH2Ph), 3.94 (dd, 1H, 
3
J3,4 
9.2 Hz, 
3
J2,3 3.4 Hz, H-3), 3.85–3.80 (m, 1H, H-5), 3.49 (t, 1H, 
3
J3,4 9.2 Hz, H-4), 2.18 (s, 3H, 
CH3CO), 2.09 (s, 3H, CH3CO), 1.35 (d, 3H, H-6). 
13
C NMR (125.8 MHz, CDCl3): δ 170.0 (CH3CO), 168.5 (CH3CO), 138.2 (i-Ph), 137.7 (i-
Ph), 128.4, 128.1, 128.0, 127.8, 127.8 (m-Ph, p-Ph, o-Ph), 91.1 (C-1), 79.5 (C-4), 77.57 (C-3), 
75.59 (CH2Ph), 71.88 (CH2Ph), 69.99 (C-5), 67.76 (C-2), 20.93 (CH3CO), 20.87 (CH3CO), 
17.98 (C6).  
(5β) 1H NMR (500.13 MHz, CDCl3): δ 7.37–7.30 (m, 10H, Ph), 5.74 (d, 1H, 
3
J1,2 1.0 Hz, H-
1), 5.62 (dd, 1H, 
3
J2,3 3.4 Hz, 
3
J1,2 1.0 Hz, H-2), 4.94 (d, 
2
J 10.8 Hz, CH2Ph), 4.73 (d, 
2
J 11.2 
Hz, CH2Ph), 4.64 (d, 
2
J 10.8 Hz, CH2Ph), 4.52 (d, 
2
J 11.2 Hz, CH2Ph), 3.71 (dd, 1H, 
3
J3,4 9.2 
Hz, 
3
J2,3 3.4 Hz, H-3), 3.56–3.51 (m, 1H,
 3
J4,5 9.5 Hz, H-5), 3.49 (t, 1H, 
3
J4,5 9.5 Hz, 
3
J3,4 9.2 
Hz, H-4), 2.23 (s, 3H, CH3CO), 2.11 (s, 3H, CH3CO), 1.39 (d, 3H, H-6). 
13
C NMR (125.8 MHz, CDCl3): δ 170.5 (CH3CO), 168.7 (CH3CO), 138.1 (i-Ph), 137.4 (i-
Ph), 128.5, 128.4, 128.1, 128,0, 127.9, 127.8 (m-Ph, p-Ph, o-Ph), 91.1 (C-1), 79.7 (C-3), 79.2 
(C-4), 75.5 (CH2Ph), 72,7 (C-5), 71.6(CH2Ph), 67.6 (C-2), 21.0 (CH3CO), 20.8 (CH3CO), 
17.9 (C6). 
Anal. Calcd for C24H28O7 (428.47): C, 67.28; H, 6.59. Found: C, 67.29; H, 6.57. 
 
2-O-Acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl bromide (27) 
 
Oxalyl bromide (1.2 mL, 8.4 mmol) was added to solution of a compound 26 (1 g, 2.3 mmol) 
in dry dichloromethane (15 mL) under an atmosphere of argon at –40 °C. After stirring for 1 h 
at that temperature, the cooling-bath was removed and stirring was continued for 4 h at 
ambient temperature (monitored by TLC). The mixture was concentrated and co-evaporated 
with toluene (3 × 5 mL). The residue was dried under high vacuum to give compound 27 as 
light-yellow syrup. Bromide 27 was used directly without further purification. 
Yeld: 995 mg (~96%) 
Rƒ : 0.55 (2 : 1 PE - EtOAc) 
 
2(-4-Nitrophenoxy)ethyl 2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranoside (28) 
 
2-(4-Nitrophenoxy)ethanol (320 mg, 1.75 mmol) compound 27 (0.6 g, 1.33 mmol) and 
molecular sieves (4Å, 0.3 g) were dried for 2 h under high vacuum in darkness. The mixture 
was dissolved in dry acetonitrile (6 mL) and stirred at ambient temperature under an 
atmosphere of argon. After 20 min Hg(CN)2 (0.2 g, 0.8 mmol), HgBr2 (0.05 g, 0.15 mmol) 
were added and stirring was continued at ambient temperature. After 24 h (monitored by 
TLC) the mixture was diluted with chloroform (10 mL) and filtered over celite. The filtrate 
was extracted with ice-water (2 × 5 mL), aq 10% KI (3 × 5 mL), ice-water (2 × 5 mL), dried 
and concentrated. Purification of the residue by column chromatography (3 : 1 PE - EtOAc) 
gave compound 28 as a yellow syrup. 
Yield: 704 mg (96%) 
Rƒ: 0.4 (2 : 1 PE - EtOAc) 
1
H NMR (300 MHz, CDCl3):  8.17 (d, 2H, m-OPhNO2), 7.30–7.23 (m, 10H, Ph), 6.94 (d, 
2H, o-OPhNO2), 5.38 (dd, 1H,
 3
J 2,3 3.4 Hz, H-2), 4.89 (d, 1H, 
2
J 10.9 Hz, CH2Ph), 4.81 (d, 
1H, 
3
J 1,2 1.7 Hz, H-1), 4.66 (d, 1H, 
2
J 11.2 Hz, CH2Ph), 4.59 (d, 1H, 
2
J 10.9 Hz, CH2Ph), 
4.49 (d, 1H, 
2
J 11.2 Hz, CH2Ph), 4.17 (t, 2H, CH2CH2O), 3.99 (m, 1H, CH2CH2O), 3.90 (dd, 
1H,
 3
J 2,3 3.4 Hz, H-3), 3.83 (m, 1H, CH2CH2O), 3.79 (m, 1H, H-5), 3.44 (t, 1H, 
3
J 4,5 9.5 Hz, 
H-4), 2.14 (s, 3H, CH3CO), 1.31 (d, 3H, H-6); 
13
C NMR (75.5 MHz, CDC13):  170.3 
(CH3CO), 163.6 (p-OPhNO2), 141.7 (i-OPhNO2), 138.3, 137.9 (i-Ph), 128.3–127.7 (o-Ph,m-
Ph,p-Ph), 125.9 (m-OPhNO2), 114.5 (o-OPhNO2), 97.9 (C-1), 79.8 (C-4), 77.8 (C-3), 
75.4(CH2Ph), 71.7 (CH2Ph), 68.7 (C-2), 67.9 (C-5), 67.5 (CH2CH2O), 65.6 (CH2CH2O), 21.0 
(CH3CO), 17.9 (C-6). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C30H34NO9 [M+H]
+
: 552.2228, found: 
552.2223; calcd for C30H34NO9 [M+Na]
+
: 574.2048, found: 574.2064. 
 
2-(4-Nitrophenoxy)ethyl 3,4-di-O-benzyl-α-L-rhamnopyranoside (29) 
 
 
Compound 28 (600 mg, 1.09 mmol was added with stirring to methanolic 0.28 M 
hydrochloric acid [prepared by adding of acetyl chloride (1.1 mL) in ice-cold dry methanol 
(50 mL)] and the mixture was stirred at ambient temperature under an atmosphere of argon. 
After 24 h (monitored by TLC) PbCO3 × Pb(OH)2 (5 g) was added to the reaction mixture and 
stirring was continued for additional 2 h at ambient temperature. Salts were filtered off by 
using glass sintered filter funnel with a layer of silica gel, washed with methanol (3 × 10 mL) 
and the combined organic solutions were concentrated. Purification of the residue by column 
chromatography (2 : 1 PE - EtOAc) gave compound 29 as a yellow syrup. 
Yield: 530 mg (95%) 
Rƒ: 0.2 (2 : 1 PE - EtOAc) 
1
H NMR (300 MHz, CDCl3):  8.21 (d, 2H, m-OPhNO2), 7.37–7.31 (m, 10H, Ph), 6.98 (d, 
2H, o-OPhNO2), 4.92 (d, 1H,
 3
J , 1.6 Hz, H-1 ), 4.70 (bs, 2H, H-2, CH2Ph ) 4.65 (d, 1H, 
2
J 
10.9 Hz, CH2Ph), 4.21 (t, 2H, CH2CH2O), 4.07(dd, 1H, H-3), 4.02 (m, 1H, CH2CH2O), 3.89–
3.81 (m, 2H, CH2CH2O, CH2Ph),3.77 (m, 1H,
 3
J 4,5 9.4 Hz, H-5), 3.48 (t, 1H, 
3
J 4,5 9.4 Hz, H-
4), 2.14 (s, 3H, CH3CO), 1.31 (d, 3H, H-6); 
13
C NMR (75.5 MHz, CDC13):  163.7 (p-
OPhNO2), 141.7 (i-OPhNO2), 138.2, 137.8 (i-Ph), 128.5, 128.4, 128.0, 127.8,127.7 (o-Ph,m-
Ph,p-Ph), 125.9 (m-OPhNO2), 114.5 (o-OPhNO2), 99.3 (C-1), 79.9 (C-4), 79.7 (C-3), 
75.4(CH2Ph), 72.0 (CH2Ph), 68.4 (C-2), 67.7 (CH2CH2O), 67.6 (C-5),65.5 (CH2CH2O), 17.9 
(C-6). 
Anal. Calcd for C28H31NO8 (509.55): C, 66.00; H, 6.13; N, 2.75.  Found: C, 66.03; H, 6.11; 
N, 2.74. 
 
Methyl 2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(allyl 2,3-di-O-benzyl-
β-D-galactopyranosid)uronate (30) 
  
Compound 27 (0.6 g, 1.3 mmol), compound 18 (0.43 g, 1.0 mmol) and molecular sieves (4Å, 
0.4 g) were dried 2 h under high vacuum in darkness. The mixture was suspended in dry 
acetonitrile (15 mL) and stirred under an atmosphere of argon. After 20 min Hg(CN)2 (0.2 g, 
0.8 mmol) and HgBr2 (0.05 g, 0.14 mmol) were added. The reaction mixture was continued to 
stirring under an atmosphere of argon. After 24 h the mixture was filtered over Celite and the 
filter was washed with chloroform (20 mL). Combined organic solution was extracted with 
ice-water (2 × 10 mL), aq 10% KI (3 × 10 mL) and ice-water (2 × 10 mL). The organic layer 
was then concentrated and the residue was purified by column chromatography (4 : 1 PE - 
EtOAc) to give compound 30 as colourless foam and corresponding β isomer in 20% yield. 
Yield: 0.54 g (67%) 
Rƒ: 0.43 (2 : 1 PE- EtOAc) 
[α] 22D : +42.3 (c 1.0, CHCl3) 
1
H NMR (500.13 MHz, CDCl3):  7.39–7.22 (m, 20H, Ph), 5.98 (dddd, 1H, J 17.3, 10.5, 6.2, 
5.0 Hz, CH2CH=CH2), 5.55 (dd, 1H, 
3
J2´,3´ 3,3 Hz, 
3
J1´,2´ 1,9 Hz, H-2´), 5.37 (d’q’, 1H, 
3
J 17,3 
Hz, 
2
J  1.5 Hz, CH2CH=CH2), 5.23 (d’q’, 1H, 
3
J  10,5 Hz, 
2
J  1.5 Hz, CH2CH=CH2), 5.22 (m, 
1H, 
3
J1´,2´ 1,9 Hz, H-1´), 4.95 (d, 1H, 
2
J 11.0 Hz, CH2Ph), 4.90 (d, 1H,
 2
J 11.3 Hz, CH2Ph), 
4.80 (d, 1H,
 2
J 11.0 Hz, CH2Ph), 4.78 (d, 1H,
 2
J 11.8 Hz, CH2Ph), 4.76 (d, 1H,
 2
J 11.8 Hz, 
CH2Ph), 4.69 (d, 1H,
 2
J 10.9 Hz, CH2Ph), 4.59 (d, 1H,
 2
J 11.3 Hz, CH2Ph), 4.52 (dd’t’, 1H,
 2
J 
13.0 Hz, 
3
J 5.0 Hz, 
4
J 1.6 Hz, CH2CH=CH2), 4.48 (d, 1H,
 2
J 10.9 Hz, CH2Ph),  4.44 (dd, 1H, 
3
J4,3 3.0 Hz, 
3
J4,5 1.4 Hz, H-4), 4.41 (d, 1H, 
3
J1,2 7.8 Hz, H-1), 4.17 (dd’t’, 1H, 
2
J 13.0 Hz,
 3
J 
6.2 Hz, 
4
J 1.4 Hz,  CH2CH=CH2), 4.04 (d, 1H, 
3
J4,5 1.4 Hz, H-5), 3.93 (dd, 1H,
 3
J3´,4´ 9.5 Hz, 
3
J2´,3´ 3.3 Hz, H-3´), 3.79 (s, 3H, OCH3), 3.78 (dd, 1H, 
3
J2,3 9.7, 
3
J1,2 7.8 Hz, Hz, H-2), 3.65 
(dq, 1H, 
3
J4´,5´ 9.5 Hz, 
3
J5´,6´ 6.2 Hz, H-5´), 3.56 (dd, 1H, 
3
J2,3 9.7 Hz, 
3
J3,4 3.0 Hz, H-3), 3.36 
(’t’, 1H, 3J3´,4´ = 
3
J4´,5´ 9.5 Hz, H-4´), 2.08 (s, 3H, CH3CO), 1.29 (d, 3H, 
3
J5´,6´ 6.2 Hz, H-6´); 
13
C NMR (125.8 MHz, CDCl3):  169.8 (CH3CO), 168.0 (COO), 138.9, 138.4, 138.2, 137.9 
(i-Ph), 133.9 (CH2CH=CH2), 128.3, 128.3, 128.2, 128.2, 128.1, 128.1, 127.6, 127.5 (o-Ph,m-
Ph), 127.6,127.6, 127.5, 127.4 (p-Ph), 117.5 (CH2CH=CH2), 102.7 (C-1), 99.1 (C-1´), 80.8 
(C-3), 79.7 (C-4´), 78.2 (C-2), 77.9 (C-3´), 75.1 (CH2Ph), 74.8 (CH2Ph), 73.7 (C-4), 73.7 (C-
5), 73.1 (CH2Ph), 71.8 (CH2Ph), 70.6 (CH2CH=CH2), 68.8 (C-2´), 68.2 (C-5´), 52.4 (OCH3), 
21.0 (CH3CO), 17.9 (C-6´). 
β-isomer 
1
H NMR (500.13 MHz, CDCl3):  7.46–7.43 (m, 2H), 7.38–7.27 (m, 18H), (4 × Ph), 5.98 
(dddd, 1H, J 17.3, 10.5, 6.1, 5.0 Hz, CH2CH=CH2), 5.58 (dd, 1H, 
3
J2´,3´ 3,3 Hz, 
3
J1´,2´ 1.0 Hz, 
H-2´), 5.36 (d’q’, 1H, 3J  17.3 Hz, , 
2
J  1.6 Hz, CH2CH=CH2), 5.21 (d’q’, 1H,
 3
J  10.5 Hz, , 
2
J  
1.6 Hz,  CH2CH=CH2), 4.94 (d, 1H, 
2
J 10.9 Hz, CH2Ph), 4.88 (d, 1H,
 2
J 11.0 Hz, CH2Ph), 
4.85 (d, 1H,
 2
J 11.6 Hz, CH2Ph), 4.77 (d, 1H,
 2
J 11.3 Hz, CH2Ph), 4.76 (d, 1H,
 2
J 11.0 Hz, 
CH2Ph), 4.73 (dd, 1H, 
3
J3,4 3.2 Hz,
 3
J4,5 1.1 Hz, H-4), 4.63 (d, 1H,
 2
J 10.9 Hz, CH2Ph), 4.60 
(d, 1H, 
3
J1´,2´ 1.0 Hz, H-1´), 4.59 (d, 1H,
 2
J 11.5 Hz, CH2Ph), 4.49 (dd’t’, 1H,
 2
J 13.0 Hz, ,
 3
J 
5.0 Hz, 
4
J 1.6 Hz, CH2CH=CH2), 4.49 (d, 1H,
 2
J 11.2 Hz, CH2Ph), 4.41 (d, 1H, 
3
J1,2 7.7 Hz, 
H-1), 4.17 (dd’t’, 1H, 2J 13.0 Hz, , 3J 6.1 Hz, 4J 1.4 Hz, CH2CH=CH2), 3.98 (d, 1H, 
3
J4,5 1.1 
Hz, H-5), 3.82 (s, 3H, OCH3), 3.75 (dd, 1H, 
3
J1,2 7.7 Hz, 
3
J2,3 9.7 Hz, H-2), 3.58 (dd, 1H,
 3
J3´,4´ 
9.2 Hz, 
3
J2´,3´ 3.3 Hz, H-3´), 3.50 (dd, 1H, 
3
J2,3 9.7 Hz, 
3
J3,4 3.2 Hz, H-3), 3.46 (’t’, 1H, 
3
J4´,5´ 
9.3 Hz, 
3
J3´,4´ 9.2 Hz,  H-4´), 3.32 (dq, 1H, 
3
J4´,5´ 9.3 Hz, 
3
J5´,6´ 6.2 Hz, H-5´), 2.03 (s, 3H, 
CH3CO), 1.36 (d, 3H,
 3
J5´,6´ 6.2 Hz, H-6´); 
13
C NMR (125.8 MHz, CDCl3):  170.4 
(CH3CO), 168.9 (COO), 138.7, 138.4, 138.4, 137.6 (i-Ph), 134.1 (CH2CH=CH2), 128.3, 
128.3, 128.2,128.1,128.1,127.9,127.8 (o-Ph,m-Ph), 127.7, 127.7, 127.4, 127.4 (p-Ph), 117.1 
(CH2CH=CH2), 102.6 (C-1), 97.8 (C-1´), 80.0 (C-3´), 79.7 (C-4´), 79.6 (C-3), 78.1(C-2), 75.3 
(CH2Ph), 75.2 (CH2Ph), 73.1 (C-5), 71.9 (C-5´), 71.7 (C-4), 71.4 (CH2Ph), 71.2 (CH2Ph), 
70.2 (CH2CH=CH2), 68.0 (C-2´), 52.4 (OCH3), 20.9 (CH3CO), 17.8 (C-6´). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C46H52O12 [M+Na]
+
: 819.3351, found: 
819.3355. 
 Methyl 2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(2-(4-
nitrophenoxy)ethyl 2,3-di-O-benzyl-β-D-galactopyranosid)uronate (31) 
  
Compound 27 (500 mg, 1.1 mmol), compound 17 (450 g, 0.8 mmol) and molecular sieves  
(4Å, 600 mg) were dried 2 h under high vacuum in darkness. The mixture was suspended in 
dry acetonitrile (15 mL) and stirred under an atmosphere of argon. After 20 min Hg(CN)2 
(300 mg, 1.2 mmol) and HgBr2 (100 g, 0.28 mmol) were added and stirring was continued. 
After 30 h the mixture was filtered over Celite by elution with CHCl3 (20 mL). Combined 
organic solution was extracted with ice-water (2 × 10 mL), aq 10% KI (3 × 10 mL) and ice-
water (2 × 10 mL). The organic layer was dried, then concentrated and the residue was 
purified by column chromatography (2 : 1 PE - EtOAc) to give compound 31 as colourless 
foam and corresponding β isomer as yellow syrup in 15% yield. 
Yield: 502 mg (68%) 
Rƒ: 0.33 (1 : 1 PE- EtOAc) 
1
H NMR (300 MHz, CDCl3):  8.17 (d, 2H, m-OPhNO2), 7.33–7.19 (m, 20H, Ph), 6.93 (d, 
2H, o-OPhNO2), 5.54 (m, 1H,
 3
J1´,2´ 1.8 Hz, 
3
J2´,3´ 3,2 Hz, H-2´), 5.17 (d, 1H,
 3
J1´,2´ 1.6 Hz, H-
1´), 4.88 (m, 2H, 2 × CH2Ph), 4.76 (d, 2H, 2 × CH2Ph), 4.67 (m, 1H, 
2
J 11.0 Hz 2 × CH2Ph), 
4.57 (m, 1H,
 2
J 11.0 Hz, CH2Ph), 4.48 (d, 1H, CH2Ph), 4.44 (m, 1H,H-1), 4.43 (dd, 1H,
 3
J3,4 
2.8 Hz, H-4), 4.37-4.30 (m, 2H, CH2CH2O), 4.24 (m, 1H, CH2CH2O), 4.06 (d, 1H, 
3
J 1.0 Hz, 
H-5), 3.99 (m, 1H,
 
CH2CH2O), 3.90 (dd, 1H, 
3
J2´,3´ 3.4, 
3
J3,4 9.5 Hz, H-3´),  3.77 (s, 3H, 
OCH3), 3.72 (dd, 1H, 
3
J1,2 7.6 Hz, 
3
J2,3 9.6 Hz, H-2), 3.65 (m, 1H,
 3
J4´´´,5´´´ 9.9 Hz, H-5´), 3.57 
(dd, 1H,
 3
J3,4 2.8 Hz, 
3
J2,3 9.6 Hz, H-3), 3.36 (t, 1H, 
3
J4´,5´ 9.9 Hz, H-4´), 2.08 (s, 3H, CH3CO), 
1.29 (d, 3H, H-6´); 
13
C NMR (62.9 MHz, CDCl3):  169.9 (CH3CO), 167.8 (COO), 163.7 (p-
OPhNO2), 141.6 (i-OPhNO2), 138.7, 138.2, 138.1, 137.7, (i-Ph), 129.0, 128.4,128.3, 128.2, 
128.1, 128.0, 127.7, 127.7, 127.6, 127.4 (o-Ph,m-Ph,p-Ph), 125.9 (m-OPhNO2), 114.5 (o-
OPhNO2), 104.0 (C-1) , 99.3 (C-1´), 80.4 (C-3), 79.7 (C-4´), 78.0 (C-2), 77.8 (C-3´), 75.0 
(CH2Ph), 74.9 (CH2Ph), 73.9 (C-4), 73.6 (C-5), 73.0 (CH2Ph), 71.8 (CH2Ph),  68.8 (C-2´), 
68.3 (C-5´), 68.1 (CH2CH2O), 67.8 (CH2CH2O), 52.5 (OCH3),  21.1 (CH3CO), 18.0 (C-6´). 
Anal. Calcd for C44H48NO14 (814.85): C, 64.85; H, 5.94; N, 1.72.  Found: C, 64.88; H, 5.92; 
N, 1.71. 
 
Methyl 2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(mthyl 2,3-di-O-benzyl-
β-D-galactopyranosid)uronate Methyl 3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(2-
(4-nitrophenoxy)ethyl 2,3-di-O-benzyl-β-D-galactopyranosid)uronate (32) 
 
Compound 31 (450 mg, 0.49 mmol) was added to stirred solution of methanolic 0.28 M 
hydrochloric acid [prepared by adding of acetyl chloride (1 mL) to ice-cold dry methanol (50 
mL)] and the mixture was stirred for 24 h at ambient temperature under an atmosphere of 
argon (monitored by TLC). The solution was filtered through a layer of alkaline alumina by 
elution with CHCl3. The combined eluates (ca. 200 mL) were dried, concentrated and the 
crude product was purified by column chromatography (1 : 1 PE - EtOAc) to provide acceptor 
32 as colourless foam. 
Yield: 680 mg (87%) 
Rƒ: 0.27 (1 : 1 PE - EtOAc) 
1
H NMR (300 MHz, CDCl3):  8.17 (d, 2H, m-OPhNO2), 7.33–7.17 (m, 20H, Ph), 6.92 (d, 
2H, o-OPhNO2), 5.17 (d, 1H,
 3
J1´,2´ 1.7 Hz, H-1´), 4.88 (d, 1H,
 2
J 11.0 Hz,  CH2Ph), 4.86 (d, 
1H,
 2
J 11.3 Hz, CH2Ph), 4.76 (d, 2H, 2 × CH2Ph), 4.71 (d, 1H,
 2
J 11.0 Hz,  CH2Ph), 4.63 (m, 
3H, 
2
J 11.0 Hz 3 × CH2Ph), 4.46 (m, 1H, , 
3
J1,2 7.6 Hz, H-1), 4.45 (dd, 1H,
 3
J3,4 2.8 Hz, H-4), 
4.37-4.30 (m, 2H, CH2CH2O), 4.24 (m, 1H, CH2CH2O), 4.06 (d, 1H, 
3
J 1.0 Hz, H-5), 4.00 (m, 
1H,
 
CH2CH2O), 3.83 (dd, 1H, 
3
J2´,3´ 3.2, 
3
J3,4 9.5 Hz, H-3´),  3.79 (s, 3H, OCH3), 3.71 (dd, 1H, 
3
J1,2 7.6 Hz, 
3
J2,3 9.6 Hz, H-2), 3.64 (m, 1H,
 3
J4´,5´ 9.3 Hz, H-5´), 3.57 (dd, 1H,
 3
J3,4 2.8 Hz, 
3
J2,3 
9.6 Hz, H-3), 3.42 (t, 1H, 
3
J4´´´,5´´´ 9.3 Hz, H-4´), 2.36 (bs, 1H, OH), 1.28 (d, 3H, H-6´); 
13
C 
NMR (125.8 MHz, CDCl3):  167.8 (COO), 163.7 (p-OPhNO2), 141.7 (i-OPhNO2), 138.7, 
138.3, 138.2, 137.6, (i-Ph), 129.0, 128.5,128.4, 128.2, 128.2, 127.9, 127.9, 127.8, 127.6, 
127.4 (o-Ph,m-Ph,p-Ph), 125.9 (m-OPhNO2), 114.5 (o-OPhNO2), 104.0 (C-1) , 100.5 (C-1´), 
80.4 (C-3), 79.7 (C-4´), 78.0 (C-2), 77.8 (C-3´), 75.0 (CH2Ph), 74.9 (CH2Ph), 73.9 (C-4), 73.6 
(C-5), 73.0 (CH2Ph), 71.8 (CH2Ph),  68.8 (C-2´), 68.3 (C-5´), 68.1 (CH2CH2O), 67.8 
(CH2CH2O), 52.2 (OCH3), 17.9 (C-6´). 
Anal. Calcd for C42H46NO13 (772.81): C, 65.27; H, 6.00; N, 1.81.  Found: C, 65.25; H, 5.99; 
N, 1.80. 
 
Methyl 4-O-acetyl-2,3-di-O-benzyl-α/β-D-galactopyranuronate (33) 
 
Methyl (allyl 4-O-acetyl-2,3-di-O-benzyl-β-D-galactopyranosid)uronate (470 mg, 1.0 mmol), 
palladium(II) chloride (180 mg, 1 mmol) and sodium acetate (656 mg, 8 mmol) were stirred 
in acetic acid (10 mL, 95%) for 3 h at 45 
o
C (monitored by TLC). The mixture was diluted 
with chloroform (20 mL), filtrated over celite, co-evaporated with toluene (3 × 10 mL) and 
concentrated. The residue was purified by column chromatography (1 : 1 PE - EtOAc) to give 
compound 33 as colourless syrup. 
Yield: 323.4 mg (75%) 
Rƒ: 0.2 (1 : 1 PE - EtOAc) 
1
H NMR (500.13 MHz, CDCl3, : = 4:1):   7.36–7.26 (m, 10H, Ph), 5.86 [dd, 1H, 
3
J3,4 3.5 
Hz, 
3
J4,5 1.5 Hz, H-4()], 5.78 [dd, 1H, 
3
J3,4 3.2 Hz, 
3
J4,5 1.5 Hz, H-4()], 5.37 [d, 1H, 
3
J1,2 3.6 
Hz, H-1()], 4.89 [d, 1H, 2J 11.0 Hz, CH2Ph()], 4.83 [d, 1H, 
2
J 11.7 Hz, CH2Ph()], 4.78 [d, 
1H, 
2
J 11.4 Hz, CH2Ph()], 4.78 [d, 1H, 
2
J 11.0 Hz, CH2Ph()], 4.77 (d, 1H, 
2
J 11.0 Hz, 
CH2Ph()], 4.76 [d, 1H, 
3
J4,5 1.5 Hz, H-5()], 4.69 [d, 1H, 
3
J1,2 7.5 Hz, H-1()], 4.66 [d, 1H, 
2
J 11.7 Hz, CH2Ph()],4.57 [d, 1H, 
2
J 11.4 Hz, CH2Ph()], 4.54 [d, 1H, 
2
J 11.0 Hz, 
CH2Ph()],4.17 [d, 1H, 
3
J4,5 1.5 Hz, H-5()], 4.02 [dd, 1H, 
3
J2,3 9.8 Hz, 
3
J3,4 3.5 Hz, H-3()], 
3.97 [br s, 1H, OH()], 3.83 [dd, 1H, 3J2,3 9.8 Hz, 
3
J1,2 3.6 Hz, H-2()], 3.76 [s, 3H, 
CH3O()], 3.74 [s, 3H, CH3O()], 3.64–3.57 [m, 2H, H-2(), H-3()], 3.40 [br s, 1H, 
OH()], 2.10 [s, 3H, CH3CO()], 2.08 [s, 3H, CH3CO()]. 
13
C NMR (125.8 MHz, CDCl3): 
 169.9, 168.3 [COO(), CH3CO()], 169.9, 167.4 [COO(), CH3CO()], 138.3, 137.4 [i-
Ph()], 137.9, 137.7 [i-Ph()], 128.4, 128.3, 128.0, 127.9 [o-Ph(), m-Ph()], 128.3, 128.3, 
128.0, 128.0 [o-Ph(), m-Ph()], 127.9, 127.7 [p-Ph()], 127.8, 127.7 [p-Ph()], 97.4 [C-
1()], 92.1 [C-1()], 79.2, 78.6 [C-2(), C-3()], 75.2 [C-3()], 74.9 [C-2()], 73.8, 72.0 
[CH2Ph ()], 72.5, 72.2 [CH2Ph ()], 68.5 [C-4()], 68.4 [C-5()], 67.6 [C-4()], 52.7 
[CH3O()], 52.5 [CH3O()], 20.7 [CH3CO()], 20.7 [CH3CO()]. 
Anal. Calcd  for C23H26O8 (430.45): C, 64.18; H, 6.09. Found: C, 64.23; H, 6.04. 
 
Methyl 4-O-acetyl-2,3-di-O-benzyl-α/β-D-galactopyranosyl uronat  N-phenyl 
trifluoroacetimidate (42)
82 
 
Cs2CO3 (652 mg, 2.0 mmol) and 2,2,2-trifluoro-N-phenyl-acetimidoyl chloride (415 mg, 2.0 
mmol) were consecutively added to compound 41 (430 mg, 1.0 mmol) in acetone (20 mL) at 
0 
o
C. The cooling bath was removed, and reaction mixture was stirred at ambient temperature. 
After 3 h (monitored by TLC) reaction mixture was diluted with CH2Cl2 (20 mL). Salts were 
filtered off and washed with EtOAc (2 × 10 mL). The combined organic solutions were 
concentrated and the residue was purified by column chromatography (3 : 1 PE - EtOAc) to 
give compound 42 as a colourless amorphous. 
Yield: 529 mg (88%) 
 Rƒ: 0.59 (PE : EtOAc= 1 : 1) 
1
H NMR (500.13 MHz, CDCl3, : = 1:5):   7.36–7.24 (m, 12H, 2 Ph, m-NPh), 7.09 (m, 
1H, p-NPh), 6.80 (d, 1H, J 7.9 Hz), 6.72 (d, 1H, J 7.9 Hz), (o-NPh), 5.91 [br s, 1H, H-4()], 
5.79 [br s, 1H, H-4()], 5.68 (br, 1H, H-1), 4.81 [qAB, 2H, 
2
J 11.7 Hz, CH2Ph()], 4.79 (d, 1H, 
2
J 12.0 Hz), 4.73 [d, 1H, 
2
J 12.0 Hz, CH2Ph()], 4.79 (d, 1H, 
2
J 11.3 Hz), 4.62 [d, 1H, 
2
J 11.3 
Hz, CH2Ph()], 4.79 (d, 1H, 
2
J 11.3 Hz), 4.56 [d, 1H, 
2
J 11.3 Hz, CH2Ph()], 4.20 (br, 1H, H-
5), 3.91 (’t’, 1H, 3J1,2 = 
3
J2,3 8.5 Hz, H-2), 3.70 (br m, 1H, H-3), 3.78 [s, 3H, CH3O()], 3.78 
[s, 3H, CH3O()], 2.15 [s, 3H, CH3CO()], 2.09 [s, 3H, CH3CO()]; 
13
C NMR (125.8 MHz, 
CDCl3):   169.8 [CH3CO()] , 169.7 [CH3CO()], 167.2 [COO()], 166.4 [COO()], 143.2 
[i-NPh()], 137.8, 137.5 [i-Ph()], 137.6, 137.2 [i-Ph()] , 128.7 [m-NPh()], 128.6 [m-
NPh()], 128.5, 128.4, 128.2, 128.1 [o-Ph(), m-Ph()], 128.4, 128.4, 127.8, 127.8 [o-Ph(), 
m-Ph()], 128.0, 128.0 [p-Ph()], 127.5, 127.5 [p-Ph()], 124.3 [p-NPh()], 123.3 [i-
NPh()], 119.4 [o-NPh()], 119.3 [o-NPh()], 96.4 [br, C-1()], 93.5 [br, C-1()], 78.7 [C-
3()], 76.9 [C-2()], 75.7, 72.3 [PhCH2()], 73.7, 72.4 [PhCH2()], 73.2 [C-5()], 68.2 [C-
4()], 67.3 [C-4()], 52.7 [CH3O()], 20.7 [CH3CO()], 20.6 [CH3CO()].  
HRMS, ESI-TOF/MS positive (m/z): calcd for C31H30F3NO8 [M+Na]
+
: 624.1816, found: 
624.1816. 
 
Methyl 4-O-acetyl-2,3-di-O-benzyl-α/β-D-galactopyranosyl uronat  trichloroacetimidate 
(35)
67 
 
1,8-Diaazabicyclo[5.4.0]undec-7-en (23 μL, 0.15 mmol) was added to mixture of compound 
33 (430 mg, 1.0 mmol) and trichloracetonitrile (2 mL, 9.6 mmol) in dry CH2Cl2 (8 ml) at –20 
o
C. After stirring for 1 h at –20 oC and an additional 1 h at room temperature (monitored by 
TLC) the reaction mixture was evaporated to dryness, dissolved in ethyl acetate (10 mL) and 
filtered over celite. Combined organic solutions were concentrated. Purification by column 
chromatography (2 : 1 PE - EtOAc) gave compound 35 as colourless foam. 
Yield: 430 mg (75%) 
 Rƒ: 0.37 (PE : EtOAc= 2 : 1) 
1
H NMR (500.13 MHz, CDCl3):  8.64 (s, 1H, NH), 7.32–7.27 (m, 10H, Ph), 6.66 (d, 1H, 
3
J1,2 3.1 Hz, H-1), 5.89 (dd, 1H,
 3
J4,5 1.5 Hz, H-4), 4.80 (d, 1H, 
2
J 11.7 Hz, CH2Ph), 4.79 (d, 
1H, 
2
J 12.0 Hz), 4.73 (d, 1H, 
2
J 12.0 Hz, CH2Ph), 4.62 (d, 1H, 
2
J 11.3 Hz, CH2Ph), 4.20 (br, 
1H, H-5), 3.91 (’t’, 1H, 3J1,2 = 
3
J2,3 8.5 Hz, H-2), 3.70 (brm, 1H, H-3), 3.75 (s, 3H, OCH3), 
2.10 (s, 3H, CH3CO). 
13
C NMR (125.8 MHz, CDCl3):   169.8 (CH3CO), 167.3 (COO), 
137.9, 137.4 (i-Ph), 128.5, 128.4, 128.2, 128.1 (o-Ph, m-Ph), 128.0, 128.0 (p-Ph), 93.5 (br, C-
1), 74.4 (C-2), 74.2 (C-3), 73.7, 72.4 (PhCH2), 73.2 (C-5), 68.2 (C-4), 52.7 (OCH3), 20.7 
(CH3CO), 20.6 (CH3CO). 
 
2-(4-Nitrophenoxy)ethyl (methyl 4-O-acetyl-2,3-di-O-benzyl-α-D-galactopyranosyl 
uronate)-(1→2)-3,4-di-O-benzyl-α-L-rhamnopyranoside (36) 
 
Via N-phenyltrifluoracetimidate. Compound 34 (700 mg, 1.16 mmol), compound 29 (770 mg, 
1.5 mmol) and molecular sieves (4Å, 8 g) were dried for 2 h under high vacuum. The mixture 
was dissolved in dry CH2Cl2 (30 mL) and stirred at ambient temperature under an atmosphere 
of argon. After 30 min the mixture was cooled to –30 oC and CF3SO3SiMe3 (60 μL, 0.33 
mmol) was added dropwise. After stirring for 1 h the mixture was slowly warmed up to room 
temperature, and stirring was continued for additional 2 h in ambient temperature (monitored 
by TLC). The solution was neutralized by Et3N (0.25 mL, 1.8 mmol), molecular sieves were 
filtered off and washed with chloroform (3 × 10 mL). The combined organic solutions were 
concentrated. Purification by column chromatography (3 : 1 PE - EtOAc) gave compound 36 
as a colourless foam. 
Yield: 908 mg (85%, α:β 20:1) 
Rƒ: 0.45 (1 :1 PE - EtOAc) 
Via Trichloracetimidate. Compound 35 (580 mg, 1.0 mmol), compound 29 (770 mg, 1.5 
mmol) and molecular sieves (4Å, 4 g) were dried for 2 h under high vacuum. The mixture was 
suspended in dry CH2Cl2 (10 mL) and stirred at ambient temperature under an atmosphere of 
argon. After 30 min the mixture was cooled to –70 oC and CF3SO3SiMe3 (30 μL, 0.16 mmol) 
was added dropwise. After stirring for 1 h the mixture was slowly warmed up to room 
temperature and stirring was continued for additional 12 h at ambient temperature (monitored 
by TLC). The solution was neutralized by Et3N (0.25 mL, 1.8 mmol), molecular sieves were 
filtered off and washed with chloroform (3 × 3 mL). The combined organic solutions were 
concentrated. Purification by column chromatography (3 : 1 PE - EtOAc) gave compound 36 
as colourless foam. 
Yield: 120 mg (67%, α:β 9:1) 
1
H NMR (500.13 MHz, CDCl3):  8.21 (d, 2H, m-OPhNO2), 7.41–7.25 (m, 20H, Ph), 6.95 
(d, 2H, o-OPhNO2), 5.83 (dd, 1H,
 3
J4´,5´ 1.6 Hz, H-4´), 5.08 (d, 1H,
 3
J1´,2´ 3.6 Hz, H-1´), 4.98 
(d, 1H, 
3
J , 1.4 Hz, H-5´), 4.89 (d, 1H, 
2
J 11.0 Hz, CH2Ph), 4.86 (d, 1H, 
2
J 11.7 Hz, CH2Ph), 
4.83 (d, 1H,
 3
J1,2 1.7 Hz, H-1 ), 4.81 (d, 1H, 
2
J 11.0 Hz, CH2Ph), 4.65 (m, 2H, 
2
J 12.6 Hz, 2 × 
CH2Ph), 4.60 (dd, 2H, 
2
J 12.0 Hz, 2 × CH2Ph), 4.19 (m, 2H, 2 × CH2CH2O), 4.10 (m, 1H, 
3
J1,2 1.7 Hz, 
3
J2,3 3.1 Hz, H-2), 4.08 (dd, 1H, 
3
J2´,3´ 10.1 Hz, H-3´), 4.00 (m, 1H, CH2CH2O),  
3.89 (dd, 1H,
 3
J2´,3´ 10.1 Hz, 
3
J1´,2´ 3.6 Hz, H-2´), 3.84 (dd, 1H, 
3
J3,4 9.5 Hz, 
3
J2,3 3.1 Hz, H-3), 
3.80 (m, 1H, CH2CH2O), 3.74 (m, 1H, 
3
J4,5 9.5 Hz, H-5), 3.50 (s, 3H, OCH3), 3.48 (t, 1H, 
3
J4,5 
9.5 Hz, H-4), 2.07 (s, 3H, CH3CO), 1.35 (d, 3H, H-6); 
13
C NMR (125.8 MHz, CDCl3):  
169.9 (CH3CO), 168.2 (COO), 163.7 (p-OPhNO2), 141.7 (i-OPhNO2), 138.8, 138.3, 138.1, 
137.8 (i-Ph), 128.4, 128.3, 128.3, 128.0, 128.0, 127.8, 127.6, 127.6, 127.5 (o-Ph,m-Ph,p-Ph), 
125.9 (m-OPhNO2), 114.5 (o-OPhNO2), 97.5 (C-1), 97.4 (C-1´), 80.0 (C-4), 78.9 (C-3), 
75.3(CH2Ph), 74.9 (C-3´), 74.7 (C-2´), 74.4 (C-2),72.7 (CH2Ph), 72.1 (CH2Ph), 71.9 (CH2Ph), 
69.4 (C-5´), 68.8 (C-4´), 68.5 (C-5), 67.7 (CH2CH2O), 65.4 (CH2CH2O), 52.2 (OCH3), 20.4 
(CH3CO), 18.0 (C-6). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C51H55NO15 [M+Na]
+
: 944.3464, found: 
944.3464. 
 
 
 
 
 
2-(4-Nitrophenoxy)ethyl (methyl 2,3-di-O-benzyl-α-D-galactopyranosyluronate)-(1→2)-
3,4-di-O-benzyl-α-L-rhamnopyranoside (37) 
 
Compound 36 (480 mg, 0.52 mmol) was added with stirring to methanolic 0.28 M 
hydrochloric acid [prepared by adding of acetyl chloride (1.1 mL) in ice-cold dry methanol 
(50 mL)] and the mixture was stirred at ambient temperature under argon atmosphere. After 
24 h (monitored by TLC) PbCO3 × Pb(OH)2 (5 g) was added to the reaction mixture and 
stirring was continued for additional 2 h. Salts were filtered off by using glass sintered filter 
funnel with layer of silica gel, washed with methanol (3 × 10 mL), and the combined organic 
solutions were concentrated. Purification of the residue by column chromatography (2 : 1 PE - 
EtOAc) gave compound 37 as a colourless foam. 
Yield: 435 mg (95%) 
Rƒ: 0.3 (1 : 1 PE - EtOAc) 
1
H NMR (500.13 MHz, CDCl3):  8.20 (d, 2H, m-OPhNO2), 7.42–7.27 (m, 20H, Ph), 6.95 
(d, 2H, o-OPhNO2), 5.05 (d, 1H,
 3
J1´,2´ 3.5 Hz, H-1´),  4.90 (d, 1H, 
2
J 11.0 Hz, CH2Ph), 4.87 
(d, 1H, H-5´), 4.81 (d, 1H,
 3
J1,2 2.8 Hz, H-1 ), 4.79 (d, 1H, 
2
J 11.7 Hz, CH2Ph), 4.77 (d, 1H, 
2
J 
11.4 Hz, CH2Ph), 4.67 (d, 1H, 
2
J 12.1 Hz, CH2Ph), 4.66 (d, 1H, 
2
J 11.7 Hz, CH2Ph), 4.64 (d, 
1H, 
2
J 10.7 Hz, CH2Ph), 4.59 (d, 1H, 
2
J 12.1 Hz, CH2Ph), 4.41 (m, 1H,
 3
J3´,4´ 3.5 Hz, H-4´), 
4.19 (m, 2H, 2 × CH2CH2O), 4.12 (m, 1H, 
3
J1,2 2.8 Hz, 
3
J2,3 3.2 Hz, H-2), 4.03–3.98 (m, 2H, 
3
J2´,3´ 9.8 Hz, H-3´, CH2CH2O), 3.93 (dd, 1H,
 3
J2´,3´ 9.8 Hz, 
3
J1´,2´ 3.5 Hz, H-2´), 3.84 (dd, 1H, 
3
J3,4 9.5 Hz, 
3
J2,3 3.2 Hz, H-3), 3.82–3.79 (m, 2H, H-5, CH2CH2O), 3.60 (s, 3H, OCH3), 3.52 
(t, 1H, 
3
J3,4 9.5 Hz, H-4), 2.50 (bs, H, OH), 1.36 (d, 3H, H-6); 
13
C NMR (125.8 MHz, 
CDCl3):  169.1 (COO), 163.7 (p-OPhNO2), 141.7 (i-OPhNO2), 138.6, 138.3, 138.2, 137.8 (i-
Ph), 128.5, 128.3, 128.3, 128.0, 128.0, 127.8, 127.6, 127.6, 127.00 (o-Ph,m-Ph,p-Ph), 125.9 
(m-OPhNO2), 114.5 (o-OPhNO2), 97.4 (C-1), 96.7 (C-1´), 80.1 (C-4), 78.8 (C-3), 76.2 (C-3´), 
75.2 (CH2Ph), 75.0 (C-2´), 73.8 (C-2),72.8 (CH2Ph), 72.5 (CH2Ph), 72.0 (CH2Ph), 70.1 (C-
5´), 68.5 (C-4´), 68.4 (C-5), 67.7 (CH2CH2O), 65.5 (CH2CH2O), 52.2 (OCH3), 18.0 (C-6). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C49H53NO14 [M+Na]
+
: 902.9289, found: 
902.9290. 
 
Methyl 3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(allyl 2,3-di-O-benzyl-β-D-
galactopyranosid)uronate (38) 
 
Compound 30 (820 mg, 1.03 mmol) was added with stirring to methanolic 0.28 M 
hydrochloric acid [prepared by adding of acetyl chloride (1 mL) to ice-cold dry methanol (50 
mL)] and the mixture was stirred for 24 h at ambient temperature under an atmosphere of 
argon (monitored by TLC). The solution was filtered through a layer of alkaline alumina by 
elution with CHCl3. The combined eluates (ca. 200 mL) were dried, concentrated and the 
crude product was purified by column chromatography (2 : 1 PE - EtOAc) to provide acceptor 
38 as colourless foam. 
Yield: 680 mg (87%) 
Rƒ: 0.27 (2 : 1 PE - EtOAc) 
[α] 22D : +18.1 (c 1.0, CHCl3) 
1
H NMR (500.13 MHz, CDCl3):  7.38–7.25 (m, 20H, Ph), 5.98 (dddd, 1H, J  17.3, 10.5, 6.2, 
5.1 Hz, CH2CH=CH2), 5.36 (d’q’, 1H, 
3
J  17.3 Hz, 
2
J  1.6 Hz, CH2CH=CH2), 5.35 (d, 1H, 
3
J1´,2´ 1.9 Hz, H-1´), 5.22 (d’q’, 1H, 
3
J  10.5 Hz, 
2
J  1.6 Hz, CH2CH=CH2), 4.93 (d, 1H, 
2
J 10.9 
Hz, CH2Ph), 4.86 (d, 1H,
 2
J 11.5 Hz, CH2Ph), 4.77 (d, 1H,
 2
J 11.8 Hz, CH2Ph), 4.75 (d, 1H,
 2
J 
10.9 Hz, CH2Ph), 4.74 (d, 1H,
 2
J 11.8 Hz, CH2Ph), 4.66 (d, 1H,
 2
J 11.4 Hz, CH2Ph), 4.64 (d, 
1H,
 2
J 11.4 Hz, CH2Ph), 4.62 (d, 1H,
 2
J 11.5 Hz, CH2Ph), 4.52 (dd’t’, 1H,
 2
J 13.0 Hz, 
3
J 5.1 
Hz, 
4
J 1.6 Hz, CH2CH=CH2), 4.46 (dd, 1H, 
3
J4,3 3.0 Hz, 
3
J4,5 1.3 Hz, H-4), 4.41 (d, 1H, 
3
J1,2 
7.8 Hz, H-1), 4.17 (m, 1H, 
2
J 13.0 Hz,
 3
J 6.2 Hz, 
4
J 1.4 Hz, CH2CH=CH2), 4.14 (dd’t’, 1H, H-
2´), 4.04 (d, 1H, 
3
J4,5 1.3 Hz, H-5), 3.85 (dd, 1H,
 3
J3´,4´ 9.0 Hz, 
 3
J2´,3´ 3.3 Hz, H-3´), 3.79 (s, 
3H, OCH3), 3.72 (dd, 1H, 
3
J2,3 9.7 Hz, 
3
J1,2 7.8 Hz, H-2), 3.62 (dq, 1H, 
3
J4´,5´ 9.6 Hz, 
3
J5´,6´ 6.2 
Hz, H-5´), 3.56 (dd, 1H, 
3
J2,3 9.7 Hz, 
3
J3,4 3.0 Hz, Hz, H-3), 3.42 (’t’, 1H,
 3
J4´,5´ 9.3 Hz,  
3
J3´,4´ 
9.0 Hz, H-4´), 2.40 (d, H, J 1.7 Hz, OH), 1.28 (d, 3H,
 3
J5´,6´ 6.2 Hz, H-6´); 
13
C NMR (125.8 
MHz, CDCl3):   168.0 (COO), 138.8, 138.4, 138.1, 137.8 (i-Ph), 133.9 (CH2CH=CH2), 
128.4, 128.4, 128.2, 128.2, 128.2, 127.8, 127.8, 127.6 (o-Ph,m-Ph), 127.8, 127.8, 127.6, 127.4 
(p-Ph), 117.5 (CH2CH=CH2), 102.7 (C-1), 100.3 (C-1´), 81.1 (C-3), 79.8 (C-4´), 79.6 (C-3´), 
78.3 (C-2), 75.2 (CH2Ph), 74.8(CH2Ph), 73.7 (C-5), 73.2 (C-4), 73.2 (CH2Ph), 72.2 (CH2Ph), 
70.6 (CH2CH=CH2), 68.7 (C-2´), 67.9 (C-5´), 52.4 (OCH3), 17.9 (C-6´). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C44H50O11 [M+Na]
+
: 777.2951 found: 
777.2964. 
 
Methyl 2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(2,3-di-O-benzyl-α/β-D-
galactopyranose)uronate (39) 
 
Compound 30 (840 mg, 1.05 mmol), palladium(II) chloride (360 mg, 2 mmol) and sodium 
acetate (1.2 g, 14.6 mmol) were stirred in acetic acid (20 mL, 95%) for 2.5 h at 45 
o
C 
(monitored by TLC). The mixture was diluted with chloroform (40 mL), filtered over celite 
and concentrated. The residue was co-evaporated with toluene (3 × 15 mL) and concentrated 
and was purified by column chromatography (1 : 1 PE - EtOAc) to give compound 39 as 
colourless syrup. 
Yield: 602 mg (76%) 
Rƒ: 0.27 (1 : 1 PE - EtOAc) 
1
H NMR (250.13 MHz, CDCl3):  7.40–7.25 (m, 20H, Ph), 5.53 (dd, 1H, 
3
J2´,3´ 3,5 Hz, H-
2´), 5.35 (t, 1H, H-1), 5.20 (m, 1H, H-1´), 4.89 (d, 1H, CH2Ph), 4.84 (d, 1H, CH2Ph), 4.80 (s, 
2H, 2 × CH2Ph), 4.76 (d, 1H, CH2Ph), 4.67–4.55 (m, 2H,
 2
J 10.9 Hz, CH2Ph, H-4), 4.53 (t, 
1H, H-3), 4.40 (d, 1H, CH2Ph), 4.03–3.90 (m, 2H, H-5, H-2), 3.84 (dd, 1H,
 3
J2´,3´ 3.5 Hz, 
3
J3´,4´ 9.5 Hz, H-3´), 3.77 (s, 3H, OCH3), 3.67–3.56 (m, 1H, 
3
J4´,5´ 9.5 Hz, H-5´), 3.36 (m, 1H, 
3
J3´,4´ 9.5 Hz, H-4´), 3.07 (d,1H, J 2.4 Hz, OH), 2.09 (s, 3H, CH3CO), 1.29 (d, 3H, H-6´); 
13
C 
NMR (62.9 MHz, CDCl3):  169.8 (CH3CO), 168.0 (COO), 138.9, 138.4, 138.2, 137.7 (i-
Ph), 133.9 (CH2CH=CH2), 128.3–127.3 (o-Ph,m-Ph,p-Ph), 117.5 (CH2CH=CH2), 102.7 (C-
1), 99.1 (C-1´), 80.8 (C-3), 79.7 (C-4´), 78.2(C-2), 77.9 (C-3´), 75.1 (CH2Ph), 74.8 (CH2Ph), 
73.7 (C-4), 73.7 (C-5), 73.1 (CH2Ph), 71.8 (CH2Ph), 70.6 (CH2CH=CH2), 68.9 (C-2´), 68.2 
(C-5´), 52.5 (OCH3), 20.9 (CH3CO), 17.9 (C-6´). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C43H48O12 [M+Na]
+
: 779.3038, found: 
779.3042. 
 
Methyl 2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(2,3-di-O-benzyl-α/β-D-
galactopyranosyl)uronate N-phenyl trifluroacedimidate (40) 
 
Cs2CO3 (600 mg, 1.8 mmol) and 2,2,2-trifluoro-N-phenyl-acetimidoyl chloride (570 mg, 2.8 
mmol) were consecutively added to compound 39 (700 mg, 0.92 mmol) in acetone (20 mL) at 
0 
o
C. The cooling bath was removed, and reaction mixture was stirred at ambient temperature. 
After 2 h (monitored by TLC) the reaction mixture was diluted with CHCl3 (20 mL). Salts 
were filtered off and washed with EtOAc (2 × 10 mL). The combined organic solutions were 
concentrated and the residue was purified by column chromatography (3 : 1 PE - EtOAc) to 
give compound 40 as a yellow foam. 
Yield: 774 mg (91%, α : β = 1 : 3) 
Rƒ: 0.63 (1 : 1 PE - EtOAc) 
α-NPhCF3 compound 
1
H NMR (500.13 MHz, CDCl3):  7.39–7.22 (m, 22H, Ph, m-NPh), 7.10 (m, 1H, p-NPh), 
6.74 (m, 2H, o-NPh), 6.65 (br, 1H, H-1), 5.50 (dd, 1H,
 3
J2´,3´ 3.3 Hz, 
3
J1´,2´ 1.9 Hz, H-2´), 5.21 
(d, 1H,
 3
J1´,2´ 1.9 Hz, H-1´), 4.87 (d, 1H,
 2
J 11.2 Hz, CH2Ph), 4.85 (d, 1H,
 2
J 11.8 Hz, CH2Ph), 
4.79 (d, 1H,
 2
J 11.8 Hz, CH2Ph), 4.78 (qAB, 2H, CH2Ph), 4.54 (br, 2H, H-4, H-5), 4.61 (d, 
1H,
 2
J 11.0 Hz, CH2Ph), 4.57 (d, 1H,
 2
J 11.2 Hz, CH2Ph), 4.37 (d, 1H,
 2
J 11.0 Hz, CH2Ph), 
4.09 (br dd, 1H,
 3
J2,3 10.0 Hz, 
3
J1,2 3.0 Hz, H-2), 4.01 (br dd, 1H, 
3
J2,3 10.0 Hz, 
3
J3,4 2.5 Hz, H-
3), 3.80 (dd, 1H, 
3
J3´,4´ 9.5 Hz,
 3
J2´,3´ 3.3 Hz,  H-3´), 3.79 (s, 3H, OCH3), 3.60 (dq, 1H, 
3
J4´,5´ 
9.5 Hz,
 3
J5´,6´ 6.2 Hz, H-5´), 3.35 (t, 1H, 
3
J3´,4´ 9.5 Hz, 
3
J4´,5´ 9.5 Hz, H-4´), 2.08 (s, 3H, 
CH3CO), 1.28 (d, 3H,
 3
J5´,6´ 6.2 Hz, H-6´); 
13
C NMR (125.8 MHz, CDCl3):  169.8 
(CH3CO), 167.7 (COO), 143.4 (i-NPh), 138.8, 138.1, 137.7, 137.6 (i-Ph), 128.7 (m-NPh), 
128.5, 128.4, 128.3, 128.2, 128.1, 127.7, 127.5 (o-Ph,m-Ph),127.9, 127.8, 127.6,127.4 (p-Ph), 
124.3 (p-NPh),119.4 (o-NPh), 99.2 (C-1´), 93.5 (br, C-1), 79.5 (C-4´), 77.9 (C-3´), 76.9 (C-3), 
74.9 (CH2Ph), 74.5 (C-4), 73.4 (CH2Ph), 73.2 (CH2Ph), 72.5 (C-2), 72.5 (C-5), 71.8 (CH2Ph), 
68.6 (C-2´), 68.4 (C-5´), 52.7 (OCH3), 21.1 (CH3CO), 18.0 (C-6´). 
β-NPhCF3 compound 
1
H NMR (500.13 MHz, CDCl3):  7.35–7.24 (m, 22H, Ph, m-NPh), 7.08 (m, 1H, p-NPh), 
6.81 (d, 2H, o-NPh), 5.60 (br, 1H, H-1) 5.53 (dd, 1H,
 3
J2´,3´ 3.3 Hz, 
3
J1´,2´ 1.8 Hz,  H-2´), 5.20 
(d, 1H,
 3
J1´,2´ 1.8 Hz, H-1´), 4.90 (d, 1H, 
2 
J 11.3 Hz, CH2Ph), 4.84 (s, 2H, CH2Ph), 4.77 (qAB, 
2H, 
2
J 11.8 Hz, CH2Ph), 4.69 (d, 1H, 
2 
J 11.1 Hz, CH2Ph), 4.59 (d, 1H,
 2
J 11.3 Hz, CH2Ph), 
4.51 (d, 1H,
 2
J 11.1 Hz, CH2Ph), 4.43 (br, 1H, H-2), 4.04 (br, 1H, H-5), 3.95 (br, 1H, H-4), 
3.91 (dd, 1H,
 3
J3´,4´ 9.4 Hz, 
 3
J2´,3´ 3.2 Hz, H-3´), 3.78 (s, 3H, OCH3), 3.63 (dq, 1H, 
3
J4´,5´ 9,5 
Hz,
 3
J5´,6´ 6.2 Hz, H-5´), 3.61 (br, 1H, H-3), 3.38 (’t’, 1H, 
3
J4´,5´ 9,5 Hz, 
3
J3´,4´ 9,4 Hz,  H-4´), 
2.09 (s, 3H, CH3CO), 1.29 (d, 3H,
 3
J5´,6´ 6.2 Hz, H-6´); 
13
C NMR (125.8 MHz, CDCl3):  
169.9 (CH3CO), 167.1 (COO), 143.3 (i-NPh), 138.8, 138.1, 137.5, 137.4 (i-Ph), 128.6 (m-
NPh), 128.5, 128.5, 128.4, 128.3, 128.2, 128.2, 127.7, 127.5 (o,m-Ph), 128.0, 127.9, 127.6, 
127.4 (p-Ph), 124.2 (p-NPh),119.3 (o-NPh), 99.1 (C-1´), 96.9 (br, C-1), 80.8 (C-3), 79.6 (C-
4´), 77.7 (C-3´), 76.9 (C-4), 75.5 (CH2Ph), 74.9 (CH2Ph), 74.3 (br, C-5), 73.2 (C-2), 73.0 
(CH2Ph), 71.9 (CH2Ph), 68.9 (C-2´), 68.4 (C-5´), 52.6 (OCH3), 21.1 (CH3CO), 18.0 (C-6´). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C51H52F3NO16 [M+Na]
+
: 950.3334, found: 
950.3333. 
 
 
Methyl 2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(2,3-di-O-benzyl-α/β-D-
galactopyranosyl)uronate trichloracedimidate (41) 
 
1,8-Diaazabicyclo[5.4.0]undec-7-en (15 μL, 0.1 mmol) was added to mixture of compound 39 
(430 mg, 0.57 mmol) and trichloracetonitrile (2 mL, 9.6 mmol) in dry CH2Cl2 (8 ml) at –20 
o
C. After stirring for 1 h at –20 oC and an additional 1 h at room temperature (monitored by 
TLC) the reaction mixture was evaporated to dryness, dissolved in ethyl acetate (10 mL) and 
filtered over celite. Combined organic solutions were concentrated. Purification by column 
chromatography (2 : 1 PE - EtOAc) gave compound 41 as colourless foam. 
Yield: 344 mg (67 %, α : β = 1.5 : 1) 
Rƒ: 0.6 α and 0.5 β (1 : 1 PE - EtOAc) 
1
H NMR (500.13 MHz, CDCl3):   8.62 (s, 1H, NH), 7.34–7.21 (m, 20H, Ph,), 6.63 (d, 1H, 
3
J1,2 3.3 Hz, H-1) 5.51 (’t’, 1H,
 3
J2´,3´ 3.2 Hz, H-2´), 5.22 (d, 1H,
 3
J1´,2´ 1.3 Hz, H-1´), 4.86 (d, 
1H,
 
J 11.2 Hz, CH2Ph), 4.81 (d, 1H,
 
J  12.0 Hz, CH2Ph), 4.77–4.75 (ds, 2H, 2 × CH2Ph), 4.72 
(d, 1H,
 
J 12.0 Hz, CH2Ph), 4.61 (d, 1H,
 
J 10.9 Hz, CH2Ph) 4.58 (s, 1H, H-5), 4.55 (d, 1H,
 
J 
11.2 Hz, CH2Ph) 4.53 (d, 1H,
 3
J  1.7 Hz, H-4),  4.37 (d, 1H,
 
J 10.9 Hz, CH2Ph), 4.11 (dd, 1H, 
3
J1,2 3,3 Hz, 
3
J2,3 10,0 Hz, H-2), 4.03 (dd, 
3
J2,3 10,0 Hz, H-3), 3.80 (dd, 1H,
 3
J2´,3´ 3.2 Hz, 
3
J3´,4´ 
9.4 Hz,H-3´), 3.74 (s, 3H, OCH3), 3.61–3.51 (m, 1H, 
3
J4´,5´ 9,5 Hz, H-5´), 3.34 (t, 1H, 
3
J4´,5´ 
9,5 Hz, H-4´), 2.07 (s, 3H, CH3CO), 1.26 (d, 3H, H-6´); 
13
C NMR (125.8 MHz, CDCl3):  
169.9 (CH3CO), 167.9 (COO), 160.6 [C(=NH)CCl3], 138.8, 138.1, 137.8, 137.7 (4 × i-Ph), 
129.0–125.3 (o-Ph,m-Ph,p-Ph), 99.1 (C-1´), 94.5 (C-1), 91.0 [C(=NH)CCl3], 79.8 (C-4´), 
77.9 (C-3´), 76.5 (C-3), 74.9 (CH2Ph), 74.3 (C-4), 74.2 (C-2), 73.0 (CH2Ph), 72.9 (CH2Ph), 
72.5 (C-5), 71.8 (CH2Ph), 68.6 (C-2´), 68.4 (C-5´), 52.7 (OCH3), 21.1 (CH3CO), 18.0 (C-6´). 
 
 
Methyl 2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(methyl 2,3-di-O-
benzyl-α-D-galactopyranosyluronate)-(1→2)-3,4-di-O-benzyl-α-L-rhamnopyranosyl-
(1→4)-(allyl 2,3-di-O-benzyl-β-D-galactopyranosid)uronate (42) 
 
 
 
Via N-phenyltrifluoracetimidate. Compound 40 (200 mg, 0.22 mmol), compound 38 (211 mg, 
0.28 mmol) and molecular sieves (4Å, 2 g) were dried for 2 h under high vacuum. The 
mixture was suspended in dry CH2Cl2 (6 mL) and stirred at ambient temperature under an 
atmosphere of argon. After 30 min the mixture was cooled to –30 oC and CF3SO3SiMe3 (30 
μL, 0.16 mmol) was added dropwise. After stirring for 1 h the mixture was slowly warmed up 
to room temperature and stirring was continued for additional 2 h at ambient temperature 
(monitored by TLC). The solution was neutralized by Et3N (0.25 mL, 1.8 mmol), molecular 
sieves were filtered off and washed with chloroform (3 × 3 mL). The combined organic 
solutions were concentrated. Purification by column chromatography (6 : 1 toluene - EtOAc) 
gave compound 42 as colourless foam. 
It should be noted that traces of β-linked tetrasaccharide were observed by NMR 
investigations. 
Yield: 295 mg (90%) 
Rƒ: 0.4 (2 : 1 PE - EtOAc) 
[α] 22D : +68.1 (c 1.0, CHCl3) 
Via Trichloracetimidate. Compound 41 (110 mg, 0.12 mmol), compound 38 (120 mg, 0.16 
mmol) and molecular sieves (4Å, 2 g) were dried for 2 h under high vacuum. The mixture was 
suspended in dry CH2Cl2 (10 mL) and stirred at ambient temperature under an atmosphere of 
argon. After 30 min the mixture was cooled to –70 oC and CF3SO3SiMe3 (30 μL, 0.16 mmol) 
was added dropwise. After stirring for 1 h the mixture was slowly warmed up to room 
temperature and stirring was continued for additional 12 h at ambient temperature (monitored 
by TLC). The solution was neutralized by Et3N (0.25 mL, 1.8 mmol), molecular sieves were 
filtered off and washed with chloroform (3 × 3 mL). The combined organic solutions were 
concentrated. Purification by column chromatography (6 : 1 toluene - EtOAc) gave compound 
42 as colourless foam. 
Yield: 120 mg (67%) 
Only traces of β-linked tetrasaccharide were observed by NMR investigations. 
1
H NMR (500.13 MHz, CDCl3):  7.41–7.16 (m, 40H, Ph), 5.96 (dddd, 1H, J  17.3, 10.4, 6.2, 
5.1 Hz, CH2CH=CH2), 5.52 (m, 1H,
 3
J2´´´,3´´´ 3,3 Hz, 
3
J1´´´,2´´´ 2.0 Hz, H-2´´´), 5.39 (d, 1H, 
3
J1´,2´ 
1.8 Hz, H-1´), 5.35 (d’q’, 1H, 3J 17.3 Hz, 4J 1.6 Hz, CH2CH=CH2), 5.22 (d’q’, 1H, 
3
J 10.4 
Hz, 
4
J 1.5 Hz, CH2CH=CH2), 5.18 (d, 1H,
 3
J1´´´,2´´´ 2.0 Hz, H-1´´´), 4.98 (d, 1H, 
3
J1´´,2´´ 3.6 Hz, 
H-1´´), 4.98 (d, 1H, 
2
J 10.8 Hz, CH2Ph), 4.88 (d, 1H, 
2
J 11.1 Hz, CH2Ph), 4.88 (d, 1H,
 2
J 11.4 
Hz, CH2Ph), 4.87 (d, 1H,
 3
J4´´,5´´ 1.2 Hz, H-5´´), 4.80 (d, 1H, 
2
J 10.8 Hz, CH2Ph), 4.74 (d, 1H, 
2
J 12.0 Hz, CH2Ph), 4.69 (d, 1H, 
2
J 12.3 Hz, CH2Ph), 4.68 (d, 2H, J 11.8 Hz, CH2Ph), 4.64 (d, 
1H, J 11.0 Hz, CH2Ph), 4.62 (d, 1H,
 2
J 11.1 Hz, CH2Ph), 4.57 (m, 3H, CH2Ph), 4.55 (d, 1H, 
2
J 
12.0 Hz, CH2Ph),  4.51 (dd’t’, 
2
J 12.9 Hz,
 3
J 5.1 Hz, 
4
J 1.6 Hz,  CH2CH=CH2), 4.46 (d, 1H, 
2
J 
12.0 Hz, CH2Ph), 4.45 (m, 2H, H-4, H-4´´), 4.40 (d, 1H, 
2
J  11.0 Hz, CH2Ph), 4.37 (d, 1H, 
3
J1,2 7.7 Hz, H-1), 4.20 (dd, 1H, 
3
J2´,3´ 3.2 Hz,
 3
J1´,2´ 1.8 Hz, H-2´), 4.15 (dd, 1H, 
2
J 12.9 Hz, 
3
J 
6.2 Hz, 
4
J 1.4 Hz, CH2CH=CH2), 4.01 (d, 1H, 
3
J4,5 1.3 Hz, H-5), 3.99 (dd, 1H, 
3
J2´´,3´´ 10.0 Hz, 
3
J3´´,4´´ 2.8 Hz, H-3´´), 3.87 (dd, 1H,
 3
J3´,4´ 9.5 Hz, 
3
J2´,3´ 3.1 Hz, H-3´), 3.84 (dd, 1H, 
3
J3´´´,4´´´ 
9.4 Hz, 
3
J2´´´,3´´´ 3.3 Hz,  H-3´´´), 3.82 (dd, 1H, 
3
J2´´,3´´ 10.0 Hz, 
3
J1´´,2´´ 3.6 Hz, H-2´´), 3.78 (s, 
3H, OCH3), 3.73 (dd, 1H, 
3
J1,2 7.7 Hz, 
3
J2,3 9.7 Hz, H-2), 3.62 (dq, 1H,
 3
J4´´´,5´´´ 9.6 Hz, 
3
J5´´´,6´´´ 
6.2 Hz, H-5´´´), 3.57 (dq, 1H,
 3
J4´,5´ 9.4 Hz,
 3
J5´,6´ 6.2 Hz,  H-5´), 3.51 (dd, 1H, 
3
J2,3 9.7 Hz,
 
3
J3,4 2.9 Hz,  H-3), 3.48 (s, 3H, OCH3), 3.43 (’t’, 1H, 
3
J4´,5´ 9.5 Hz,
 3
J3´,4´ 9.5 Hz, H-4´), 3.35 
(’t’, 1H, 3J4´´´,5´´´ 9.6 Hz, 
3
J3´´´,4´´´ 9.4 Hz, H-4´´´), 2.08 (s, 3H, CH3CO), 1.34 (d, 3H,
 3
J5´,6´ 6.2 
Hz,  H-6´), 1.27 (d, 3H,
 3
J5´´´,6´´´ 6.2 Hz,  H-6´´´); 
13
C NMR (125.8 MHz, CDCl3):  169.9 
(CH3CO), 168.8,168.2 (2 × COO), 138.9, 138.9, 138.6, 138.4, 138.4, 138.1, 138.0, 137.6 (8 × 
i-Ph), 133.9 (CH2CH=CH2), 128.4, 128.3,128.2, 128.2, 128.2, 128.2, 128.1, 128.1, 128.1, 
128.1, 127.7, 127.6, 127.5, 127.4, 127.4, 127.0 (o-Ph,m-Ph), 127.7, 127.7, 127.5, 127.4, 
127.3, 127.3, 127.3, 127.1 (p-Ph), 117.5 (CH2CH=CH2), 102.7 (C-1) , 98.9 (C-1´´´), 97.96 
(C-1´), 96.5 (C-1´´), 80.6 (C-3), 79.9 (C-4´), 79.6 (C-4´´´), 78.7 (C-3´), 78.6 (C-2), 78.0 (C-
3´´´), 76.9 (C-3´´), 75.2 (CH2Ph), 74.8 (CH2Ph), 74.8 (C-4´´), 74.6 (CH2Ph), 74.3 (C-2´´), 
74.1 (C-2´), 73.7 (C-5), 73.1(CH2Ph), 72.5 (C-4), 72.4 (CH2Ph), 72.0 (CH2Ph), 71.8 (CH2Ph), 
71.7 (CH2Ph), 70.6 (CH2CH=CH2),70.5 (C-5´´), 68.7 (C-2´´´), 68.5 (C-5´), 68.2 (C-5´´´), 52.5 
(OCH3), 52.1 (OCH3),  21.1 (CH3CO), 18.1 (C-6´´´), 18.0 (C-6´). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C87H96O22 [M+Na]
+
: 1515.6286, found: 
1515.6301. 
 
Methyl 3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(methyl 2,3-di-O-benzyl-α-D-
galactopyranosyluronate)-(1→2)-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(allyl 
2,3-di-O-benzyl-β-D-galactopyranosid)uronate (43) 
 
Compound 42 (240 mg, 0.16 mmol) was added with stirring to methanolic 0.28 M 
hydrochloric acid [prepared by adding of acetyl chloride (0.4 mL) to ice-cold dry methanol 
(20 mL)] and the mixture was stirred for 24 h at ambient temperature under an atmosphere of 
argon (monitored by TLC). The solution was filtered through a layer of alkaline alumina by 
elution with CHCl3. The combined organic solution (ca. 100 mL) were dried, concentrated 
and the crude product was purified by column chromatography (2 : 1 PE - EtOAc) to provide 
acceptor 43 as colourless foam. 
Yield: 199 mg (86%) 
Rƒ: 0.24 (2 : 1 PE - EtOAc) 
[α] 22D : +69.5 (c 1.0, CHCl3) 
1
H NMR (500.13 MHz, CDCl3):  7.42–7.17 (m, 40H, Ph), 5.97 (dddd, 1H, 
3
J  17.3, 10.4, 
6.2, 5.1 Hz, CH2CH=CH2), 5.40 (d, 1H,
3
J1´,2´ 1.8 Hz,  H-1´), 5.36 (d’q’, 1H,
 3
J 17.3 Hz, J 1.6 
Hz, CH2CH=CH2), 5.27 (d, 1H,
 3
J1´´´,2´´´ 2.0 Hz, H-1´´´), 5.22 (d’q’, 1H,
 3
J 10.5 Hz, J 1.5 Hz,  
CH2CH=CH2), 5.02 (d, 1H, 
3
J1´´,2´´ 3.6 Hz, H-1´´), 4.99 (d, 1H, 
2
J 10.7 Hz, CH2Ph), 4.88 (d, 
1H, 
2
J 11.4 Hz, CH2Ph), 4.87 (d, 1H,
 3
J4´´,5´´ 1.4 Hz, H-5´´), 4.85 (m, 1H, 
2
J 12.6 Hz, CH2Ph), 
4.81 (d, 1H, 
2
J 10.7 Hz, CH2Ph), 4.73 (d, 2H,
 2
J 11.4 Hz, CH2Ph), 4.68 (m, 1H, J 11.5 Hz, 2 × 
CH2Ph), 4.68 (s, 2H, CH2Ph), 4.62 (d,1H, 
2
J 11.4 Hz, CH2Ph), 4.61 (d, 1H, 
 2
J 11.5 Hz, 
CH2Ph), 4.61 (d, 1H,
 2
J 11.4 Hz, CH2Ph), 4.59 (s,2H, CH2Ph), 4.52 (d, 1H, 
2
J 11.6 Hz, 
CH2Ph), 4.51 (dd’t’, 1H,  
2
J 12.9 Hz,
 3
J 5.1 Hz, 
4
J 1.6 Hz, CH2CH=CH2), 4.47 (dd, 1H, 
3
J3´´,4´´ 
2.8 Hz,
 3
J4´´,5´´ 1.4 Hz, H-4´´), 4.45 (dd, 1H, 
3
J3,4 2.9 Hz, 
3
J4,5 1.3 Hz, H-4), 4.43 (d, 1H, 
2
J 
11.6 Hz, CH2Ph), 4.38 (d, 1H, 
3
J1,2 7.7 Hz, H-1), 4.22 (dd, 1H,
 3
J2´,3´ 3.1 Hz,
 3
J1´,2´ 1.8 Hz, H-
2´), 4.15 (dd’t’, 1H, 2J 12.9 Hz, 3J 6.2 Hz, 4J´ 1.4 Hz, CH2CH=CH2), 4.13 (m, 1H, H-2´´´), 
4.02 (d, 1H, 
3
J4,5 1.3 Hz, H-5), 3.99 (dd, 1H, 
3
J2´´,3´´ 10.1 Hz, 
3
J3´´,4´´ 2.8 Hz, H-3´´), 3.88 (dd, 
1H,
 3
J3´,4´ 9.6 Hz,  
3
J2´,3´ 3.1 Hz, H-3´), 3.80 (dd, 1H, 
3
J2´´,3´´ 10.1 Hz, 
3
J1´´,2´´ 3.6 Hz, H-2´´), 
3.79 (s, 3H, O CH3), 3.76 (dd. 1H,
 3
J3´´´,4´´´ 9.0 Hz, 
3
J2´´´,3´´´ 3.2 Hz, H-3´´´), 3.74 (dd, 1H, 
3
J1,2 
7.7 Hz, 
3
J2,3 9.7 Hz, H-2), 3.61 (dq, 1H,
 3
J4´´´,5´´´ 9.6 Hz,
 3
J5´´´,6´´´ 6.2 Hz, H-5´´´), 3.57 (dq, 1H,
 
3
J4´,5´ 9.5 Hz,
 3
J5´,6´ 6.2 Hz,   H-5´), 3.52 (m, 1H,
 3
J2,3 9.7 Hz, 
3
J3,4 2.9 Hz, H-3), 3.50 (s, 3H, 
OCH3), 3.43 (’t’, 1H,
 3
J3´,4´ 9.6 Hz, 
3
J4´,5´ 9.5 Hz, H-4´), 3.41 (’t’, 1H, 
3
J4´´´,5´´´ 9.6 Hz,
 3
J3´´´,4´´´ 
9.0 Hz, H-4´´´), 2.37 (brd, 1H,
 3
J2´´´,OH  1.8 Hz, OH), 1.34 (d, 3H,
 3
J5´´´,6´´´ 6.2 Hz, H-6´´´), 1.27 
(d, 3H,
 3
J5´,6´ 6.2 Hz, H-6´); 
13
C NMR (125.8 MHz, CDCl3):  168.7, 168.2 (COO), 138.9, 
138.8, 138.7, 138.4, 138.4, 138.0, 138.0, 137.6 (i-Ph), 133.8 (CH2CH=CH2), 128.4, 128.4, 
128.3, 128.3, 128.2, 128.2, 128.1, 128.0, 127.8, 127.8, 127.5, 127.4, 127.4, 127,4, 127.0 (o-
Ph,m-Ph), 127.7, 127.7, 127.6, 127.6, 127.3, 127.3, 127.2, 127.1 (p-Ph), 117.5(CH2CH=CH2), 
102.7 (C-1) , 100.4 (C-1´´´), 97.9 (C-1´), 96.4 (C-1´´), 80.7 (C-3), 79.9 (C-4´), 79.7 (C-4´´´), 
79.6 (C-3´´´), 78.7 (C-3´), 78.6 (C-2), 76.9 (C-3´´), 75.2 (CH2Ph), 74.8 (C-4´´), 74.7 (CH2Ph), 
74.6 (CH2Ph), 74.6 (C-2´´), 74.0 (C-2´), 73.7 (C-5), 73.0 (CH2Ph), 72.4 (CH2Ph), 72.4 (C-4), 
72.0 (CH2Ph), 71.9 (CH2Ph), 71.6 (CH2Ph), 70.6 (CH2CH=CH2), 70.5 (C-5´´), 68.5 (2)(C-
2´´´, C-5´), 67.8 (C-5´´´), 52.5 (OCH3), 52.0 (OCH3),  18.0 (C-6´´´), 17.9 (C-6´). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C85H94O21 [M+Na]
+
: 1473.6180, found: 
1473.6178. 
 
 
Methyl α-L-rhamnopyranosyl-(1→4)-(methyl α-D-galactopyranosyluronate)-(1→2) α-L-
rhamnopyranosyl-(1→4)-(propyl β-D-galactopyranosid)uronate (44) 
 
10% Palladium on charcoal (30 mg) was added to a solution of compound 43 (145 mg, 0.1 
mmol) in methanol (10 mL), and the reaction mixture was stirred at ambient temperature 
under an atmosphere of hydrogen. After 24 h (monitored by TLC) the reaction mixture was 
filtered over celite by elution with methanol, and combined organic solutions were 
concentrated. The residue was dissolved in water and lyophilized to obtain compound 44 as a 
colourless foam. Compound 44 was used without further structural characterization  for the 
next step. 
Yield: 71 mg (97%) 
Rƒ: 0.22 (2 : 1 CHCl3 - MeOH), 0.81 (1 : 2 CHCl3 - MeOH) 
 
  Propyl α-L-rhamnopyranosyl-(1→4)-α-D-galactopyranosyluronic acid-(1→2) α-L-
rhamnopyranosyl-(1→4)- β-D-galactopyranosiduronic acid (45) 
 
Lithiumhydroxid (5 mg, 0.2 mmol) was added to a suspension of tetrasaccharide 44 (71 mg, 
0.097 mmol) in a mixture of methanol and water (2 : 1, v/v, 10 ml). After stirring for 15 min 
at ambient temperature (monitored by TLC), the solution was passed through a column of 
Dowex-50 (H
+
). Methanol was removed from solution by evaporation under reduced pressure 
and the residue was repeatedly dissolved in water and lyophilized to obtain tetrasaccharid 45 
as a colourless foam. 
Yield: 63 mg (92%)  
Rƒ: 0.22 (1 : 2 CHCl3 - MeOH) 
1
H NMR (500.13 MHz, DMSO-d6):   5.15 (d, 1H, 
3
J1´,2´ 1.4 Hz, H-1´), 5.13 (dd, 1H,
 3
J1´´´,2´´´ 
1.4 Hz, H-1´´´), 4.95 (d, 1H, 
3
J1´´,2´´ 3.1 Hz, H-1´´), 4.33 (d, 1H, H-5´´), 4.31 (dd, 1H, 
3
J4´´,5´´ 
0.9 Hz, H-4´´), 4.26 (d, 1H, dd, 
3
J1,2 7.3 Hz, H-1), 4.22 (dd, 1H, 
3
J4,5 0.9 Hz, H-4), 3.92 (d, 
1H, H-5), 4.02–3.40 (m,11H, H-2´, H-3, H-3´, H-4´, H-5´, H-2´´, H-3´´, H-2´´´, H-3´´´, H-
4´´´, H-5´´´), 3.32 (dd, 1H, , 
3
J2,3 9.7 Hz, H-1), 3.24 (m, 2H, CH2CH2CH3), 1.53 (dt, 2H, 
CH2CH2CH3), 1.16, 1.14 (2d, 6H, H-6´, H-6´´´), 0.83 (t, 3H, CH2CH2CH3); NMR (125.8 
MHz, DMSO-d6):  171.3, 170.4 (COO, C´´OO), 103.4 (C-1), 100.1 (C-1´), 99.7 (C-1´´´), 
99.5 (C-1´´), 79.2, 78.7, 78.1, 75.0, 74.5, 73.8, 73.0, 72.1, 72.0, 71.8, 71.5, 71.0, 70.3 (C-2, C-
3, C-4, C-5, C-2´, C-3´, C-4´, C-5´, C-2´´, C-3´´, C-4´´, C-5´´, C-2´´´, C-3´´´, C-4´´´, C-5´´´, , 
CH2CH2CH3), 18.2, 18.1 (C-6´, C-6´´´), 10.8 (CH2CH2CH3).   
HRMS, ESI-TOF/MS positive (m/z): calcd for C27H44O21 [M+Na]
+
: 727.2081, found: 
727.2073. 
 
 
 
 
 
 
 
 
 Methyl 2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(methyl 2,3-di-O-
benzyl-α-D-galactopyranosyluronate)-(1→2)-3,4-di-O-benzyl-α-L-rhamnopyranosyl-
(1→4)-(methyl 2,3-di-O-benzyl-α-D-galactopyranosyluronate)-(1→2)-3,4-di-O-benzyl-α-
L-rhamnopyranosy-(1→4)-(allyl 2,3-di-O-benzyl-β-D-galactopyranosid)uronate (46) 
 
 Via N-phenyltrifluoracetimidate. Compound 40 (47 mg, 0.05 mmol), compound 43 (45 mg, 
0.03 mmol) and molecular sieves (4Å, 2 g) were dried for 2 h under high vacuum. The 
mixture was suspended in dry CH2Cl2 (6 mL) and stirred at ambient temperature under an 
atmosphere of argon. After 30 min the mixture was cooled to –30 oC and CF3SO3SiMe3 (30 
μL, 0.16 mmol) was added dropwise. After stirring for 1 h the mixture was slowly warmed up 
to room temperature, and stirring was continued for additional 3 h at ambient temperature 
(monitored by TLC). The solution was neutralized by Et3N (0.25 mL, 1.8 mmol), molecular 
sieves were filtered off and washed with chloroform (3 × 3 mL). The combined organic 
solutions were concentrated. Purification by column chromatography (6 : 1 Toluene - EtOAc) 
gave compound 46 as a colourless foam. 
Yield: 52 mg (79%) 
Rƒ: 0.55 (1 : 1 PE - EtOAc) 
Only traces of β-linked tetrasaccharide were observed by NMR investigations. 
Via Trichloracedimidate. Compound 41 (45 mg, 0.05 mmol), compound 43 (45 mg, 0.03 
mmol) and molecular sieves (4Å, 2 g) were dried for 2 h under high vacuum. The mixture was 
suspended in dry CH2Cl2 (6 mL) and stirred at ambient temperature under an atmosphere of 
argon. After 30 min the mixture was cooled to –70 oC and CF3SO3SiMe3 (30 μL, 0.16 mmol) 
was added dropwise. After stirring for 1 h the mixture was slowly warmed up to room 
temperature, and stirring was continued for additional 18 h at ambient temperature (monitored 
by TLC). The solution was neutralized by Et3N (0.25 mL, 1.8 mmol), molecular sieves were 
filtered off and washed with chloroform (3 × 3 mL). The combined organic solutions were 
concentrated. Purification by column chromatography (6 : 1 Toluene - EtOAc) gave 
compound 46 as a colourless foam. 
Yield: 33 mg (60%) 
1
H NMR (500.13 MHz, CDCl3):  7.44–7.17 (m, 60H, 12 × Ph), 5.96 (dddd, 1H, J  17.3, 
10.4, 6.2, 5.1 Hz, CH2CH=CH2), 5.54 (’q’, 1H, 
3
J1´´´´´,2´´´´´ 1.9 Hz,
 3
J2´´´´´,3´´´´´ 3.2 Hz, H-2´´´´´), 
5.39 (bs, 2H, H-1´, H-1´´´),5.35 (d’q’, 1H, 3J 17.3 Hz, 4J 1.6 Hz, CH2CH=CH2), 5.22 (d’q’, 
1H, 
3
J 10.4 Hz, 
4
J 1.5 Hz, CH2CH=CH2), 5.19 (’d’,1H,
 3
J1´´´´´,2´´´´´ 1.9 Hz, H-1´´´´´), 5.03 (d, 
1H, 
3
J1´´,2´´ 3.5 Hz, H-1´´), 4.98 (m, 2H, J 10.7 Hz, CH2Ph, H-1´´´´), 4.89 (m, 3H, CH2Ph, H-
5´´, H-5´´´´), 4.85 (d, 2H, CH2Ph), 4.81 (m, 2H, CH2Ph), 4.75 (s, 2H, CH2Ph), 4.71 (m, 1H, 
CH2Ph), 4.68 (d, 1H, CH2Ph), 4.66 (m, 3H, CH2Ph), 4.65 (d, 3H, CH2Ph), 4.61 (m, 2H, 
CH2Ph), 4.58 (m, 2H, CH2Ph), 4.55 (m, 2H, CH2Ph), 4.52 (m, 3H, J 12.9 Hz, CH2CH=CH2, 2 
× CH2Ph), 4.46 (m, 4H, CH2Ph, H-4, H-4´´, H-4´´´´), 4.41 (m, 2H, CH2Ph), 4.38 (d, 1H, 
3
J1,2 
7.6 Hz, H-1), 4.21 (m, 1H, 
3
J1´,2´ 1.9 Hz, H-2´), 4.18 (m, 1H, 
3
J1´´´,2´´´ 1.9 Hz, H-2´´´), 4.15 (m, 
1H, J 12.9 Hz, CH2CH=CH2), 4.02 (d, 1H, H-5), 3.98 (dd, 1H, 
3
J 2.8 Hz, H-3´´´´), 3.95 (dd, 
1H, 
3
J 2.5 Hz, H-3´´ ), 3.86 (dd, 1H,  
3
J2´´´´´,3´´´´´ 3.2 Hz, H-3´´´´´), 3.84 (m, 2H, , H-2´´´´, H-
3´´´), 3.82 (d, 1H, 
3
J 3.7 Hz, H-2´´), 3.80 (m, 2H, H-3´, H-), 3.78 (s, 3H, OCH3), 3.76 (m, 1H,
 
3
J  6.9 Hz, H- ), 3.72 (dd, 1H, 
3
J1,2 7.6 Hz, H-2), 3.63 (m, 1H, 
3
J  9.5 Hz, H-5´´´´´), 3.55 (m, 
2H, H-5´´´), 3.52 (m, 2H, H-5´, H-3), 3.50 (s, 3H, OCH3), 3.47 (s, 3H, OCH3), 3.43 (m, 1H, 
3
J  
9.5 Hz, H-4´), 3.39 (m, 1H, 
3
J  9.5 Hz, H-4´´´), 3.36 (m, 1H, 
3
J  9.5 Hz, H-4´´´´´), 2.08 (s, 3H, 
CH3CO), 1.34–1.27 (m, 9H, H-6´, H-6´´´, H-6´´´´´); 
13
C NMR (125.8 MHz, CDCl3):  169.9 
(CH3CO), 168.9,168.8, 168.2 (3 × COO), 138.9, 138.9, 138.9, 138.7, 138.6, 138.5, 138.4, 
138.4, 138.1, 138.1, 137.8, 137.6 (12 × i-Ph), 133.9 (CH2CH=CH2), 128.4–1276.8 (o-Ph,m-
Ph,p-Ph), 117.5 (CH2CH=CH2), 102.7 (C-1) , 98.9 (C-1´´´´´), 97.8 (C-1´´´), 97.7 (C-1´), 96.6 
(C-1´´´´), 96.0 (C-1´´), 80.8 (C-3), 80.0 (C-4´´´´´), 79.8 (C-4´), 79.6 (C-4´´´), 79.0 (C-2´´´´), 
78.6 (C-3´´´), 78.6 (C-2), 78.0 (C-3´´´´´), 76.8 (C-3´´´´), 76.6 (C-3´´), 75.2 (CH2Ph), 75.0 (C-
3´), 74.8 (C-4´´´´), 74.8 (CH2Ph), 74.7 (CH2Ph), 74.6 (CH2Ph), 74.3 (C-2´´), 74.2 (C-2´), 73.7 
(C-5), 73.7 (C-2´´´), 73.6 (C-4´´), 73.1(CH2Ph), 72.6 (CH2Ph), 72.5 (CH2Ph), 72.2 (C-4), 72.0 
(CH2Ph), 71.9 (CH2Ph), 71.8 (CH2Ph), 71.7 (CH2Ph), 71.6 (CH2Ph),70.6 (CH2CH=CH2),70.6 
(C-5´´), 70.4 (C-5´´´´), 68.7 (C-2´´´´´), 68.6 (C-5´), 68.5 (C-5´´´) 68.2 (C-5´´´´´), 52.5 (OCH3), 
52.0 (2 × OCH3),  21.1 (CH3CO), 18.1 (C-6´´´´), 18.0 (C-6´, C-6´´´). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C128H140O32 [M+Na]
+
: 2213.4492, found: 
2213.4486. 
 
Methyl 3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(methyl 2,3-di-O-benzyl-α-D-
galactopyranosyluronate)-(1→2)-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(methyl 
2,3-di-O-benzyl-α-D-galactopyranosyluronate)-(1→2)-3,4-di-O-benzyl-α-L-
rhamnopyranosyl-(1→4)-(allyl 2,3-di-O-benzyl-β-D-galactopyranosid)uronate (47) 
 
 
Compound 46 (85 mg, 0.04 mmol) was added with stirring to methanolic 0.28 M 
hydrochloric acid [prepared by adding of acetyl chloride (0.1 mL) to ice-cold dry methanol (5 
mL)] and the mixture was stirred for 24 h at ambient temperature under an atmosphere of 
argon (monitored by TLC). The solution was filtered through a layer of alkaline alumina by 
elution with CHCl3. The combined organic solutions (ca. 20 mL) were concentrated and the 
crude product was purified by column chromatography (2 : 1 PE- EtOAc) to provide 
compound 47 as a colourless foam. 
Yield: 78 mg (93%) 
Rƒ: 0.36 (1 : 1 PE - EtOAc) 
HRMS, ESI-TOF/MS positive (m/z): calcd for C126H138O31 [M+Na]
+
: 2171.4494, found: 
2171.4502. 
Methyl α-L-rhamnopyranosyl-(1→4)-(methyl α-D-galactopyranosyluronate)-(1→2)-α-L-
rhamnopyranosyl-(1→4)-(methyl α-D-galactopyranosyluronate)-(1→2)-α-L-
rhamnopyranosyl-(1→4)-(propyl β-D-galactopyranosid)uronate (48) 
 
10% Palladium on charcoal (25 mg) was added to a solution of compound 47 (65 mg, 0.03 
mmol) in methanol (10 mL) and the reaction mixture was stirred at ambient temperature 
under an atmosphere of hydrogen. After 28 h (monitored by TLC) the reaction mixture was 
filtered over celite by elution with with methanol and combined organic solutions were 
concentrated. The residue was dissolved in water and lyophilized to obtain compound 48 as a 
colourless foam. Compound 48 was used for the next step without structural characterization. 
Yield: 33 mg (95%) 
Rƒ: 0.27 (1 : 1 CHCl3 - MeOH)  
HRMS, ESI-TOF/MS positive (m/z): calcd for C42H68O31 [M+Na]
+
: 1091.3637, found: 
1091.3652 
 
 
 
 
 Propyl α-L-rhamnopyranosyl-(1→4)-α-D-galactopyranosyluronic acid-(1→2)-α-L-
rhamnopyranosyl-(1→4)-α-D-galactopyranosyluronic acid-(1→2)-α-L-
rhamnopyranosyl-(1→4)-β-D-galactopyranosiduronic acid (49) 
 
Lithiumhydroxid (4 mg, 0.17 mmol) was added to a suspension of compound 48 (33 mg, 
0.029  mmol) in a mixture of methanol and water (2 : 1, v/v, 5 ml). After stirring for 15 min at 
ambient temperature (monitored by TLC) the solution was passed through a column of 
Dowex-50 (H
+
). Methanol was removed from the solution by evaporation under reduced 
pressure and the residue was repeatedly dissolved in water and lyophilized to obtain 
tetrasaccharid 49 as a colourless foam. 
Yield: 30 mg (93%) 
Rƒ: 0.2 (1 : 2 CHCl3 - MeOH) 
1
H NMR (500.13 MHz, DMSO-d6):   5.28 (d, 1H, 
3
J1´´´,2´´´ 1.3 Hz, H-1´´´), 5.24 (d, 2H, 
3
J1,2 
1.5 Hz, H-1´´´´´, H-1´), 5.08 (dd, 1H, 
3
J1´´´,2´´´ 2.2 Hz, H-1´´´), 5.02 (d, 1H, 
3
J1´´,2´´ 3.5 Hz, H-
1´´), 4.66 (dd,1H, 
3
J 1.3 Hz, 
3
J1,2  7.9 Hz, H-2), 4.42 (m, 1H, 
3
J 1.6 Hz, H-2´), 4.38 (d, 1H, 
3
J1,2 
7.9 Hz, H-1), 4.33 (m, 1H, 
3
J 2.2 Hz, 
3
J  3.5 Hz, H-2´´´), 4.12 (m, 3H),  4.06 (q, 1H,
 3
J 1.6 Hz, 
3
J  3.5 Hz, H-3´), 4.02 (d,1H, H-5), 3.93 (m, 1H, 
3
J 1,2 1.3 Hz, 
3
J 2´´´,3´´´ 5.4 Hz, H-2´´´), 3.91 
(m, 2H,
 3
J 2´´´,3´´´ 5.4 Hz, 
3
J 2.3  9.8 Hz, H-3´´´, H-3), 3.83 (m, 1H, 
3
J  3.2 Hz, 
3
J  1.0 Hz, H-4), 
3.82 (m, 1H, H-5´´´), 3.80 (m, 1H, 
 3
J  3.8 Hz, 
3
J  1.0 Hz, H-4´´´´), 3.79 (m, 1H, 
3
J  3.5 Hz, H-), 
3.78 (m, 1H, 
3
J  3.2 Hz, 
3
J  9.5 Hz, H-3´), 3.59 (m, 2H), 3.42 (m, 1H, 
3
J2,3  9.8, H-2), 3.36 (m, 
2H, CH2CH2CH3), 1.63 (m, 2H, CH2CH2CH3),1.34-1.22 (m, 9H, H-6´, H-6´´´, H-6´´´´´), 0.93 
(t, 3H, CH2CH2CH3); 
13
C NMR (125.8 MHz, DMSO-d6):   175.0, 174.2, 171.1 (3×COO), 
102.1 (C-1), 100.5 (C-1´´´´´), 98.5 (C-1´, C-1´´´), 97.4 (C-1´´, C-1´´´´), 77.2, 76.8, 76.7, 76.3, 
76.1, 74.5, 73.8, 72.2, 72.0, 70.4, 70.1, 69.4, 69.0, 68.7, 68.5, 67.9, 65.9 (C-2´, C-3´, C-4´, C-
5´, C-2´´, C-3´´, C-4´´, C-5´´, C-2´´´, C-3´´´, C-4´´´, C-5´´´, C-2´´´´, C-3´´´´, C-4´´´´, C-5´´´´, 
C-2´´´´´, C-3´´´´´, C-4´´´´´, C-5´´´´´, 22.2, 20.1(CH2), 16.8.16.7, 16.6 (C-6´, C-6´´´, C-6´´´´´), 
9.7 (CH2CH2CH3). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C39H62O31 [M+Na]
+
: 1049.3541, found: 
1049.3536 
 
Methyl 2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(methyl 2,3-di-O-
benzyl-α-D-galactopyranosyluronate)-(1→2)-3,4-di-O-benzyl-α-L-rhamnopyranosyl-
(1→4)-( 2-(4-aminophenoxy)ethyl 2,3-di-O-benzyl-β-D-galactopyranosid)uronate (50) 
 
Compound 40 (100 mg, 0.11 mmol), compound 32 (130 mg, 0.15 mmol) and molecular 
sieves (4Å, 200 mg) were dried for 2 h under high vacuum. The mixture was suspended in dry 
CH2Cl2 (3 mL) and stirred at ambient temperature under an atmosphere of argon. After 30 
min the mixture was cooled to –30 oC and TMSOTf (20 μL, 0.11 mmol) was added dropwise. 
After stirring for 1 h the mixture was slowly warmed up to room temperature and stirring was 
continued for additional 12 h at ambient temperature (monitored by TLC). The solution was 
neutralized by Et3N (0.25 mL, 1.8 mmol), molecular sieves were filtered off and washed with 
chloroform (3 × 3 mL). The combined organic solutions were concentrated. Purification by 
column chromatography (6 : 1 toluene - EtOAc) gave compound 50 as colourless foam. 
It should be noted that traces of β-linked (~10%) tetrasaccharide were observed by NMR 
investigations. 
Yield: 140 mg (77%) 
Rƒ: 0.36 (2 : 1 PE - EtOAc) 
[α] 22D : +53.4 (c 1.0, CHCl3) 
1
H NMR (300 MHz, CDCl3):  8.15 (d, 2H, m-OPhNO2), 7.35–7.17 (m, 40H, Ph), 6.90 (d, 
2H, o-OPhNO2), 5.51 (m, 1H,
 3
J1´´´,2´´´ 1.9 Hz, 
3
J2´´´,3´´´ 3,2 Hz, H-2´´´), 5.36 (d, 1H, ,
 3
J1´,2´ 1.9   
H-1´), 5.17 (d, 1H,
 3
J1´´´,2´´´ 1.6 Hz, H-1´´´), 4.97 (d, 1H, 
 3
J1´´,2´´ 3.6 Hz H-1´´), 4.92 (d, 1H, J 
10.7 Hz, CH2Ph), 4.88 (m, 3H, 2 × CH2Ph, H-5), 4.75 (d, 2H, 2 × CH2Ph), 4.68 (m, 2H, 2 × 
CH2Ph), 4.66 (d,1H, J 11.0 Hz, CH2Ph), 4.61 (bs, 1H, CH2Ph), 4.57 (m, 3H, CH2Ph), 4.46 (m, 
3H, CH2Ph, H-4, H-4´´), 4.44 (m, 1H,H-1), 4.40 (dd, 1H, H-), 4.36 (m, 1H, CH2Ph), 4.31 (m, 
1H, ), 4.24 (m, 2H, 2 × CH2CH2O), 4.19 (m, 1H, 
3
J2´,3´ 3.1 Hz, H-2´), 4.03 (d, 1H, 
3
J 1.3 Hz, 
H-5´´), 3.99 (dd, 1H, 
3
J2´´,3´´ 2.8 Hz, H-3´´), 3.96 (m, 1H,
 
CH2CH2O), 3.86 (dd, 1H, 
3
J2´,3´ 3.0 
Hz, H-3´), 3.81 (m, 2H, 
3
J3´´´,4´´´ 9.5 Hz, H-3´´´), 3.77 (s, 3H, CH3OCO), 3.72 (dd, 1H, , 
3
J1,2 
7.9 Hz, 
3
J2,3 9.8 Hz, H-2), 3.67 (m, 1H, )3.59 (m, 1H,
 3
J4´´´,5´´´ 9.5 Hz, H-5´´´), 3.54 (m, 1H,
 
3
J4´,5´ 9.5 Hz, H-5´), 3.51 (dd, 1H, 
3
J2,3 9.8 Hz, H-3), 3.46 (s, 3H, CH3OCO), 3.41 (t, 1H, 
3
J4´,5´ 
9.5 Hz, H-4´), 3.33 (t, 1H, 
3
J4´´´,5´´´ 9.5 Hz, H-4´´´), 2.07 (s, 3H, CH3CO), 1.32 (d, 3H, H-6´´´), 
1.26 (d, 3H, H-6´); 
13
C NMR (125.8 MHz, CDCl3):  169.9 (CH3CO), 168.8,168.2 (2 × 
COO), 163.7 (p-OPhNO2), 141.7 (i-OPhNO2), 138.8, 138.7, 138.4,138.3, 138.1, 138.1, 137.8, 
137.6 (8 × i-Ph), 128.5–127.5 (o-Ph,m-Ph,p-Ph), 125.9 (2 × m-OPhNO2), 114.5 (2 × o-
OPhNO2), 104.1 (C-1) , 98.9 (C-1´´´), 98.2 (C-1´), 96.7 (C-1´´), 80.3 (C-3), 79.9 (C-4´), 79.6 
(C-4´´´), 78.2 (C-3´), 78.6 (C-2), 78.0 (C-3´´´), 77.0 (C-3´´), 75.1 (CH2Ph), 74.8 (2 × CH2Ph), 
74.8 (CH2Ph), 74.3 (C-2´´), 74.1 (C-2´), 73.7 (C-5), 73.1(CH2Ph), 72.5 (C-4), 72.4 (C-4´´), 
72.0 (CH2Ph), 71.8 (CH2Ph), 71.7 (CH2Ph), 70.5 (C-5´´), 68.8 (C-2´´´), 68.7 (C-5´), 68.2 (C-
5´´´),67.8 (CH2CH2O), 67.7 (CH2CH2O), 52.5 (CH3OCO), 52.1 (CH3OCO),  21.1 (CH3CO), 
18.1 (C-6´´´), 18.0 (C-6´). 
Anal. Calcd  for C78H85NO23 (1404.50): C, 66.70; H, 6.10; N, 1.00. Found: C, 66.74; H, 6.11; 
N, 0.98 
 
 
 
 
Allyl α-L-rhamnopyranoside (51)82 
 
Acetyl chloride (1.35 mL, 18.9 mmol) was added dropweise to allyl alcohol (20 mL) at 0 
o
C. 
After stirring for 20 min L-rhamnose monohydrate (2.5 g, 13.7 mmol) was added and the 
reaction mixture was heated under reflux. After 3 h (monitored by TLC) the reaction mixture 
was neutralized with NaHCO3 (3 g). The salts were filtered off and then washed with 
chloroform (3 × 10 mL). The combined organic solutions were concentrated and the residue 
was purified by column chromatography (1 : 1→0 : 1 PE - EtOAc) to give compound 51 as a 
colourless syrup. 
Yield: 2.27g (81%) 
Rƒ: 0.25 (EtOAc) 
[α] 22D : –123.8 (c 1.0, CHCl3): 
1
H NMR (300.13 MHz, CDCl3): δ 5.87 (dddd, 1H, 
3
J8,9(Z) 17.2 Hz, 
3
J7a,8 5.2 Hz, 
3
J7b,8 6.0 Hz, 
3
J8,9(E) 10.4 Hz, H-8), 5.27 (d’q’, 1H, 
3
J8,9(Z) 17.2 Hz, 
4
J7,9 = 
2
J 1.5 Hz, H-9(Z)), 5.18 (d’q’, 1H, 
3
J8,9(E) 10.4 Hz, 
4
J7,9 = 
2
J 1.5 Hz, H-9(E)), 4.79 (d, 1H, 
3
J1,2 1.3 Hz, H-1), 4.66 (d, 1H, 
3
J3,OH 6.4 
Hz, OH-3), 4.30 (d, 1H, 
3
J4,OH 4.7 Hz, OH-4), 4.22 (d, 1H, 
3
J2,OH 4.9 Hz, OH-2), 4.15 (dd’t’, 
1H, 
2
J7a,7b 13.0  Hz, 
3
J7a,8 5.2 Hz, 
4
J7a,9 1.5 Hz, H-7a), 3.96 (dd’t’, 1H, 
2
J7a,7b 13.0 Hz, 
3
J7b,8 6.0 
Hz, 
4
J7b,9 1.5 Hz, H-7b), 3.95–3.92 (m, 1H, H-2), 3.77 (ddd, 1H, 
3
J3,4 9.5 Hz, 
3
J3,OH 6.4 Hz, 
3
J2,3 3.2 Hz, H-3), 3.64 (dq, 1H, 
3
J4,5 9.5 Hz, 
3
J5,6 6.2 Hz, H-5), 3.46 (ddd, 1H, 
3
J3,4 = 
3
J4,5 9.5 
Hz, 
3
J4,OH 4.7 Hz, H-4), 1.29 (d, 3H, 
3
J5,6 6.2 Hz, H-6); 
13
C NMR (75.5 MHz, CDCl3): δ 
133.6 (C-8), 117.6 (C-9), 98.9 (C-1), 72.8 (C-4), 71.7 (C-3), 71.0 (C-2), 68.2 (C-5), 68.0 (C-
7), 17.5 (C-6).  
Anal. Calcd  for C9H16O5 (204.22): C, 52.88; H, 7.83. Found: C, 52.84; H, 7.81. 
 
 
 
Allyl 3-O-benzyl-α-L-rhamnopyranoside (52) 
 
A mixture of allyl α-L-rhamnopyranoside (1.43 g, 7.0 mmol) and dibutyltin oxide (1.74 g, 7.0 
mmol) in distilled toluene (35 mL) was refluxed for 3.5 h in a Dean-Stark apparatus. 
Powdered CsF (2.11 g, 14.0 mmol) was added before the mixture was concentrated. The 
residue was suspended in DMF (30 mL), benzyl bromide (1.2 mL, 14.0 mmol) was added and 
the resulting mixture was stirred overnight at room temperature and then concentrated. The 
residue was triturated with CH2Cl2 (30 mL), the mixture was filtered off, and the solids were 
repeatedly washed with CH2Cl2 (3 × 10 mL). The combined filtrates were washed with brine 
(3 mL) and the organic phase concentrated. The residue was purified by column 
chromatography (2 : 1 PE - EtOAc) to provide compound 52  as a colourless syrup. 
Yield: 1.45 g (70%) 
Rƒ: 0.33 (1 : 1 PE - EtOAc) 
 [α] 22D : –42.5 (c 1.0, CHCl3) 
 
1
H NMR (300.13 MHz, CDCl3): δ 7.39–7.32 (m, 5H, Ph), 5.89 (dddd, 1H, 
3
J8,9(Z) 17.2 Hz, 
3
J8,9(E) 10.4 Hz, 
3
J7b,8 6.1 Hz, 
3
J7a,8 5.1 Hz, H-8), 5.28 (d’q’, 1H, 
3
J8,9(Z) 17.2 Hz, 
4
J7,9 = 
2
J 1.5 
Hz, H-9(Z)), 5.20 (d’q’, 1H, 
3
J8,9(E) 10.4 Hz, 
4
J7,9 = 
2
J 1.5 Hz, H-9(E)), 4.86 (d, 1H, 
3
J1,2 1.6 Hz, 
H-1), 4.71 (d, 1H, 
2
J 11.5 Hz, CH2Ph), 4.57 (d, 1H, 
2
J 11.5 Hz, CH2Ph), 4.17 (dd’t’, 1H, 
2
J7a,7b 13.0 Hz, 
3
J7a,8 5.1 Hz, 
4
J7a,9 1.5 Hz, H-7a), 4.04 (m, 1H, H-2), 3.98 (dd’t’, 1H, 
2
J7a,7b 
13.0 Hz, 
3
J7b,8 6.1 Hz, 
4
J7b,9 1.5 Hz, H-7b), 3.74–3.65 (m, 2H, H-3, H-5), 3.55 (ddd, 1H, 
3
J3,4= 
3
J4,5 9.2 Hz, 
3
J4,OH 2.5 Hz, H-4), 2.43 (d, 1H, 
3
J2,OH 2.5 Hz, OH-2), 2.26 (d, 1H, 
3
J4,OH 2.5 Hz, 
OH-4), 1.30 (d, 3H, 
3
J5,6 6.1 Hz, H-6); 
13
C NMR (75.5 MHz, CDCl3): δ 137.7 (i-Ph), 133.7 
(C-8), 128.7, 127.9 (o-Ph, m-Ph), 128.2 (p-Ph), 117.4 (C-9), 98.4 (C-1), 79.9 (C-3), 71.6 (C-
4), 71.6 (CH2Ph), 67.9 (C-7), 67.8 (C-2), 67.7 (C-5), 17.6 (C-6).  
Anal. Calcd  for C16H22O5 (294.34): C, 65.30; H, 7.47. Found: C, 65.33; H, 7.46. 
 
 
Allyl 2-O-acetyl-3-O-benzyl-α-L-rhamnopyranoside (53) 
 
A solution of acetyl chloride (0.64 mL, 8.9 mmol) in toluene (10 mL) was added dropwise to 
a solution of compound 52 (2.0 g, 6.8 mmol) in dry pyridine (50 mL) at –40 oC under 
atmosphere of argon. The mixture was stirred 2 h at –40 oC, 2 h at –20 oC and 12 h at –10 oC 
(monitored by TLC). After concentration the residue was co-evaporated with toluene (4 × 10 
mL). Purification by column chromatography (4 : 1 PE - EtOAc) gave compound 53 (1.41 g, 
60%) and allyl 2,4-di-O-acetyl-3-O-benzyl-α-L-rhamnopyranoside (0.58 g, 14%) both as 
colourless syrup. 
Yield: 1.41g (60%) 
Rƒ: 0.36 (2 : 1 PE - EtOAc) 
 [α] 23D : –0.2 (c 1.0, CHCl3) 
1
H NMR (300.13 MHz, CDCl3): δ 7.38–7.27 (m, 5H, Ph), 5.89 (dddd, 1H, 
3
J8,9(Z) 17.2 Hz, 
3
J8,9(E) 10.4 Hz, 
3
J7b,8 6.1 Hz, 
3
J7a,8 5.1 Hz, H-8), 5.38 (dd, 1H, 
3
J2,3 3.2 Hz,
 3
J1,2 1.8 Hz, H-2), 
5.28 (d’q’, 1H, 3J8,9(Z) 17.2 Hz, 
4
J7,9 = 
2
J 1.5 Hz, H-9(Z)), 5.21 (d’q’, 1H, 
3
J8,9(E) 10.4 Hz, 
4
J7,9 = 
2
J 1.5 Hz, H-9(E)), 4.79 (d, 1H, 
3
J1,2 1.7 Hz, H-1), 4.72 (d, 1H, 
2
J 11.1 Hz, CH2Ph), 4.42 (d, 
1H, 
2
J 11.1 Hz, CH2Ph), 4.17 (dd’t’, 1H, 
2
J7a,7b 13.0 Hz, 
3
J7a,8 5.1 Hz, 
4
J7a,9 1.5 Hz, H-7a), 
3.98 (dd’t’, 1H, 2J7a,7b 13.0 Hz, 
3
J7b,8 6.1 Hz, 
4
J7b,9 1.5 Hz, H-7b), 3.77-3.68 (m, 2H, H-3, H-
5), 3.55 (’t’, 1H, 3J3,4 = 
3
J4,5 9.5 Hz, H-4), 2.35 (br s, 1H, OH), 2.12 (s, 3H, CH3CO), 1.32 (d, 
3H,
 3
J 6.2 Hz, H-6); 
13
C NMR (75.5 MHz, CDCl3): δ 170.3 (CH3CO), 137.6 (i-Ph), 133.5 
(C-8), 128.5, 128.1(o-Ph, m-Ph), 128.0 (p-Ph), 117.6 (C-9), 97.0 (C-1), 77.7 (C-3), 71.6 (C-
4), 71.4 (CH2Ph), 68.1 (C-5) 68.1 (C-2), 68.0 (C-7), 20.9 (CH3CO), 17.7 (C-6). 
 Anal. Calcd  for C18H24O6 (336.38): C, 64.21; H, 7.14. Found: C, 64.27; H, 7.11.  
HRMS, ESI-TOF/MS positive (m/z): calcd for C18H24O6 [M+Na]
+
: 359.2412, found: 
359.2531. 
 
 
1,2,3,4,6-Penta-O-benzoyl-D-galactopyranoside (54) 
 
Molecular sieves (4Å, 200 mg) were added to a solution of D-galactose (2 g, 11.1 mmol) in 
dry pyridine (25 mL) and the mixture was stirred for 30 min under an atmosphere of argon. 
Benzoyl chloride (8.5 mL, 66.6 mmol) was added to them with intensive stirring at –7 oC. 
After stirring for 18 h at room temperature (monitored by TLC) the reaction mixture was 
cooled to 0 
o
C and excess of benzoyl chloride was destroyed with methanol (3 mL). The 
molecular sieves were filtrated off and washed with chloroform (2 × 10 mL). The combined 
filtrate and washings were concentrated, and the residue was co-evaporated with 
toluene/ethylacetat/ethanol (5 : 3 : 1, 4 × 3 mL). The crude product was dissolved in 
chloroform/heptane (1 : 2, 50 mL), washed with ice-water (2 × 10 mL), satd aq NHCO3 (3 × 
10 mL), ice-water (10 ml), filtered through cotton and concentrated. The purification of the 
residue by column chromatography (4 : 1 PE - EtOAc) gave a compound 54 as colourless 
crystals. 
Yield: 7.7 g  (99%) 
M.p.: 158–159 oC, lit.4158–159 oC  
Rƒ: 0.35 (2 : 1 PE - EtOAc) 
[α] 22D :+187.1 (c 1.0, CHCl3), lit.
4 
+187.1 
1
H NMR (300.13 MHz, CDCl3): δ 8.15–7.81 (m, 10H, o-Ph), 7.68–7.24 (m, 15H, m-Ph, p-
Ph), 6.97 (d, 1H, 
3
J1,2 3.6 Hz, H-1), 6.21 (dd, 1H,
 3
J3,4 3.2 Hz, 
3
J4,5 1.2 Hz, H-4), 6.15 (dd, 1H, 
3
J2,3 10.6 Hz, 
3
J3,4 3.2 Hz, H-3), 6.05 (dd, 1H, 
3
J2,3 10.6 Hz, 
3
J1,2 3.6 Hz, H-2), 4.85 (d’t’, 1H, 
3
J5,6b 7.0 Hz, 
3
J5,6a 6.5 Hz, 
3
J4,5 1.2 Hz, H-5), 4.65 (dd, 1H, 
2
J 11.3 Hz, 
3
J5,6a 6.5 Hz, H-6a), 
4.44 (dd, 1H, 
2
J 11.3 Hz, 
3
J5,6b 7.0 Hz, H-6b); 
13
C NMR (75.5 MHz, CDCl3): δ 165.9, 165.7, 
165.5, 165.4, 164.5 (C=O), 133.9, 133.7, 133.4, 133.4 133.2 (p-Ph), 129.9, 129.9, 129.7 (o-
Ph), 129.5, 129.3, 129.0, 128.9, 128.8 (i-Ph), 128.7, 128.7, 128.4, 128.4, 128.3 (m-Ph), 90.6 
(C-1), 69.4 (C-5), 68.5 (C-3), 68.4 (C-4), 67.7 (C-2), 61.8 (C-6).  
Anal. Calcd  for C41H32O11 (700.69): C, 70.18; H, 4.56. Found: C, 70.27; H, 4.48. 
 2,3,4,6-Tetra-O-benzoyl-α-D-galactopyranosyl bromide (55) 
 
The foregoing 40% HBr solution in acetic acid (10 mL) was added to a solution of compound 
54 (2.1 g, 3.0 mmol) in dry chloroform (10 mL) at 0 
o
C. The ice bath was removed and the 
reaction mixture was stirred 45 min at ambient temperature (monitored by TLC). After 
cooling to 5 
o
C and dilution with cold chloroform (20 mL), the mixture was poured into ice-
water (30 mL). The organic layer was separated and the aqueous layer was extracted with 
chloroform (3 × 3 mL), the combined organic layers were washed with ice- water (2 × 10 
mL), satd aq NHCO3 (3 × 10 mL), ice-water (10 mL), filtered through cotton and 
concentrated. The residue was dried under high vacuum to give compound 55 as colourless 
foam. Bromide 55 was used for the next step directly without further purification. 
Yield: 1.93 g (97%) 
[α] 23D : +237.3 (c 1.0, CHCl3) 
Rƒ: 0.5 (2 : 1 PE - EtOAc) 
1
H NMR (300.13 MHz, CDCl3): δ 8.10–7.20 (m, 20H, 4×Ph), 6.00 (d, 1H, 
3
J1,2 4.0 Hz, H-1), 
6.15 (dd, 1H,
 3
J3,4 3.2 Hz, 
3
J4,5 1.2 Hz, H-4), 6.07 (dd, 1H, 
3
J2,3 10.4 Hz, 
3
J3,4 3.2 Hz, H-3), 
5.67 (dd, 1H, 
3
J2,3 10.4 Hz, 
3
J1,2 4.0 Hz, H-2), 4.95 (t, 1H, 
3
J5,6b 6.8 Hz,
3
J5,6a 6.4 Hz, H-5), 
4.66 (dd, 1H, 
2
J 11.5 Hz, 
3
J5,6a 6.4 Hz, H-6a), 4.44 (dd, 1H, 
2
J 11.5 Hz, 
3
J5,6b 6.8 Hz, H-6b); 
13
C NMR (75.5 MHz, CDCl3): δ 165.9, 165.5, 165.3, 164.3 (C=O), 133.8, 133.8, 133.3, 
133.3 (p-Ph), 130.0, 129.9, 129.8, 129.7 (o-Ph), 129.2, 128.8, 128.7, 128.7, (i-Ph), 128.5, 
128.5, 128.4, 128.3 (m-Ph), 88.3 (C-1), 71.8 (C-5), 68.9 (C-3), 68.6 (C-4), 68.1 (C-2), 61.6 
(C-6). 
 
 
 
 
Allyl (2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-(1→4)-2-O-acetyl-3-O-benzyl-α-L-
rhamnopyranoside (56) 
 
Compound 55 (1.05 g, 1.6 mmol), compound 53 (0.4 g, 1.2 mmol) and molecular sieves (4Å, 
0.4 g) were dried for 2 h under high vacuum in darkness. The mixture was suspended in dry 
acetonitrile (8 mL) and stirred under an atmosphere of argon at ambient temperature. After 20 
min Hg(CN)2 (0.3 g, 1.2 mmol), HgBr2 (0.2 g, 0.6 mmol) were added and stirring was 
continued at ambient temperature. After 24 h (monitored by TLC) the mixture was diluted 
with chloroform (40 mL) and filtrated over celite. The filtrate was extracted with ice-water (2 
× 10 mL), aq 10% KI (3 × 10 mL), ice-water (2 × 10mL), dried and concentrated. Purification 
of the residue by column chromatography (4 : 1 PE - EtOAc) gave compound 56 (0.9 g, 82%) 
as a colourless foam. 
Yield: 0.9 g (82%) 
 Rƒ: 0.43 (2 : 1 PE - EtOAc)  
 [α] 23D : +72.4 (c 1.0, CHCl3) 
1
H NMR (500.13 MHz, CDCl3): δ 8.09 (m, 2H), 8.02 (m, 2H), 7.88 (m, 2H), 7.76 (m, 2H, o-
Bz), 7.65–7.21 (m, 17H, m-Bz, p-Bz, Ph), 5.98 (dd, 1H, 3J3´,4´ 3.5 Hz, 
3
J4´,5´ 0.9 Hz, H-4´), 
5.86 (m, 1H, H-8), 5.80 (dd, 1H, 
3
J2´,3´ 10.4 Hz, 
3
J1´,2´ 7.9 Hz, H-2´), 5.60 (dd, 1H, 
3
J2´,3´ 10.4 
Hz, 
3
J3´,4´ 3.5 Hz, H-3´), 5.33 (d, 1H, 
3
J1´,2´ 7.9 Hz, H-1´), 5.28–5.18 (m, 3H, H-2, H-9), 4.73 
(d, 1H, 
3
J1,2 1.6 Hz, H-1), 4.68 (dd, 1H, 
2
J 11.1 Hz, 
3
J5´,6a´ 6.5 Hz, H-6a´), 4.42 (dd, 1H, 
2
J 
11.1 Hz,
 3
J5´,6b´ 6.8 Hz, H-6b´), 4.41 (d, 1H, 
2
J 11.0 Hz, CH2Ph), 4.32 (d’t’, 1H,
 3
J5´,6b´ 6.8 Hz, 
3
J5´,6a´ 6.5 Hz, 
3
J4´,5´ 0.9 Hz, H-5´), 4.20 (d, 1H, 
2
J 11.0 Hz, CH2Ph), 4.13 (dd’t’, 1H, 
2
J7a,7b 
12.6 Hz, 
3
J7a,8 5.3 Hz, 
4
J7a,9 1.3 Hz, H-7a), 3.95 (dd’t’, 1H, 
2
J7a,7b 12.6 Hz, 
3
J7b,8 6.3 Hz, 
4
J7b,9 
1.3 Hz, H-7b), 3.82–3.75 (m, 3H, H-3, H-4, H-5), 2.03 (s, 3H, CH3CO), 1.43 (d, 3H, 
3
J5,6 5.7 
Hz, H-6); 
13
C NMR (125.8 MHz, CDCl3): δ 170.2 (CH3CO), 166.0, 165.6, 165.6, 165.4 
(C=O), 137.8 (i-Ph), 133.4 (C-8), 133.5, 133.2, 133.2, 133.2 (p-Bz), 129.9, 129.7, 129.7, 
129.6 (o-Bz), 129.4, 129.3, 129.2 128.8 (i-Bz), 128.7, 128.5, 128.5, 128.4, 128.3, 127.4 (m-
Bz, o-Ph, m-Ph), 127.8 (p-Ph), 117.9 (C-9), 101.1 (C-1´), 96.6 (C-1), 77.8, 77.1 (C-3, C-4), 
71.8 (C-3´), 71.5 (CH2Ph), 70.8 (C-5´), 70.3 (C-2´), 68.5 (C-2), 68.3 (C-4´), 68.2 (C-7), 67.0 
(C-5), 61.9 (C-6´), 20.9 (CH3CO), 18.0 (C-6).  
Anal. Calcd  for C52H50O15 (Mol.Wt.: 914.94): C, 68.20; H, 5.46. Found: C, 68.23; H, 5.49. 
 
2,3,4,6-Tetra-O-benzoyl-β-D-galactopyranosyl-(1→4)-2-O-acetyl-3-O-benzyl-L-
rhamnopyranose (57) 
 
Compound 56 (460 mg, 0.5 mmol) was added to a solution of PdCl2 (180 mg, 1 mmol) and 
sodium acetate (136 mg, 1mmol) in aq 90% acetic acid (6 ml). After stirring for 2 h at 45 
o
C 
(monitored by TLC) the reaction mixture was filtered through layer of silica, and the 
remaining salts were washed with methanol (2 × 3 mL). The combined organic solutions were 
concentrated to a half of the volume (~ 6 mL) and toluene (6 mL) was added. After 
concentration to the half of the volume toluene (6 mL) was added again. The procedure was 
repeated two times more. After concentration of the mixture to dryness the residue was 
purified by column chromatography (5 : 1 Toluene - EtOAc) gave compound 57 as a colorless 
foam.  
Yield: 340 mg (77.8%) 
Rƒ: 0.3 (4 : 1 Toluene - EtOAc) α and β 
 Anal. Calcd  for C49H46O15 (874.88): C, 67.27; H, 5.30. Found: C, 67.41; H, 5.42. 
 
2,3,4,6-Tetra-O-benzoyl-β-D-galactopyranosyl-(1→4)-2-O-acetyl-3-O-benzyl-α/β-L-
rhamnopyranoside N-phenyl trifluoroacetimidate (58) 
 
Cs2CO3 (60 mg, 0.18 mmol) and 2,2,2-trifluoro-N-phenyl-acetimidoyl chloride (35 mg, 0.19 
mmol) were consecutively added to compound 57 (200 mg, 0.23 mmol) in acetone (8 mL) at 
0 
o
C. The cooling bath was removed, and the reaction mixture was stirred at ambient 
temperature. After 2 h (monitored by TLC) the reaction mixture was diluted with CH2Cl2 (5 
mL), salts were filtered off and washed with EtOAc (2 × 3 mL). The combined organic 
solutions were concentrated and the residue was purified by column chromatography (3 : 1 PE 
- EtOAc) to give compound 58 as a colourless amorphous.  
Yield: 190 mg (79%, α/β 1/10) 
 Rƒ: 0.36 α, 0.37 β (2 : 1 PE - EtOAc) 
NMR -40 
o
C 
1
H NMR (500.13 MHz, CDCl3): 8.07 (m, 2H), 8.02 (m, 2H), 7.91 (m, 2H), 7.79 (m, 2H), (o-
Bz), 7.63–7.10 (m, 20H, m-Bz, p-Bz, Bn), 6.80 (m, 2H, Ph), 6.15 (d, 1H, , 3J1,2 1.6 Hz, H-1), 
6.01 (d, 1H, 
3
J3,4 3.5 Hz, H-4´), 5.83 (dd, 1H, 
3
J2´,3´ 10.4 Hz, 
3
J1´,2´ 8.0 Hz, H-2´), 5.59 (dd, 1H, 
3
J2´,3´ 10.4 Hz, 
3
J3´,4´ 3.5 Hz, H-3´), 5.29 (d, 1H, 
3
J1´,2´ 8.0 Hz, H-1´), 5.24 (m, 1H,
 3
J1,2 1.6 Hz, 
H-2), 4.72 (dd, 1H, 
2
J 13.0 Hz, H-6´), 4.41 (d, 1H, 
2
J 11.1 Hz, CH2Ph), 4.37 (m, 2H, 
2
J 13.0 
Hz, H-6´, H-5´), 4.28 (d, 1H, 
2
J 11.1 Hz, CH2Ph), 3.94 (m, 1H,
 3
J4,5 9.5 Hz, 
3
J5,6 6.0 Hz, H-5), 
3.89 (t, 1H, 
3
J4,5 9.5 Hz, H-4), 3.78 (dd, 1H,
 3
J2,3 3.2 Hz, 
3
J3,4 9.5 Hz, H-3), 2.09 (s, 3H, 
CH3CO), 1.50 (d, 3H, 
3
J5,6 6.0 Hz, H-6); 
13
C NMR (125.8 MHz, CDCl3):  170.2 (CH3CO), 
166.0, 165.5, 165.3, 165.3 (C=O), 14l.9 (C=N), 136.8 (i-Ph), 133.8, 133.5, 133.5, 133.5 (p-
Bz), 129.8, 129.6, 129.6, 128.7 (o-Bz), 128.6, 128.6, 128.5, 128.4 (i-Bz), 128.3, 128.1, 127.9, 
127.4, 124.2, 120.4. 119.1 (m-Bz, o-Ph, m-Ph, p-Ph, NPh), 100.8 (C-1´), 92.8 (C-1), 76.4 (C-
3), 76.0 (C-4), 72.0 (CH2Ph), 71.5 (C-3´), 70.2 (C-5´), 69.5 (C-5), 67.5 (C-4´), 67.0 (C-2),  
61.0 (C-6´),  21.0 (CH3CO), 18.0 (C-6). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C57H50F3NO15 [M+Na]
+
: 1068.3025, found: 
1068.3028. 
 
 
 
 
2,3,4,6-Tetra-O-benzoyl-β-D-galactopyranosyl-(1→4)-1,2-di-O-acetyl-3-O-benzyl-α-L-
rhamnopyranoside (59) 
 
Acetic anhydride (3 mL) was added to a solution of compound 57 (300 mg, 0.34 mmol) in dry 
pyridine (7 mL) at 0 
o
C and stirred for 24 h at ambient temperature (monitored by TLC). The 
reaction mixture was poured into ice-water (10 mL), the aq layer was extracted with 
chloroform (3 × 3 mL). The combined organic solutions were washed with ice-water (2 mL), 
satd aq NHCO3 (3 × 2 mL), ice-water (2 mL), dried and concentrated. Purification of the 
residue by column chromatography (3 : 1 Toluene - EtOAc) gave compound 59 (240 mg, 
77%) as a colourless foam. 
Yield: 240 mg (77%) 
Rƒ : 0.55 (2 : 1 Toluen - EtOAc) 
[α] 23D : +69.8 (c 1.0, CHCl3) 
 
1
H NMR (500.13 MHz, CDCl3): δ 8.08 (m, 2H), 8.02 (m, 2H), 7.90 (m, 2H), 7.76 (m, 2H), 
(o-Bz), 7.65–7.17 (m, 17H, m-Bz, p-Bz, Bn), 5.98 (dd, 1H, 3J3´,4´ 3.5 Hz, 
3
J4´,5´ 0.9 Hz, H-4´), 
5.96 (d, 1H, 
3
J1,2 1.9 Hz, H-1), 5.81 (dd, 1H, 
3
J2´,3´ 10.4 Hz, 
3
J1´,2´ 8.0 Hz, H-2´), 5.61 (dd, 1H, 
3
J2´,3´ 10.4 Hz, 
3
J3´,4´ 3.5 Hz, H-3´), 5.32 (d, 1H, 
3
J1´,2´ 8.0 Hz, H-1´), 5.18 (m, 1H , 
3
J2,3 3.5 Hz, 
3
J1,2 1.9 Hz, H-2), 4.68 (dd, 1H, 
2
J 11.3 Hz, 
3
J5´,6a´ 6.6 Hz, H-6a´), 4.44 (d, 1H, 
2
J 11.0 Hz, 
CH2Ph), 4.43 (dd, 1H, 
2
J  11.3 Hz, 
3
J5´,6b´ 6.6 Hz, H-6b´), 4.33 (dt, 1H,
 3
J5´,6´ 6.6 Hz, 
3
J4´,5´ 0.9 
Hz, H-5´), 4.25 (d, 1H, 
2
J 11.0 Hz, CH2Ph), 3.88–3.82 (m, 2H, H-4, H-5), 3.73 (m, 1H, H-3), 
2.07 (s, 3H, CH3CO), 2.03 (s, 3H, CH3CO), 1.44 (d, 3H, 
3
J5,6 5.7 Hz, H-6); 
13
C NMR (125.8 
MHz, CDCl3): δ 169.9, 168.5 (CH3CO), 166.0, 165.5, 165.4, 165.4 (C=O), 137.4 (i-Ph), 
133.6, 133.3, 133.3, 133.2 (p-Bz), 129.9, 129.7, 129.7, 129.6 (o-Bz), 129.4, 129.2, 129.1, 
128.7 (i-Bz), 128.6, 128.5, 128.5, 128.4, 128.2, 127.8 (m-Bz, o-Ph, m-Ph), 128.2 (p-Ph), 101.1 
(C-1´), 90.9 (C-1), 77.3 (C-3), 76.5 (C-4), 71.8 (C-3´), 71.7 (CH2Ph), 70.9 (C-5´), 70.3 (C-2´), 
69.3 (C-5), 68.2 (C-4´), 67.4 (C-2), 61.8 (C-6´), 20.9 (CH3CO), 20.8 (CH3CO), 18.0 (C-6). 
Anal. Calcd for C51H48O16 (916.92): C, 66.75; H, 5.23. Found: C, 66.78; H, 5.24. 
HRMS, ESI-TOF/MS positive (m/z): calcd for C51H48O16 [M+Na]
+
: 939.2834, 
found:939.2824.  
 
2,3,4,6-Tetra-O-benzoyl-β-D-galactopyranosyl-(1→4)-2-O-acetyl-3-O-benzyl-α-L-
rhamnopyranosyl bromide (60) 
 
Oxalylbromide (0.38 mL, 2.7 mmol) was added to a solution of compound 59 (250 mg, 0.27 
mmol) in dry CH2Cl2 (7 mL) at –40 
o
C under an atmosphere of argon. After stirring for 1h the 
cooling bath was removed and stirring was continued for 4 h at ambient temperature 
(monitored by TLC). The reaction mixture diluted with toluene (10 mL), the organic solution 
was concentrated to a half of the volume (~ 8 mL) and toluene (8 mL) was added. After 
concentration to the half of the volume toluene (8 mL) was added again and concentrated. 
Obtained syrup of compound 60 was unstable for storage and was used for the next step 
directly without further purification. 
Yield: 215 mg (85%) 
Rƒ: 0.4 (2 : 1 PE - EtOAc). 
 
Allyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl-(1→4)-3-O-benzyl-α-L-
rhamnopyranoside (61) 
 
Compound 56 (3.4 g, 3.7 mmol) was added with stirring to methanolic 0.28 M hydrochloric 
acid [prepared by adding of acetyl chloride (2 mL) in ice-cold dry methanol (110 mL)] and 
the mixture was stirred at ambient temperature under an atmosphere of argon. After 24 h 
(monitored by TLC) PbCO3 × Pb(OH)2 (10 g) was added to the reaction mixture and stirring 
was continued for additional 2 h to neutralize hydrochloric acid. Salts were filtered off by 
using glass sintered filter funnel with layer of silica gel, washed with methanol (3 × 30 mL) 
and the combined organic solutions were concentrated. Purification of the residue by column 
chromatography (3 : 1 PE - EtOAc) gave compound 61 as a colourless foam. 
Yield: 2.04 g (63%) 
[α] 23D : + 49.4 (c 1.0, CHCl3) 
 Rƒ : 0.3 (2 : 1 PE - EtOAc)  
1
H NMR (500.13 MHz, CDCl3): δ 8.08 (m, 2H), 8.01 (m, 2H), 7.87 (m, 2H), 7.77 (m, 2H, o-
Bz),  7.65–7.16 (m, 17H, m-Bz, p-Bz, Bn), 5.99 (dd, 1H, 3J3´,4´ 3.5 Hz, 
3
J4´,5´ 0.9 Hz, H-4´), 
5.87 (dddd, 1H, 
3
J8,9(Z) 17.2 Hz, 
3
J8,9(E) 10.4 Hz, 
3
J7b,8 6.0 Hz, 
3
J7a,8 5.2 Hz, H-8), 5.81 (dd, 1H, 
3
J2´,3´ 10.4 Hz, 
3
J1´,2´ 8.0 Hz, H-2´), 5.63 (dd, 1H, 
3
J2´,3´ 10.4 Hz, 
3
J3´,4´ 3.5 Hz, H-3´), 5.30 (d, 
1H, 
3
J1´,2´ 8.0 Hz, H-1´), 5.25 (d’q’, 1H, 
3
J8,9(Z) 17.2 Hz, 
4
J7,9 = 
2
J 1.5 Hz, H-9(Z)), 5.19 (d’q’, 
1H, 
3
J8,9(E) 10.4 Hz, 
4
J7,9 = 
2
J 1.5 Hz, H-9(E)), 4.81 (d, 1H, 
3
J1,2 1.6 Hz, H-1), 4.63 (dd, 1H, 
2
J 
11.3 Hz, 
3
J5´,6a´ 6.5 Hz, H-6a´), 4.43 (d, 1H, 
2
J 11.3 Hz,
 3
J5´,6b´ 6.9 Hz, H-6b´), 4.35 (center of 
AB spectrum, 2H, 
2
J 12.5 Hz, CH2Ph), 4.30 (ddd, 1H,
 3
J5´,6b´ 6.9 Hz, 
3
J5´,6a´ 6.5 Hz, 
3
J4´,5´ 0.9 
Hz, H-5´), 4.14 (dd’t’, 1H, 2J7a,7b 12.9 Hz, 
3
J7a,8 5.4 Hz, 
4
J7a,9 1.5 Hz, H-7a), 3.96 (dd’t’, 1H, 
2
J7a,7b 12.9 Hz, 
3
J7b,8 6.3 Hz, 
4
J7b,9 1.5 Hz, H-7b), 3.88 (m, 1H, H-2), 3.86-3.76 (m, 2H, H-4, 
H-5), 3.67 (dd, 1H, 
3
J3,4 8.8 Hz, 
3
J2,3 3.5 Hz, H-3), 2.27 (d, 1H, 
3
J2,OH 2.2 Hz, OH), 1.42 (d, 
3H, 
3
J5,6 6.0 Hz, H-6); 
13
C NMR (125.8 MHz, CDCl3): δ 166.0, 165.6, 165.5, 165.3 (C=O), 
137.8 (i-Ph), 133.7 (C-8), 133.5, 133.2, 133.2, 133.2 (p-Bz), 129.9, 129.7, 129.7, 129.6 (o-
Bz), 129.4, 129.3, 129.2, 128.8 (i-Bz), 128.6, 128.6, 128.4, 128.3, 128.2, 127.2 (m-Bz, o-Ph, 
m-Ph), 128.0 (p-Ph), 117.7 (C-9), 101.3 (C-1´), 98.1 (C-1), 80.1 (C-3), 77.3 (C-4), 71.8 
(CH2Ph), 71.8 (C-3´), 71.0 (C-5´), 70.3 (C-2´), 68.3 (C-4´), 68.0 (C-7), 68.0 (C-2), 66.6 (C-5), 
61.9 (C-6´), 17.9 (C-6).  
Anal. Calcd  for C50H48O14 (872.91): C, 68.80; H, 5.50. Found: C, 68.81; H, 5.48. 
HRMS, ESI-TOF/MS positive (m/z): calcd for C50H48O14 [M+Na]
+
: 895.2936, found: 
895.2937. 
 
 
Methyl (2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-(1→4)-(2-O-acetyl-3-O-benzyl-α-
rhamnopyranosyl)-(1→4)-(allyl 2,3-di-O-benzyl-β-D-galactopyranosid)uronate (62) 
 
Compound 60 (250 mg, 0.25 mmol), compound 8 (94 mg, 0.22 mmol) and molecular sieves 
(4Å, 300 mg) were dried for 2 h under high vacuum in darkness. The mixture was suspended 
in dry acetonitrile (4 mL) and stirred at ambient temperature under an atmosphere of argon. 
After 20 min Hg(CN)2 (60 mg, 0.24 mmol) and HgBr2 (50 mg, 0.14 mmol) were added and 
stirring was continued. After 24 h (monitored by TLC) the mixture was diluted with 
chloroform (20 mL) and filtered through a layer of celite. The filtrate was extracted with ice-
water (2 × 5 mL), aq 10% KI (3 × 5 mL), ice-water (2 × 5 mL), dried and concentrated. The 
residue was purified by column chromatography (2 : 2 PE - EtOAc) to give compound 62 
(186 mg, 65%) as colourless foam. 
Yield: 186 mg (65%)  
Rƒ: 0.27 (2 : 1 PE - EtOAc) 
 [α] 24D : + 71.4 (c 1.0, CHCl3)  
1
H NMR (500.13 MHz, CDCl3):  8.07 (m, 2H), 8.01 (m, 2H), 7.87 (m, 2H), 7.77 (m, 2H, o-
Bz), 7.63–7.20 (m, 27H, m-Bz, p-Bz, Bn), 5.97 (dd, 1H, 3J3´´,4´´ 3.5 Hz, 
3
J4´´,5´´ 0.9 Hz, H-4´´), 
5.94 (m, 1H, H-8), 5.77 (dd, 1H, 
3
J2´´,3´´ 10.4 Hz, 
3
J1´´,2´´ 8.0 Hz, H-2´´), 5.56 (dd, 1H, 
3
J2´´,3´´ 
10.4 Hz, 
3
J3´´,4´´ 3.5 Hz, H-3´´), 5.42 (dd, 1H, 
3
J2´,3´ 3.2 Hz, 
3
J1´,2´ 1.9 Hz, H-2´), 5.35 (m, 1H, 
H-1´), 5.33 (m, 1H, H-9(Z)), 5.31 (d, 1H, 
3
J1´´,2´´ 8.0 Hz, H-1´´), 5.20 (m, 1H, H-9(E)), 4.89 (d, 
1H, 
2
J 11.9 Hz, CH2Ph), 4.73 (d, 1H, 
2
J 11.9 Hz, CH2Ph), 4.73 (br s, 2H, CH2Ph), 4.66 (dd, 
1H, 
2
J 11.2 Hz, 
3
J5´´,6a´´ 6.5 Hz, H-6a´´), 4.51–4.46 (m, 2H, H-4, H-7a), 4.50 (d, 1H, 
2
J 10.7 
Hz, CH2Ph), 4.41 (dd, 1H, 
2
J 11.2 Hz, 
3
J5´´,6b´´ 6.9 Hz, H-6b´´), 4.37 (d, 1H, 
3
J1,2 7.8 Hz, H-1), 
4.29 (d’t’, 1H, 3J5´´,6b´´ 6.9 Hz, 
3
J5´´,6a´´ 6.5 Hz, 
3
J4´´,5´´ 0.9 Hz, H-5´´), 4.18 (d, 1H, 
2
J 10.7 Hz, 
CH2Ph), 4.13 (m, 1H, H-7b), 4.06 (d, 1H, 
3
J4,5 1.3 Hz, H-5), 3.79 (s, 3H, OCH3), 3.78–3.72 
(m, 3H, H-2, H-3´, H-4´), 3.59 (dq, 1H, 
3
J4´,5´ 9.5 Hz, 
3
J5´,6´ 6.2 Hz, H-5´), 3.55 (dd, 1H, 
3
J2,3 
9.8 Hz, 
3
J3,4 2.8 Hz, H-3), 1.95 (s, 3H, CH3CO), 1.42 (d, 3H, 
3
J5´,6´ 6.2 Hz, H-6´); 
13
C NMR 
(125.8 MHz, CDCl3):  169.6 (CH3CO), 168.3 (COO), 166.0, 165.5, 165.5, 165.3 (C=O), 
138.3, 138.0, 137.8 (i-Ph), 133.7 (C-8), 133.5, 133.2, 133.2, 133.2 (p-Bz), 129.9, 129.8, 
129.7, 129.7 (o-Bz), 129.5, 129.3, 129.2, 128.8 (i-Bz), 128.7, 128.5, 128.4, 128.4, 128.3, 
128.3, 128.2, 127.6, 127.6, 127.5 (m-Bz, o-Ph, m-Ph), 128.3. 127.7, 127.6 (p-Ph), 117.6 (C-
9), 102.7 (C-1), 100.8 (C-1´´), 98.2 (C-1´), 81.0 (C-3), 78.1 (C-2), 77.4, 76.3 (C-3´, C-4´), 
75.2 (CH2Ph), 73.8 (C-5), 73.0 (CH2Ph), 71.8 (C-4), 71.8 (C-3´´), 71.5 (CH2Ph), 70.8 (C-5´´), 
70.7 (C-7), 70.1 (C-2´´), 68.3 (C-4´´), 68.1 (C-2´), 67.3 (C-5´), 61.8 (C-6´´), 52.8 (OCH3), 
20.9 (CH3CO), 17.9 (C-6´).  
Anal. Calcd  for C73H72O21 (1285.34): C, 68.21; H, 5.65. Found: C, 68.29; H, 5.58.  
HRMS, ESI-TOF/MS positive (m/z): calcd for C73H72O21 [M+Na]
+
: 1307.4458, 
found:1307.4477, calcd for C73H72O21 [M+K]
+
: 1323.4198, found:1323.4204. 
 
Allyl (methyl 4-O-acetyl-2,3-di-O-benzyl-α-D-galactopyranosyluronat)-(1→2)-[2,3,4,6-
tetra-O-benzoyl-β-D-galactopyranosyl]-(1→4)-3-O-benzyl-α-L-rhamnopyranoside (63) 
 
Compound 61 (235 mg, 0.27 mmol), compound 34 (120 mg, 0.2 mmol) and molecular sieves 
(4Å, 2 g) were dried for 2 h under high vacuum. The mixture was suspended in dry CH2Cl2 
(20 mL). After 20 min the mixture was cooled to –30 oC and CF3SO3SiMe3 (25 μL, 0.14 
mmol) was added dropwise. After stirring for 1 h the mixture was slowly warmed up to room 
temperature, and stirring was continued for additional 2 h at ambient temperature (monitored 
by TLC). The solution was neutralized by Et3N (0.25 mL, 1.8 mmol), molecular sieves were 
filtered off and washed with chloroform (3 × 3 mL). The combined organic solutions were 
concentrated. Purification by column chromatography (6 : 1 Toluene - EtOAc) gave 
compound 63 as colourless foam.  
Yield: 170 mg (66%), colourless foam  
Rƒ: 0.45 (4 : 1 Toluene - EtOAc) 
[α] 24D : +111.85 (c 1.0, CHCl3) 
1
H NMR (500.13 MHz, CDCl3):  8.08 (m, 2H), 8.01 (m, 2H), 7.73 (m, 2H), 7.61 (m, 2H, o-
Bz), 7.50–7.03 (m, 27H, m-Bz, p-Bz, Bn), 6.02 (d, 1H, 3J3´´,4´´ 3.5 Hz, H-4´´), 5.86 (m, 1H, H-
8), 5.81 (dd, 1H, 
3
J2´´,3´´ 10.4 Hz, 
3
J1´´,2´´ 8.0 Hz, H-2´´), 5.80 (dd, 1H, 
3
J2,3 3.5 Hz, 
3
J1,2 1.5 Hz, 
H-2), 5.60 (dd, 1H, 
3
J2´´,3´´ 10.4 Hz, 
3
J3´´,4´´ 3.5 Hz, H-3´´), 5.41 (d, 1H, 
3
J1´´,2´´ 8.0 Hz, H-1´´), 
5.23 (d’q’, 1H, 3J8,9(Z) 17.2 Hz, 
4
J7,9 = 
2
J 1.5 Hz, H-9(Z)), 5.18 (d’q’, 1H, 
3
J8,9(E) 10.4 Hz, 
4
J7,9 = 
2
J 1.5 Hz, H-9(E)), 4.97 (d, 1H, 
3
J1´,2´ 3.8 Hz, H-1´), 4.83 (d, 1H, 
2
J 11.8 Hz), 4.61 (d, 1H, 
2
J 
11.8 Hz), (CH2Ph), 4.71 (d, 1H, 
2
J 11.0 Hz), 4.44 (d, 1H, 
2
J 11.0 Hz), (CH2Ph), 4.54 (d, 1H, 
2
J 12.3 Hz), 4.18 (d, 1H, 
2
J 12.3 Hz), (CH2Ph), 4.80 (br s, 2H, H-1, H-5´), 4.65 (m, 1H, H-
6a´´), 4.47 (m, 1H, H-6b´´), 4.45 (m, 1H, H-5´´), 4.04 (dd, 1H, 
3
J3,4 10.1 Hz, 
3
J2,3 3.5 Hz, H-
3), 4.00 (dd, 1H, 
3
J3´,4´ 3.5 Hz, 
3
J4´,5´ 1.8 Hz, H-4´), 4.13 (m, 1H, H-7a), 3.92 (m, 1H, H-7b), 
3.85–3.75 (m, 3H, H-2´, H-4, H-5), 3.29 (s, 3H, OCH3), 2.01 (s, 3H, CH3CO), 1.45 (d, 3H, 
3
J5,6 6.0 Hz, H-6); 
13
C NMR (125.8 MHz, CDCl3):  169.7 (CH3CO), 167.9 (COO), 166.1, 
165.5, 165.5, 165.4 (C=O), 138.6, 137.9, 137.9 (i-Ph), 133.7 (C-8), 133.5, 133.3, 133.2, 132.9 
(p-Bz), 129.9, 129.7, 129.7, 129.5 (o-Bz), 129.3, 129.2, 129.0, 128.7 (i-Bz), 128.7, 128.6, 
128.4, 128.3, 128.2, 128.2, 127.9, 127.7, 127.6, 125.9 (m-Bz, o-Ph, m-Ph), 128.3. 127.6, 
127.3 (p-Ph), 117.6 (C-9), 101.3 (C-1´´), 98.1 (C-1´), 96.4 (C-1), 78.9 (C-3´), 77.8 (C-4), 75.2 
(C-3), 74.5 (C-2´), 74.4 (C-4´), 72.9 (CH2Ph), 71.9 (CH2Ph), 71.8 (C-3´´), 71.1 (CH2Ph), 70.8 
(C-5´´), 70.1 (C-2´´), 69.4 (C-5´), 68.7 (C-2), 68.2 (C-4´´), 67.9 (C-7), 67.2 (C-5), 61.8 (C-
6´´), 52.1 (OCH3), 20.7 (CH3CO), 18.1 (C-6).  
Anal. Calcd  for C73H72O21 (Mol.Wt.: 1285.34): C, 68.21; H, 5.65. Found: C, 68.24; H, 5.61. 
HRMS, ESI-TOF/MS positive (m/z): calcd for C73H72O21 [M+Na]
+
: 1307.4458, 
found:1307.4436. 
 
 
 
2-(4-Nitrophenoxy)ethyl (2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-(1→4)-2-O-
acetyl-3-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(methyl 2,3-di-O-benzyl-α-D-
galactopyranosyluronate)-(1→2)-3,4-di-O-benzyl-α-L-rhamnopyranoside (64) 
 
Compound 58 (190 mg, 0.18 mmol), compound 32 (180 mg, 0.2 mmol) and molecular sieves 
(4Å, 2 g) were dried for 2 h under high vacuum. The mixture was suspended in dry CH2Cl2 
(10 mL). After 20 min the mixture was cooled to –25 oC and CF3SO3SiMe3 (25 μL, 0.14 
mmol) was added dropwise. After stirring for 1 h the mixture was slowly warmed up to room 
temperature, and stirring was continued for additional 2 h at ambient temperature (monitored 
by TLC). The solution was neutralized by Et3N (0.15 mL, 1.1 mmol), molecular sieves were 
filtered off and washed with chloroform (3 × 5 mL). The combined organic solutions were 
concentrated. Purification by column chromatography (6 : 1 toluene - EtOAc) gave compound 
64 as colourless foam. 
Yield: 240 mg (77%) 
Rƒ: 0.15 (2 : 1 PE - EtOA) 
1
H NMR (500.13 MHz, CDCl3):  8.19 (m, 2H, m-OPhNO2), 8.07 (m, 2H), 8.01 (m, 2H), 
7.83 (m, 2H), 7.75 (m, 2H), (o-Bz), 7.63–7.20 (m, 37H, m-Bz, p-Bz, Bn), 6.94 (m, 2H, o-
OPhNO2), 5.97 (d, 1H, 
3
J3´´´,4´´´ 3.5 Hz, H-4´´´), 5.74 (dd, 1H, 
3
J2´´´,3´´´ 10.4 Hz, 
3
J1´´´,2´´´ 8.0 Hz, 
H-2´´´), 5.54 (dd, 1H, 
3
J2´´´,3´´´ 10.4 Hz, 
3
J3´´´,4´´´ 3.5 Hz, H-3´´´), 5.38 (m, 1H, 
3
J1´´,2´´ 1.7 Hz, 
3
J2´´,3´´ 3.2 Hz, H-2´´), 5.36 (d, 1H,
 3
J1´´,2´´ 1.7 Hz, H-1´´), 5.29 (d, 1H, 
3
J1´´´,2´´´ 8.0 Hz, H-1´´´), 
4.97 (d, 1H, 
3
J1´,2´ 3.5 Hz, H-1´), 4.87 (d, 1H,
 2
J 10.7 Hz, CH2Ph ), 4.83 (d, 1H, 
3
J 1.0 Hz, H-
5´), 4.80 (d, 1H,
 3
J1,2 1.0 Hz, H-1), 4.78 (m, 2H, 
2
J 12.0 Hz, CH2Ph, H-4´), 4.74 (d, 1H,
 2
J 
12.0 Hz, CH2Ph), 4.66 (d, 1H, 
2
J 11.0 Hz, H-6´´´), 4.65 (d, 1H, 
2
J 11.2 Hz, CH2Ph), 4.62 (d, 
1H, 
2
J 12.0 Hz, CH2Ph), 4.61 (d, 1H, 
2
J 10.7 Hz, CH2Ph), 4.53 (m, 2H, 
2
J 12.3 Hz, CH2Ph), 
4.45 (d, 1H, 
2
J 10.7 Hz, CH2Ph), 4.40 (dd, 1H, 
3
J5´´´,6´´´ 6.9 Hz, H-6´´´), 4.29 (t, 1H, 
3
J5´´´,6´´´ 
6.9 Hz, H-5´´´), 4.15 (m, 3H, 
2
J 11.0 Hz, CH2CH2O, CH2Ph), 4.02 (m, 2H, 
3
J2,3 3.2 Hz, 
3
J2´,3´ 
10.1 Hz, H-2, H-3´), 3.97 (m, 1H,
 2
J 6.6 Hz, CH2CH2O), 3.80 (m, 1H,
 3
J2,3 3.2 Hz, H-3), 3.79 
(m, 1H, 
2
J 6.6 Hz, CH2CH2O), 3.77 (m, 1H, 
3
J3´´,4´´ 9.5 Hz, H-4´´), 3.72 (m, 1H, 
3
J4,5 9.5 Hz, 
3
J5,6 6.3 Hz, H-5), 3.62 (dd, 1H,
 3
J2´´,3´´ 3.5 Hz, 
3
J3´´,4´´ 9.5 Hz, H-3´´), 3.55(m, 1H,
 3
J4´´,5´´ 9.5 
Hz, 
3
J5´´,6´´ 6.3 Hz,  H-5´´),  3.51 (s, 3H, OCH3), 3.43 (t, 1H, 
3
J4,5 9.5 Hz, H-4), 1.96 (s, 3H, 
CH3CO), 1.40 (d, 3H, 
3
J5´´,6´´ 6.3 Hz, H-6´´), 1.34 (d, 3H, 
3
J5,6 6.0 Hz, H-6); 
13
C NMR (125.8 
MHz, CDCl3):  169.8 (CH3CO), 168.8 (COO), 166.0, 165.5, 165.5, 165.2 (C=O), 163.7 (p-
OPhNO2), 141.7 (i-OPhNO2), 138.5, 138.3, 138.2, 138.0, 137.9 (i-Ph), 133.5, 133.2, 133.2, 
133.2 (p-Bz), 129.9, 129.7, 129.7, 129.6 (o-Bz), 129.4, 129.2, 128.8, 128.7 (i-Bz), 128.4, 
128.4, 128.3, 128.2, 128.0, 127.8, 127.8, 127.7, 127.6, 127.6, 127,3, 126.9, (m-Bz, o-Ph, m-
Ph, p-Ph), 125.9 (m-OPhNO2), 114.5 (o-OPhNO2), 100.8 (C-1´´´), 97.8 (C-1´´), 97.6 (C-1, C-
1´), 80.1 (C-4), 78.8 (C-3), 77.7 (C-3´´), 77.1 (C-3´), 76.3 (C-4´´), 75.3 (CH2Ph), 74.6 (C-2), 
74.4 (C-2´), 72.8 (CH2Ph), 72.6 (C-4´), 72.4 (CH2Ph), 71.8 (C-3´´), 71.8 (CH2Ph), 71.5 
(CH2Ph), 70.9 (C-5´), 70.8 (C-5´´´), 70.1 (C-2´´´), 68.4 (C-4´´´), 68.3 (C-5), 68.1 (C-4´´´´´, C-
5´´´´), 67.8 (C-2´´),  67.7 (CH2CH2O), 67.5 (C-5´´), 65.4 (CH2CH2O), 61.8 (C-6´´´), 52.5 
(OCH3),  20.9 (CH3CO), 18.0 (C-6), 18.0 (C-6´´). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C98H97NO28 [M+Na]
+
: 1758.6089, found: 
1758.6099. 
 
2-(4-nitrophenoxy)ethyl (2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-(1→4)-3-O-
benzyl-α-L-rhamnopyranosyl-(1→4)-(methyl 2,3-di-O-benzyl-α-D-
galactopyranosyluronate)-(1→2)-3,4-di-O-benzyl-α-L-rhamnopyranoside (65) 
  
Compound 64 (200 mg, 0.115 mmol) was added with stirring to methanolic 0.28 M 
hydrochloric acid [prepared by adding of acetyl chloride (0.4 mL) in ice-cold dry methanol 
(18 mL)] and the mixture was stirred at ambient temperature under an atmosphere of argon. 
After 20 h (monitored by TLC) PbCO3 × Pb(OH)2 (2 g) was added to the reaction mixture and 
stirring was continued for additional 2 h. Salts were filtered off by using glass sintered filter 
funnel, with a layer of silica gel, washed with methanol (3 × 5 mL) and the combined organic 
solutions were concentrated. Purification of the residue by column chromatography (2 : 1 PE - 
EtOAc) gave compound 65 as a colourless foam. 
Yield: 160 mg (82%) 
Rƒ: 0.46 (1 : 1 PE - EtOAc) 
1
H NMR (500.13 MHz, CDCl3):  8.19 (m, 2H, m-OPhNO2), 8.06 (m, 2H), 8.01 (m, 2H), 
7.85 (m, 2H), 7.76 (m, 2H), (o-Bz), 7.63–7.20 (m, 37H, m-Bz, p-Bz, Bn), 6.93 (m, 2H, o-
OPhNO2), 5.98 (d, 1H, 
3
J3´´´,4´´´ 3.5 Hz, H-4´´´),  5.75 (dd, 1H, 
3
J2´´´,3´´´ 10.4 Hz, 
3
J1´´´,2´´´ 8.0 Hz, 
H-2´´´), 5.58 (dd, 1H, 
3
J2´´´,3´´´ 10.4 Hz, 
3
J3´´´,4´´´ 3.5 Hz, H-3´´´), 5.41 (d, 1H,
 3
J1´´,2´´ 1.5 Hz, H-
1´´), 5.26 (d, 1H, 
3
J1´´´,2´´´ 8.0 Hz, H-1´´´),  5.00 (d, 1H, 
3
J1´,2´ 3.6 Hz, H-1´), 4.87 (d, 1H,
 2
J 
10.7 Hz, CH2Ph ), 4.82 (d, 1H, 
3
J 1.1 Hz, H-5´), 4.79 (m, 2H,
 3
J1,2 1.0 Hz,
 2
J 10.7 Hz, CH2Ph, 
H-1), 4.73 (m, 2H,
 2
J 12.0 Hz, 2 × CH2Ph), 4.65 (d, 1H, 
2
J 12.3 Hz, CH2Ph), 4.63 (d, 1H, 
2
J 
10.2 Hz, CH2Ph), 4.60 (m, 2H, 
2
J 10.7 Hz, CH2Ph, C-6´´´), 4.58 (m, 1H, 
2
J 10.7 Hz, CH2Ph), 
4.53 (d, 1H, 
2
J 12.3 Hz, CH2Ph), 4.51 (m, 1H, 
3
J4´,5´ 1.7 Hz, H-4´), 4.41 (dd, 1H, 
3
J5´´´,6´´´ 6.9 
Hz, H-6´´´), 4.32 (s, 2H, 2 × CH2Ph), 4.27 (t, 1H, 
3
J5´´´,6´´´ 6.9 Hz, H-5´´´), 4.15 (m, 2H, 
2
J 
11.0 Hz, CH2CH2O ), 4.02 (m, 2H, 
3
J2,3 3.2 Hz, 
3
J2´,3´ 10.1 Hz, H-2, H-3´),  3.97 (m, 2H,
 2
J 6.6 
Hz, CH2CH2O, H-2´´), 3.87 (dd, 1H, 
3
J1´,2´ 3.6 Hz, H-2´), 3.83 (d, 1H, 
3
J3´´,4´´ 9.5 Hz, H-4´´), 
3.80 (dd, 1H,
 3
J2,3 3.2 Hz, 
3
J3,4 9.5 Hz, H-3), 3.79 (m, 1H, 
2
J 12.3 Hz, 
2
J 6.60 Hz,  CH2CH2O), 
3.72 (m, 1H, 
3
J4,5 9.5 Hz, 
3
J5,6 5.99 Hz, H-5), 3.55 (dd, 1H,
 3
J2´´,3´´ 3.5 Hz, Hz, H-3´´), 3.52 
(bs, 4H, H-5´´, OCH3), 3.43 (t, 1H, 
3
J4,5 9.5 Hz, H-4), 1,39 (d, 3H, 
3
J5´´,6´´ 6.3 Hz, H-6´´), 1.34 
(d, 3H, 
3
J5,6 5.99 Hz, H-6); 
13
C NMR (125.8 MHz, CDCl3):  168.8 (COO), 166.0, 165.5, 
165.5, 165.1 (C=O), 163.6 (p-OPhNO2), 141.7 (i-OPhNO2), 138.6, 138.3, 138.2, 137.9, 137.9 
(i-Ph), 133.5, 133.2, 133.2, 133.1 (p-Bz), 129.9, 129.8, 129.7, 129.6 (o-Bz), 129.4, 129.2, 
128.8, 128.6 (i-Bz), 128.5, 128.4, 128.4, 128.3, 128.2, 128.0, 127.9, 127.8, 127.7, 127.6, 
127.5, 127,4, 127.1, 126.9, (m-Bz, o-Ph, m-Ph, p-Ph), 125.9 (m-OPhNO2), 114.5 (o-
OPhNO2), 101.1 (C-1´´´), 99.4 (C-1´´), 97.6 (C-1), 97.4 (C-1´),  80.0 (C-4), 79.7 (C-3´´), 78.8 
(C-3), 77.2 (C-3´), 76.6 (C-4´´), 75.3 (CH2Ph), 74.8 (C-2´), 74.5 (C-2), 72.9 (C-4´), 72.6 
(CH2Ph), 72.5 (CH2Ph), 71.8 (C-3´´), 71.8 (CH2Ph), 71.7 (CH2Ph), 71.0 (C-5´´´), 70.8 (C-5´), 
70.1 (C-2´´´), 68.4 (C-5), 68.2 (C-4´´´), 68.0 (C-2´´),   67.7 (CH2CH2O), 67.1 (C-5´´), 65.4 
(CH2CH2O), 61.9 (C-6´´´), 52.5 (OCH3),  18.0 (C-6), 17.9 (C-6´´). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C96H95NO27 [M+Na]
+
: 1716.5984, found: 
1716.5979. 
 
Allyl 2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(methyl 2,3-di-O-benzyl-
α-D-galactopyranosyluronate)-(1→2)-[2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl]-
(1→4)-3-O-benzyl-α-L-rhamnopyranoside (66) 
 
Compound 61 (220 mg, 0.25 mmol), compound 40 (180 mg, 0.19 mmol) and molecular 
sieves (4Å, 2 g) were dried for 2 h under high vacuum. The mixture was suspended in dry 
CH2Cl2 (15 mL). After 20 min the mixture was cooled to –25 
o
C and CF3SO3SiMe3 (30 μL, 
0.16 mmol) was added dropwise. After stirring for 1 h the mixture was slowly warmed up to 
room temperature, and stirring was continued for additional 2 h at ambient temperature 
(monitored by TLC). The solution was neutralized by Et3N (0.25 mL, 1.8 mmol), molecular 
sieves were filtered off and washed with chloroform (3 × 5 mL). The combined organic 
solutions were concentrated. Purification by column chromatography (6 : 1 toluene - EtOAc) 
gave compound 66 as colourless foam. 
Yield: 245 mg (80%) 
Rƒ: 0.36 (2 : 1 PE - EtOA) 
1
H NMR (500.13 MHz, CDCl3):  8.08 (m, 2H), 8.01 (m, 2H), 7.73 (m, 2H), 7.62 (m, 2H, o-
Bz), 7.56 (m, 2H), 7.49–7.04 (m, 35H, m-Bz, p-Bz, Bn), 6.02 (d, 1H, 3J3´´´,4´´´ 3.5 Hz, H-4´´´), 
5.87 (m, 1H, CH2CH=CH2), 5.80 (dd, 1H, 
3
J2´´´,3´´´ 10.4 Hz, 
3
J1´´´,2´´´ 8.0 Hz, H-2´´´), 5.58 (dd, 
1H, 
3
J2´´´,3´´´ 10.4 Hz, 
3
J3´´´,4´´´ 3.5 Hz, H-3´´´), 5.47 (m, 1H,
 3
J1´´,2´´ 1,9 Hz, 
3
J2´´,3´´ 3.2 Hz, H-
2´´) 5.41 (d, 1H, 
3
J1´´´,2´´´ 8.0 Hz, H-1´´´), 5.23 (d’q’, 1H, 
3
J8,9(Z) 17.2 Hz, 
4
J7,9 = 
2
J 1.5 Hz, H- 
CH2CH=CH2), 5.20 (d’q’, 1H, 
3
J8,9(E) 10.4 Hz, 
4
J7,9 = 
2
J 1.5 Hz, CH2CH=CH2), 5.13 (d, 1H, 
3
J1´´,2´´ 1.9 Hz, H-1´´), 4.91 (d, 1H, 
3
J1´,2´ 3.7 Hz, H-1´), 4.83 (d, 1H, 
2
J 11.4 Hz, CH2Ph), 4.82 
(d, 1H, 
3
J1,2 1.7 Hz, H-1), 4.80 (d, 1H, 
2
J 12.3 Hz, CH2Ph), 4.68 (d, 2H, CH2Ph), 4.66 (m, 3H, 
CH2Ph, H-6´´´, H-5´),  4.59 (d, 1H, 
2
J 10.8 Hz, CH2Ph), 4.58 (d, 1H, 
2
J 12.5 Hz, CH2Ph), 4.53 
(d, 1H, 
2
J 11.4 Hz, CH2Ph), 4.48–4.42 (m, 3H, H-6´´´, H-5´´´, H-4´), 4.33 (d, 1H,
 2
J 10.9 Hz, 
CH2Ph), 4.14 (m, 2H, 
2
J 12.9 Hz, CH2Ph, CH2CH=CH2), 4.00 (dd, 1H, 
3
J3´,4´ 10.1 Hz, 
3
J2´,3´ 
3.6 Hz, H-3´), 3.98 (m, 1H,
 3
J1,2 1.9 Hz, H-2), 3.96 (m, 1H, CH2CH=CH2), 3.90 (dd, 1H, 
3
J1´,2´ 
3.7 Hz, H-2´), 3.83 (m, 1H, 
3
J3,4 9.1 Hz, H-4), 3.78 (m, 1H, H-5) 3.75 (dd, 1H, 
3
J2´´,3´´ 3.2 Hz, 
H-3´´), 3.70 (dd, 1H, 
3
J2,3 3.5 Hz, 
3
J3,4 9.1 Hz, H-3), 3.51 ( m, 1H,
 3
J4´´,5´´ 9.5 Hz, H-5´´ ), 3.29 
(t, 1H, 
3
J4´´,5´´ 9.5 Hz, H-4´´), 3.26 (s, 3H, OCH3), 2.03 (s, 3H, CH3CO), 1.45 (d, 3H, 
3
J5,6 6.0 
Hz, H-6), 1.20 (d, 3H, H-6´´); 
13
C NMR (125.8 MHz, CDCl3):  169.8 (CH3CO), 168.4 
(COO), 166.1, 165.5, 165.5, 165.4 (C=O), 138.9, 138.4, 138.2, 138.1, 138.1 (i-Ph), 133.7 
(CH2CH=CH2), 133.5, 133.3, 133.2, 132.9 (p-Bz), 129.9, 129.7, 129.7, 129.5 (o-Bz), 129.3, 
129.2, 129.0, 128.7 (i-Bz), 128.7, 128.6, 128.4, 128.3,128.3, 128.2, 128.2, 127.9, 127.9, 
127.7, 127.6, 127.6, 127.2, 125.7 (m-Bz, o-Ph, m-Ph), 128.3. 127.6, 127.5, 127.4,127.3 (p-
Ph), 117.6 (CH2CH=CH2), 101.3 (C-1´´´), 98.8 (C-1´´), 98.2 (C-1´), 96.5 (C-1), 79.6 (C-4´´), 
79.0 (C-3), 78.0 (C-3´´), 77.7 (C-4), 77.3 (C-3´),74.7 (CH2Ph), 74.6 (C-4´), 74.4 (C-2), 74.1 
(C-2´), 72.9 (CH2Ph), 72.5 (CH2Ph), 71.9 (C-3´´´), 71.7 (CH2Ph), 70.8 (C-5´´´), 70.7 
(CH2Ph), 70.6 (C-5´), 70.0 (C-2´´´), 68.7 (C-2´´), 68.2 (C-4´´´), 67.9 (CH2CH=CH2), 67.1 (C-
5), 61.8 (C-6´´´), 52.0 (OCH3), 21.0 (CH3CO), 18.1 (C-6), 18.0 (C-6´´).  
HRMS, ESI-TOF/MS positive (m/z): calcd for C93H94O25 [M+Na]
+
: 1633.5976, found: 
1633.5965. 
  
 
 
 
 
 
 
2-O-Acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-methyl 2,3-di-O-benzyl-α-D-
galactopyranosyluronate-(1→2)-[2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl]-(1→4)-
3-O-benzyl-α/β-L-rhamnopyranose (46) 
 
PdCl2 (10 mg, 0.056 mmol) was added to a solution of compound 66 (240 mg, 0.15 mmol) in 
methanol-CH2Cl2 (1.6 : 1 v/v, 10 mL). After stirring for 16 h at ambient temperature 
(monitored by TLC) the reaction mixture was filtered through layer of silica by elution with 
methanol (2 × 3 mL). The combined organic solutions were concentrated and the residue was 
purified by column chromatography (5 : 1 Toluene - EtOAc) gave compound 67 as a 
colourless foam. 
Yield: 208 mg (88%) 
 Rƒ: 0.3 α, 0.2 β (6 : 1 toluene - EtOAc) 
1
H NMR (500.13 MHz, CDCl3):  8.08 (m, 2H), 8.01 (m, 2H), 7.97 (m, 2H), 7.76 (m, 2H, o-
Bz), 7.63–7.10 (m, 37H, m-Bz, p-Bz, Bn), 6.01 (d, 1H, 3J3´´´,4´´´ 3.5 Hz, H-4´´´),  5.82 (dd, 1H, 
3
J2´´´,3´´´ 10.4 Hz, 
3
J1´´´,2´´´ 8.0 Hz, H-2´´´), 5.65 (dd, 1H, 
3
J2´´´,3´´´ 10.4 Hz, 
3
J3´´´,4´´´ 3.5 Hz, H-
3´´´), 5.49 (m, 1H,
 3
J1´´,2´´ 1,9 Hz, 
3
J2´´,3´´ 3.2 Hz, H-2´´), 5.34 (d, 1H, 
3
J1´´´,2´´´ 8.0 Hz, H-1´´´),  
5.13 (d, 1H, 
3
J1´´,2´´ 1.9 Hz, H-1´´), 4.98 (d, 1H, 
3
J1´,2´ 3.7 Hz, H-1´), 4.88 (d, 1H, 
2
J 11.4 Hz, 
CH2Ph), 4.78 (d, 1H, 
2
J 10.7 Hz, H-6´´´), 4.77 (d, 1H, 
2
J 11.3 Hz, CH2Ph), 4.67 (d, 1H, 
2
J 
11.3 Hz, CH2Ph), 4.64 (d, 1H, 
2
J 11.0 Hz, CH2Ph), 4.59 (d, 1H, H-5´), 4.57 (d, 1H, 
2
J 11.4 
Hz, CH2Ph), 4.54 (d, 1H, 
2
J 12.3 Hz, CH2Ph), 4.51 (bs, 1H, H-1), 4.44 (m, 1H, H-4´), 4.32 
(m, 2H,
 2
J 11.0 Hz, CH2Ph, H-3´), 4.40–4.31(m, 2H, H-6´´´, H-5´´´), 4.21 (d, 1H, 
2
J 12.3 Hz, 
CH2Ph), 3.98 (dd, 1H,
 3
J1´,2´ 3.7 Hz, H-2´), 3.82 (dd, 1H,
 3
J2´´,3´´ 3.2 Hz, H-3´´ ), 3.78 (m, 1H, 
3
J3,4 9.5 Hz, H-4), 3.78 (s, 3H, OCH3), 3.67 (d, 1H, 
3
J2,3 3.8 Hz, H-2),  3.61 (m, 1H, 
3
J4´´,5´´ 9.5 
Hz, H-5´´), 3.41 (dd, 1H, 
3
J2,3 3.8 Hz, 
3
J3,4 9.5 Hz, H-3), 3.36 ( m, 1H,
 3
J4,5 9.5 Hz, H-5), 3.34 
(t, 1H, 
3
J4´´,5´´ 9.5 Hz, H-4´´), 2.05 (s, 3H, CH3CO), 1.43 (d, 3H, 
3
J5,6 6.0 Hz, H-6), 1.30 (d, 
3H, H-6´´); 
13
C NMR (125.8 MHz, CDCl3):  169.7 (CH3CO), 168.0 (COO), 165.8, 165.5, 
165.5, 165.4 (C=O), 138.9, 138.5, 138.2, 138.1, 137.5 (i-Ph), 133.6, 133.4, 133.3, 133.3, (p-
Bz), 129.9, 129.7, 129.4, 129.3 (o-Bz), 129.3, 129.2, 129.0, 128.7 (i-Bz), 128.7, 128.6, 128.4, 
128.3,128.3, 128.2, 128.2, 127.9, 127.9, 127.7, 127.6, 127.6, 127.2, (m-Bz, o-Ph, m-Ph), 
128.3. 127.6, 127.5, 127.4,127.3 (p-Ph), 101.1 (C-1´´´), 99.1 (C-1´´), 95.7 (C-1´), 91.6 (C-1), 
80.2 (C-3), 79.5 (C-4´´), 77.7 (C-3´´),77.5 (C-4´),  76.5 (C-4), 74.8 (CH2Ph), 74.5 (C-3´), 73.8 
(C-2), 73.0 (2 × CH2Ph), 72.5 (C-5´), 71.7 (C-3´´´, CH2Ph),  71.0 (C-5), 70.9 (C-5´´´), 70.3 
(C-2´, C-2´´´), 68.6 (C-2´´), 68.3 (C-4´´´, C-5´´), 61.7 (C-6´´´), 52.4 (OCH3), 21.0 (CH3CO), 
18.5 (C-6), 18.0 (C-6´´). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C90H90O25 [M+Na]
+
: 1593.5663, found: 
1593.5661 
 
2-O-Acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(methyl 2,3-di-O-benzyl-α-D-
galactopyranosyluronate)-(1→2)-[2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl]-(1→4)-
3-O-benzyl-α/β-L-rhamnopyranoside N-phenyl trifluoroacetimidate (68) 
 
Cs2CO3 (45 mg, 0.14 mmol) and 2,2,2-trifluoro-N-phenyl-acetimidoyl chloride (30 mg, 0.14 
mmol) were consecutively added to compound 67 (160 mg, 0.1 mmol) in acetone (5 mL) at 0 
o
C. The cooling bath was removed, and the reaction mixture was stirred at ambient 
temperature. After 2 h (monitored by TLC) the reaction mixture was diluted with CH2Cl2 (5 
mL), salts were filtered off and washed with EtOAc (2 × 3 mL). The combined organic 
solutions were concentrated and the residue was purified by column chromatography (3 : 1 PE 
- EtOAc) to give compound 68 as a colourless amorphous.  
Yield: 150 mg (86%) 
 Rƒ: 0.39 (2 : 1 PE - EtOAc) 
NMR at RT 
1
H NMR (500.13 MHz, CDCl3):  8.07 (m, 2H), 7.98 (m, 2H), 7.72 (m, 2H, o-Bz), 7.62–
7.07 (m, 44H, m-Bz, p-Bz, Bn, NPh), 6.80 (m, 2H, m-Bz), 6.01 (d, 1H, 
3
J3´´´,4´´´ 3.4 Hz, 
3
J4´´´,5´´´ 0.8 Hz, H-4´´´), 5.80 (dd, 1H, 
3
J2´´´,3´´´ 10.4 Hz, 
3
J1´´´,2´´´ 7.9 Hz, H-2´´´), 5.75 (bs, 1H, 
H-1), 5.65 (d, 1H, 
3
J1´,2´ 3.2 Hz, H-1´), 5.60 (dd, 1H, 
3
J2´´´,3´´´ 10.4 Hz, 
3
J3´´´,4´´´ 3.4 Hz, H-3´´´), 
5.46 (m, 1H,
 3
J1´´,2´´ 2,0 Hz, H-2´´), 5.39 (d, 1H,
 3
J1´´´,2´´´ 7.9 Hz, H-1´´´), 5.10 (d, 1H, 
3
J1´´,2´´ 
2.0 Hz, H-1´´), 4.90 (d, 1H, 
2
J 11.7 Hz, CH2Ph), 4.85 (d, 2H, 
2
J 11.4 Hz, CH2Ph), 4.77 (d, 1H, 
3
J4´´´,5´´´ 0.8 Hz, H-5´´´), 4.72 (d, 1H, 
2
J 11.6 Hz, CH2Ph), 4.66 (d, 2H, 
2
J 11.7 Hz, CH2Ph), 
4.63 (m, 1H, 
2
J 11.0 Hz, CH2Ph), 4.61 (d, 1H, 
2
J 8.8 Hz, H-6´´´), 4.57 (d, 2H, CH2Ph), 4.53 
(d, 1H, 
2
J 11.0 Hz, CH2Ph), 4.48 (d, 1H, 
2
J 11.0 Hz, H-6´´´), 4.44 (m, 3H, H-2, H-3´, H-5´´´), 
4.32 (d, 1H,
 2
J 11.0 Hz, CH2Ph), 4.22 (d, 1H,
 2
J 12.6 Hz, CH2Ph), 3.99 (m, 2H, H-2´), 3.92 
(m, 1H, 
3
J3,4 9.2 Hz, H-4), 3.78 (dd, 1H,
 3
J2´´,3´´ 3.2 Hz, 
3
J3´´,4´´ 9.2 Hz,  H-3´´ ), 3.55 (m, 1H, 
3
J4´´,5´´ 9.5 H-5´´), 3.52 (m, 1H, H-5), 3.47 (m, 1H, Hz, H-3), 3.30 (t, 1H, 
3
J4´´,5´´ 9.5 Hz, H-4´´), 
3.28 (s, 3H, OCH3), 2.04 (s, 3H, CH3CO), 1.54 (d, 3H, 
3
J5,6 6.0 Hz, H-6), 1.20 (d, 3H, H-6´´); 
13
C NMR (125.8 MHz, CDCl3):  169.7 (CH3CO), 168.5 (COO), 166.1, 165.5, 165.5, 165.2 
(C=O), 143.2 (i-NPh),138.9, 138.6, 138.3, 138.1, 137.2 (i-Ph), 133.6, 133.3, 133.2, 133.0, (p-
Bz), 129.9, 129.7, 129.4, 129.3 (o-Bz), 129.3, 129.2, 129.0, 128.7 (i-Bz), 128.7, 128.6, 128.4, 
128.3,128.3, 128.2, 128.2, 127.9, 127.8, 127.8, 127.6, 127.6, 127.2, (m-Bz, o-Ph, m-Ph), 
128.3. 127.6, 127.5, 127.4, 127.3, 119.2 (p-Ph), 101.3 (C-1´´´), 99.2 (C-1´´), 97.4 (C-1´), 95.3 
(C-1), 81.4 (C-3),79.6 (C-4´´), 77.8 (C-3´´), 77.4 (C-4), 76.9 (C-4´), 75,3 (C-3´),74.6 
(CH2Ph), 74.6 (C-2´), 72.9 (CH2Ph), 72.5 (C-5), 71.7 (C-3´´´), 71.6 (2 × CH2Ph), 71.5 
(CH2Ph), 71.1 (H-3´), 70.9 (C-2), 70.2 (C-5´´´), 70.1 (C-2´´´), 68.7 (C-2´´), 68.2 (C-5´´), 68.1 
(C-4´´´), 61.9 (C-6´´´), 52.0 (OCH3), 21.1 (CH3CO), 18.0 (C-6, C-6´´). 
NMR at -40 
o
C 
1
H NMR (500.13 MHz, CDCl3):  8.05 (m, 2H), 8.00 (m, 2H), 7.73 (m, 2H,), 7.65 (m, 2H, 
o-Bz), 7.53–7.01 (m, 41H, m-Bz, p-Bz, Bn), 6.81 (m, 2H, m-Bz), 6.02 (d, 1H, 3J3´´´,4´´´ 3.2 Hz, 
H-4´´´), 5.88 (bs, 1H, H-1), 5.77 (dd, 1H, 
3
J2´´´,3´´´ 10.4 Hz, 
3
J1´´´,2´´´ 7.9 Hz, H-2´´´), 5.61 (d, 
1H,
 3
J1´,2´ 3.2 Hz, H-1´), 5.55 (dd, 1H, 
3
J2´´´,3´´´ 10.4 Hz, 
3
J3´´´,4´´´ 3.2 Hz, H-3´´´), 5.42 (m, 2H,
 
3
J1´´,2´´ 1,9 Hz, 
3
J1´´´,2´´´ 7.9 Hz, H-2´´, H-1´´´),  5.06 (bs, 1H, 
3
J1´´,2´´ 1.9 Hz, H-1´´), 4.97 (d, 1H, 
2
J 12.0 Hz, CH2Ph), 4.83 (d, 2H, 
2
J 11.0 Hz, CH2Ph), 4.74 (d, 1H, 
2
J 11.7 Hz, CH2Ph), 4.70–
4.64 (m, 4H, 
2
J 11.3 Hz, CH2Ph, H-6´´´), 4.50 (m, 5H, 
2
J 11.4 Hz, CH2Ph, H-2, H-4´, H-5´´´), 
4.43 (m, 1H, 
2
J 10.7 Hz, H-6´´´), 4.22 (d, 1H,
 2
J 10.4 Hz, CH2Ph), 4.13 (d, 1H, 
2
J 12.6 Hz, 
CH2Ph), 4.05 (dd, 1H,
 3
J2´,3´ 10.3 Hz, H-3´ ), 4.00 (dd, 1H,
 3
J1´,2´ 3.2 Hz, 
3
J2´,3´ 10.3 Hz, H-2´), 
3.90 (m, 1H, 
3
J3,4 9.5 Hz, H-4), 3.73 (dd, 1H,
 3
J2´´,3´´ 3.0 Hz, 
3
J3´´,4´´ 9.5 Hz,  H-3´´ ), 3.65 (m, 
1H, H-5), 3.53 (dd, 1H, 
3
J3,4 9.5 Hz, H-3), 3.47 (m, 1H, 
3
J4´´,5´´ 9.5 Hz, H-5´´), 3.25 (t, 1H, 
3
J4´´,5´´ 9.5 Hz, H-4´´), 3.12 (s, 3H, OCH3), 2.03 (s, 3H, CH3CO), 1.58 (d, 3H, 
3
J5,6 6.0 Hz, H-
6), 1.20 (d, 3H, H-6´´); 
13
C NMR (125.8 MHz, CDCl3):  169.9 (CH3CO), 168.6 (COO), 
165.8, 165.5, 165.5, 165.4 (C=O), 138.5, 138.0, 137.8, 137.4, 137.0 (i-Ph), 133.7, 133.5, 
133.4, 133.1, (p-Bz), 129.8, 129.7, 129.4, 129.3 (o-Bz), 129.3, 129.2, 129.0, 128.7 (i-Bz), 
128.7, 128.6, 128.4, 128.3,128.3, 128.2, 128.2, 127.9, 127.9, 127.7, 127.6, 127.6, 127.2, (m-
Bz, o-Ph, m-Ph), 128.3. 127.6, 127.5, 127.4,127.3 (p-Ph), 100.9 (C-1´´´), 98.9 (C-1´´), 97.3 
(C-1´), 94.6 (C-1), 81.5 (C-4´´), 77.6 (C-3´´),77.5 (C-4´),  76.7 (C-4), 76,3 (C-3´),74.6 
(CH2Ph), 73.3 (C-2´), 72.3 (C-5, CH2Ph), 71.5 (CH2Ph), 71.3 (C-3´´´),  71.0 (CH2Ph), 70.8 
(CH2Ph), 70.2 (C-5´´´), 69.7 (C-2), 69.2 (C-2´´´), 68.0 (C-2´´), 67.8 (C-5´´), 67.4 (C-4´´´), 
61.6 (C-6´´´), 52.3 (OCH3), 21.3 (CH3CO), 17.9 (C-6, C-6´´). 
 
2-(4-Nitrophenoxy)ethyl (2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→4)-
(methyl 2,3-di-O-benzyl-α-D-galactopyranosyluronate)-(1→2)-[2,3,4,6-tetra-O-benzoyl-
β-D-galactopyranosyl]-(1→4)-3-O-benzyl-α-L-rhamnopyranosyl-(1→4)-(methyl 2,3-di-O-
benzyl-α-D-galactopyranosyluronate)-(1→2)-3,4-di-O-benzyl-α-L-rhamnopyranoside 
(69) 
 
 
 
Via 68 and 32. Compound 68 (120 mg, 0.07 mmol), compound 32 (80 mg, 0.09 mmol) and 
molecular sieves (4Å, 2 g) were dried for 2 h under high vacuum. The mixture was suspended 
in dry CH2Cl2 (5 mL). After 20 min the mixture was cooled to –25 
o
C and CF3SO3SiMe3 (20 
μL, 0.11 mmol) was added dropwise. After stirring for 1 h the mixture was slowly warmed up 
to room temperature, and stirring was continued for additional 2 h at ambient temperature 
(monitored by TLC). The solution was neutralized by Et3N (0.15 mL, 1.1 mmol), molecular 
sieves were filtered off and washed with chloroform (3 × 2 mL). The combined organic 
solutions were concentrated. Purification by column chromatography (6 : 1 toluene - EtOAc) 
gave compound 69 as colourless foam.  
Yield: 87 mg (51%) 
Rƒ: 0.18 (2 : 1 PE - EtOA) 
Via 65 and 40. Compound 65 ( 122 mg, 0.07 mmol), compound 40 ( 84 mg, 0.09 mmol) and 
molecular sieves (4Å, 2 g) were dried for 2 h under high vacuum. The mixture was suspended 
in dry CH2Cl2 (5 mL). After 20 min the mixture was cooled to –25 
o
C and CF3SO3SiMe3 (20 
μL, 0.11 mmol) was added dropwise. After stirring for 1 h the mixture was slowly warmed up 
to room temperature, and stirring was continued for additional 2 h at ambient temperature 
(monitored by TLC). The solution was neutralized by Et3N (0.15 mL, 1.1 mmol), molecular 
sieves were filtered off and washed with chloroform (3 × 2 mL). The combined organic 
solutions were concentrated. Purification by column chromatography (6 : 1 Toluene - EtOAc) 
gave compound 69 as colourless foam. 
Yield: 51 mg (30%) 
1
H NMR (500.13 MHz, CDCl3):  8.19 (m, 2H, m-OPhNO2), 8.05 (m, 2H), 7.89 (m, 2H), 
7.71 (m, 2H), (o-Bz), 7.63–7.02 (m, 59H, o-Bz, m-Bz, p-Bz, Bn), 6.91 (m, 2H, o-OPhNO2), 
6.00 (d, 1H, 
3
J3´´´´´,4´´´´´ 3.5 Hz, H-4´´´´´),  5.75 (dd, 1H, 
3
J2´´´´´,3´´´´´ 10.5 Hz, 
3
J1´´´´´,2´´´´´ 8.0 Hz, 
H-2´´´´´), 5.60 (d, 1H,
 3
J1´´,2´´ 1.3 Hz, H-1´´), 5.53 (dd, 1H, 
3
J2´´´´´,3´´´´´ 10.5 Hz, 
3
J3´´´´´,4´´´´´ 3.5 
Hz, H-3´´´´´), 5.45 (dd, 1H,
 3
J1´´´´,2´´´´ 1,8 Hz, 
3
J2´´´´,3´´´´ 3.2 Hz, H-2´´´´), 5.41 (d, 1H, 
3
J1´´´´´,2´´´´´ 
8.0 Hz, H-1´´´´´),  5.09(d, 1H, 
3
J1´´´´,2´´´´ 1.8 Hz, H-1´´´´), 5.04 (d, 1H, 
3
J1´,2´ 3.5 Hz, H-1´), 4.97 
(d, 1H, 
3
J1´´´,2´´´ 3.7 Hz, H-1´´´), 4.84 (d, 1H, CH2Ph ), 4.82 (m, 2H, 
2
J 11.0 Hz, CH2Ph, H-5´), 
4.76 (d, 1H,
 3
J1,2 1.7 Hz, H-1), 4.69 (m, 2H, CH2Ph, H-5´´´), 4.63 (m, 3H, CH2Ph), 4.60 (m, 
3H, H-6´´´´´, CH2Ph), 4.58 (m, 3H, 
2
J 11.0 Hz, CH2Ph), 4.54 (m, 4H, 
2
J 11.0 Hz, CH2Ph, H-
6´´´´´, H-4´´´), 4.50 (d, 1H, 
2
J 11.7 Hz, CH2Ph), 4.45 (m, 2H, 
2
J 11.7 Hz, CH2Ph), 4.42 (m, 
3H,
 2
J 11.7 Hz, CH2Ph, H-5´´´´´, H-5´´´), 4.32 (d, 1H,
 2
J 11.0 Hz, CH2Ph), 4.21 (d, 1H, 
2
J 
12.3 Hz, CH2Ph), 4.16 (m, 1H, 
3
J1´´,2´´ 1.3 Hz, H-2´´), 4.13 (m, 2H, CH2CH2O, H-4´), 4.00 (m, 
2H, H-2, CH2CH2O),  3.94 (m, 3H,
 2
J 12.9 Hz, 
3
J1´,2´ 3.5 Hz,
 3
J2´´´,3´´´ 3.2 Hz, CH2CH2O, H-2´, 
H-3´´´), 3.85 (t, 1H,
 3
J3´´,4´´ 9.5 Hz, H-4´´), 3.79 (m, 2H, 
3
J2´´´,3´´´ 3.2 Hz, H-2´´´, H-3), 3.75 (m, 
2H, 
3
J2´´´´,3´´´´ 3.2 Hz, 
3
J3´´´´,4´´´´ 9.5 Hz, H-3´´´´, H-3´), 3.69 (m, 2H, 
3
J4,5 9.5 Hz, 
3
J5,6 6.3 Hz, 
H-5), 3.60 (dd, 1H,
 3
J2´´,3´´ 3.2 Hz, H-3´´), 3.53(m, 2H, H-5´´, H-5´´´´),  3.51 (s, 3H, OCH3), 
3.38 (t, 1H, 
3
J4,5 9.5 Hz, H-4), 3.28 (t, 1H,
 3
J3´´´´,4´´´´ 9.5 Hz, H-4´´´´), 3.21 (s, 3H, OCH3), 2.02 
(s, 3H, CH3CO), 1.45 (d, 3H, 
3
J5´´,6´´ 6.0 Hz, H-6´´), 1.32 (d, 3H, 
3
J5,6 6.3 Hz, H-6), 1.20 (d, 
3H, 
3
J5´´´´,6´´´´ 6.3 Hz, H-6´´´´); 
13
C NMR (125.8 MHz, CDCl3):  169.8 (CH3CO), 169.0, 
168.0 (COO), 166.1, 165.5, 165.5, 165.2 (C=O), 163.7 (p-OPhNO2), 141.7 (i-OPhNO2), 
138.9, 138.6, 138.4, 138.3, 138.2, 138,2, 138.2, 138.1, 137.7 (i-Ph), 133.5, 133.3, 133.2, 
132.9 (p-Bz), 129.9, 129.7, 129.6, 129.5 (o-Bz), 129.3, 129.2, 128.8, 128.8 (i-Bz), 128.7, 
128.6, 128.4, 128.3, 128.3, 128.2, 128.2, 128.1, 128.1, 128.0, 127.8, 127.7, 127.7, 127.5, 
127.4, 127.4, 127,3, 126.9, 125.5 (m-Bz, o-Ph, m-Ph, p-Ph), 125.9 (m-OPhNO2), 114.5 (o-
OPhNO2), 101.1 (C-1´´´´´), 98.9 (C-1´´´´), 97.5 (C-1), 97.3 (C-1´´´), 97.1 (C-1´, C-1´´), 80.2 
(C-4), 79.6 (C-4´´´´), 79.0 (C-3´´), 78.7 (C-3), 78.0 (C-3´, C-3´´´´), 77.4 (C-3´´´), 77.2 (C-4´´), 
75.5 (C-2´), 75.3 (CH2Ph), 74.8 (CH2Ph), 74.6 (C-5´´´), 74.3 (C-2), 73.9 (C-2´´´), 73.5 (C-
2´´), 72.7 (2 × CH2Ph), 72.4 (CH2Ph), 72.1 (CH2Ph), 72.0 (C-3´´´´´, C-4´´´), 71.8 (CH2Ph), 
71.7 (CH2Ph), 70.9 (C-5´), 70.8 (C-5´´´´´), 70.4 (C-5´´´), 69.9 (C-2´´´´´), 68.7 (C-2´´´´), 68.4 
(C-5), 68.1 (C-4´´´´´, C-5´´´´), 67.7 (CH2CH2O), 67.6 (C-5´´), 65.4 (CH2CH2O), 61.8 (C-
6´´´´´), 52.7 (OCH3), 52.0 (OCH3),  21.1 (CH3CO), 18.1 (C-6´´), 18.0 (C-6, C-6´´´´). 
HRMS, ESI-TOF/MS positive (m/z): calcd for C139H141NO38 [M+Na]
+
: 2454.9024, found: 
2454.9028. 
 
 
 
 
 
 
2-(4-aminoperoxy)ethyl (α-L-rhamnopyranosyl-(1→4)-(α-D-galactopyranosyluronate)-
(1→2)-[β-D-galactopyranosyl]-(1→4)-α-L-rhamnopyranosyl-(1→4)-(α-D-
galactopyranosyluronate)-(1→2)-α-L-rhamnopyranoside (71) 
 
10% Palladium on charcoal (20 mg) was added to a solution of compound 69 (95 mg, 0.04 
mmol) inmixture of methanol and ethylacetat (1 : 1, v/v, 10 mL), and the reaction mixture was 
stirred at ambient temperature under an atmosphere of hydrogen. After 48 h (monitored by 
TLC) the reaction mixture was filtered over celite by elution with methanol, and combined 
organic solutions were concentrated to obtain compound 70. Lithiumhydroxid (4 mg, 0.17 
mmol) was added to a suspension of compound 70 in a mixture of methanol and water (2 : 1, 
v/v, 5 ml). After stirring for 15 min at ambient temperature (monitored by TLC) the solution 
was passed through a column of Dowex-50 (H
+
). Methanol was removed from the solution by 
evaporation under reduced pressure and the residue was repeatedly dissolved in water and 
lyophilized to obtain tetrasaccharid 71 as a colourless foam. 
Yield: 37 mg (85%) 
Rƒ: 0.15 (1 : 1 CHCl3 - MeOH) 
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6. ABBREVIATIONTS 
abs.   absolute 
Ac     acetyl 
All  allyl 
aq  aqueous 
Bz  benzoyl 
Bn  benzyl 
br.  broud 
calcd  calculated 
CI  chemical ionization 
COSY  correlated spectroscopy 
dd  doublet of doublets 
ddd  doublet of doublets doublet of doublets 
dddd  doublet of doublets doublet of doublets doublet of doublets 
dec.  decomposition 
DBU  1,8-Diaazabicyclo[5.4.0]undec-7-en 
DEPT  distortionless enhancement by polarization transfer 
DMF  N,N-dimethylformamide 
DMSO  dimethylsulfoxide 
DNA  deoxyribonucleic acid 
dq  doublet of quartets 
dt  doublet of triplets 
dRG  dimmer of rhamnogalacturonan 
EI  electron impact 
ESI  electrospray 
Et  ethyl 
FAB  fast atom bombardment 
Fig.  Figure 
GalA  galacturonic acid 
GalpA  galactopyranuronic acid 
HG  homogalacturonan 
HMBC  heteronuclear multiple bond correlation 
HPLC  high performance liquid chromatography 
HRMS  high resolution mass spectroscopy 
HSQC  heteronuclear single quantum coherence 
Hz  hertz 
lit.  literature 
m  multiplet 
Me  methyl 
MHz  megahertz 
M.p.  melting point 
MPLC  medium pressure liquid chromatography 
MS  Mass spectroscopy 
MS 4Å  molecular sieves 4 angstrem 
m/z   mass to charge ratio 
NMR  Nuclear magnetic resonance 
NOESY nuclear Overhauser effect spectroscopy  
pH  pondus hydrogenii 
Ph  phenyl 
q  quartet 
ref.  Referenced 
Rƒ   retention factor 
RG  rhamnogalacturonan 
RT  room temperature  
s  singlet 
t  triplet 
TfOH  trifluromethan sulfonic acid 
TMSOTf trimethylsilyl trifluromethane sulfonate 
TLC  thin layer chromatography 
[α]  optical rotation 
  chemical shift 
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